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Allostery is the regulation of protein function from a remote non-active binding site. Ligand
binding incites a rapid process whereby information travels signiﬁcant biomolecular distances
to enact energetic changes to the the protein’s functional centre. Despite the demonstrated
importance of protein allostery in maintaining cellular homeostasis, investigating the mecha-
nisms over the molecular temporal and spatial scales remains a challenge.
Fructose 1,6-bisphosphate (FBP) activates pyruvate kinase M2 (PKM2) through a well-described
feed-forward process in glycolysis. Less understood, however, is how allosteric regulation of
PKM2 occurs on a molecular level. Moreover, as several amino acids can compete for an
additional binding site, it has thus far been unclear how concurrently bound ligands control
PKM2 catalysis.
This thesis shows that, in a panel of cancer cell lines, the intracellular concentration of FBP
exceeds that which is required to fully saturate binding to PKM2. Moreover, PKM2 is ex-
posed to a dynamic concentration range of amino acids including the activator L-serine (Ser)
and the inhibitor L-phenylalanine (Phe). When FBP is constitutively bound, Ser and Phe
competitively regulate the maximal velocity of the PKM2-catalysed reaction, independent
from changes to the protein’s oligomeric state. To investigate the molecular determinants of
multi-ligand regulation, a novel computational method AlloHubMat is developed and applied
towards the analyses of molecular dynamics simulations of PKM2, identifying a number of
’allosteric hub’ residues. A selection of the allosteric hub residues are mutated and an integra-
tive approach is used to elucidate their impact on FBP- and Phe-mediated regulation of PKM2.
The ﬁndings herein demonstrate a role for residues involved in FBP-induced allostery in en-
abling the integration of allosteric input from Phe and reveal a mechanism that underlies the
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1.1 Enzyme catalysts are required to sustain cellular life
Life on earth is dependent on the chemical synthesis of molecules, which constitute the build-
ing blocks of cellular organisms. Early proto-organisms had to adopt a way in which they
could ensure a constant nutrient supply, without which life would be unlikely to persist on
geological time scales. The selective pressure for auxotropy witnessed the emergence of es-
sential chemical reactions that convert naturally available nutrients into various molecules to
support speciﬁc functions. This included the provision of a wide variety of molecules suitable
for the many complex anabolic and catabolic reactions essential for the support of organismic
growth and division such as sugars, lipids, nucleotides and amino acids. The ability to perform
chemical synthesis is achieved through pathways of sequential reactions collectively known as
metabolism, and subsequently rendered organisms non-reliant on speciﬁc geochemical condi-
tions enabling them to colonise a diversity array of ecological niches.
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1.1.1 The evolutionary emergence of biological catalysts
Metabolism can be viewed as a network of inter-connected chemical reactions, whose topolog-
ical features are largely conserved in all studied organisms. Two important inferences can be
drawn from the highly conserved nature of metabolic reactions: (i) metabolic networks likely
reached a state of eﬃciency very early on in evolutionary time scales that could barely be im-
proved further by natural selection, and (ii) all present forms of metabolism likely descend from
the same original network1. These conclusions give rise to the hypothesis, originally proposed
by Aleksandr Oparin in his 1938 book ’The Origin of Life’2, that a common metabolic network
topology dates back to non-enzymatic chemistry in the presence of simple inorganic ions as
found in the highly reducing geochemical environment that made up the Archaen sediment.
Indeed, metabolic intermediates of two pathways in central carbon metabolism - glycolysis and
the pentose phosphate pathway (PPP) - were shown to undergo non-enzymatic interconver-
sion in chemical compositions replicating the pre-biotoic Archaen ocean3. Additionally, ions
that were abundant in the Archaean sediment, such as Fe2+ and PO3−, can catalyse reactions
which are reminiscent of the modern PPP, suggesting that modern metabolic reactions did not
necessarily result from the evolutionary selection of complex enzyme catalysts, but rather that
such reactions were able to proceed under prevailing chemical conditions in the Archaean sea4.
Small molecules such as metal ions can eﬃciently catalyse many chemical reactions. Sev-
eral constraints on biological systems, however, render their utility insuﬃcient for supporting
complex cellular life per se. Many metal ion catalysts found at high concentrations in the Ar-
chaean ocean, do not accumulate to suﬃcient concentrations in modern biological conditions,
such that they can function as eﬃcient catalysts. For example, ferrous iron is readily water
soluble in the absence of oxygen, and anoxic conditions in the earth’s early surface environ-
ment resulted in the Archaean milieu preserving a high iron content, whereas its oxidised form
was readily depleted upon the great oxygenation event5. This likely imposed a strong selection
pressure for species to evolve their metabolism, becoming less dependent on the presence of
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increasingly rare and/or insoluble molecules, eventually leading to the emergence of macro-
molecular catalysts.
The RNA world hypothesis provides a conceptual framework whereby the emergence of ge-
netic selection can be explained by RNA molecules acting as self-replicators, thereby unifying
heritability and the propensity for stochastic evolution6. Indeed, RNA molecules have been
used in directed evolution experiments and, in a milestone paper, Lincoln and Joyce (2009)7
presented an experimentally designed in vitro self-replicating RNA enzyme. Nevertheless, the
ability for RNA enzymes to catalyse reactions, other than phosphoester cleavage or ligation,
is limited. The design of an RNA enzyme by Fusz et al. (2005)8 that could act as an in-
termolecular catalyst of the aldol reaction was found to be Zn2+-dependent. Peptides can
also bind to metal ions, and simple metal-binding RNA or peptide structures could provide
the starting point for positive selection by supporting multiple reactions, and would have pre-
vented the loss of low concentrations of metal ions through diﬀusion and/or precipitation4. A
likely consequence of non-enzymatic metabolism was that early enzyme and RNA catalysts
were able to evolve in the background of non-speciﬁc metal ion-catalysed reactions. To avoid
the production of superoxide from hydrogen peroxide by ferrous iron, modern cells evolved a
complex iron transport mechanism to prevent accumulation of ferrous iron in the cytoplasm9.
Subsequently, peptide and RNA secondary structures would have increased the aﬃnity for
some substrates, facilitating access to the retained metal catalyst, giving rise to early enzymes.
A dynamic chemical system operating at typical biological rates, with all intermediates at
concentrations in the nanomolar to millimolar range, can be constructed only by use of ef-
ﬁcient catalysts. The emergence of enzyme catalysts enabled metabolism to cope with the
high demand for biomass, necessary to sustain the requirements of cellular organisms (Fig.
1.1). Enzymes can achieve unrivalled substrate speciﬁcity due to their complex protein folds
and can distinguish between very similar compounds, which prevents the progression of un-
desirable side-reactions4. In addition to greater ﬁdelity, the phenomenon of enzyme substrate
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speciﬁcity frequently results in the binding of metabolites, which closely resemble the natu-
ral substrate, to the active site of the enzyme, resulting in a steric preclusion of the natural
substrate from the catalytic site. This phenomenon manifests as competitive inhibition, and
provides an example of how the kinetic properties of enzyme catalysts can be reversibly regu-
lated. Compared to small-molecule catalysts, whose catalytic activity is not readily regulated,
the complex three-dimensional structure of enzymes houses pockets which allow metabolites
and other small molecules to bind and regulate enzyme activity. The implications of enzyme
regulation for metabolism are discussed in the following section.
Figure 1.1: Biological catalysts. An illustration of the structural complexity of small molecule
catalysts, ribozymes and enzymes, and their advantages and limitations.
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1.1.2 Metabolic homeostasis is maintained by allosteric regulation
The in vivo capacity of an enzyme to realise a particular catalytic ﬂux, at steady-state, is
determined by its abundance and kinetic properties. Enzyme abundance can be regulated by
gene expression, whereas the kinetic properties of enzyme-catalysed reactions are regulated
post-translationally through covalent modiﬁcations under the control of signalling pathways
and via interactions of enzymes with small molecules. The average concentration of a metabo-
lite in central carbon metabolism is of the order of 1 mM, while glycolytic ﬂux varies between
0.1 and 0.3 (mM· s−1).10 Assuming steady-state conditions, where the rate of metabolite
production is approximately equal to the rate of consumption, the rate of turnover of the pool








where P is the pool size, v is ﬂux and t is time. The turnover time of metabolites in gly-
colysis therefore has an approximate range in mammalian cells between 2.8 s and 0.93 s. A
quantitative model of time-dependent gene expression changes in mouse ﬁbroblast cells esti-
mated a median transcription rate of approximately 3 mRNAs per hour and and a median
translation rate of about 140 proteins per mRNA per hour11. Therefore, if the reactions of
metabolite consumption and production are not in balance, the metabolite pool will become
rapidly consumed (or compounded) before gene expression can aﬀect changes to enzyme ac-
tivity by changing expression levels. Uncontrollable ﬂux imbalances in cells would precipitate
an unsustainable biological situation where the metabolite pool would be converted into a
handful of compounds, consistent with the end-products of the most energetically favoured
enzyme-catalysed reactions in the metabolic network. In essence: metabolism cannot aﬀord
to wait for gene expression changes. Instead, the kinetic properties of metabolic enzymes must
be tightly regulated to ensure homeostasis.
Feedback inhibition in metabolism was ﬁrst hypothesised by Novick and Szilard (1950)12,
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when studying the regulation the tryptophan synthesis pathway, and has since been found
in almost every biosynthetic pathway. Computational models of simple metabolic networks
found that product-feedback inhibition enables optimal growth of cells by minimizing futile
cycling and optimizing ﬂuxes13. Goyal et al. (2010)13 showed that, while feedback inhibition
is suﬃcient to control ﬂuxes, the eﬀectiveness of simple product-feedback inhibition comes at
the cost of producing high levels of certain metabolite pools, which would likely cause toxicity
and osmotic imbalance in cells. Large metabolite pool sizes can be restricted if feedback inhi-
bition is ultra-sensitive. In addition to active (orthosteric) sites, complex enzyme structures
present additional allosteric binding pockets to which metabolites and other small molecules
can bind. Subsequent to binding to an allosteric pocket, information can be propagated over
signiﬁcant biomolecular distances to enact changes to the active site, thereby changing the
kinetic properties of the enzyme. This mechanism is known as allosteric regulation and has
the potential to both inhibit and activate enzyme activity on very short temporal scales (typ-
ically in the range of ns to ms), thus providing a highly sensitive regulatory mechanism for
the maintenance of homeostasis.
Tight regulation of enzyme catalysis on short timescales is particularly evident in glycolysis,
where feed-forward and feed-back regulation manifests in rapidly oscillating concentrations
of glycolytic metabolites. This oscillatory behavior of glycolysis was ﬁrst discovered in yeast
cells14. In early investigations, glucose was fed at a continuous rate to yeast cell extracts and
oscillations were observed in the concentrations of glycolytic intermediates with a frequency of
several minutes15. Acute changes to the composition of the extracellular environment also leads
to rapid changes in mammalian cell glycolysis, which can be rationalised by enzyme regulation
on short temporal scales. Empirical evidence for this hypothesis has been provided recently by
studies using ﬂuorescence sensors to monitor the redox balance between nicotinamide adenine
dinucleotide in its oxidised (NAD+) and its reduced (NADH) forms, as representative of the
balance between oxidative and reductive metabolism. Using a genetically-encoded ﬂuorescence
peredox sensor, Hung et al. (2011)16 found that the exchange between cytosolic NADH and
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NAD+ occurred within minutes of acute changes to culture media of mouse neuroblastoma
cells, suggesting that glycolytic ﬂux rapidly reaches the steady-state. Taken together, the rapid
equilibration of cellular metabolites in response to changed extracellular conditions shows that
metabolic homeostasis is maintained on far shorter time scales than can be achieved by gene
expression changes, requiring allosteric regulation of enzyme catalysts.
Due to the importance of allosteric regulation in maintaining homeostatic control of cellu-
lar metabolism, subtle changes to the regulation of metabolic enzymes can result in signiﬁcant
alterations to the phenotype of a cell. This is well exempliﬁed in several disease states in-
cluding cancer, where characteristic changes to central carbon metabolism have been shown
to play essential roles in sustaining rapid growth and proliferation. Some pro-tumorigenic
features of metabolism can be attributed to changes in gene expression, such as oncogenic
mutations in the Ras/Erk pathway resulting in enhanced glucose uptake. Ras-driven over
expression of hexokinase-2 in 3T3 cells was shown to lead to increased rates of glycolytic ﬂux,
thus increasing the rate of turnover of the metabolite pool by up to 30 %10. This introduces
a greater requirement of cancer cells for allosteric regulation of metabolic enzymes, to main-
tain metabolic homeostasis in the context of increased ﬂux. Indeed, many of the changes to
metabolic reprogramming in cancer cells have been linked to altered allosteric regulation of
key metabolic enzymes. Changes to enzyme regulation is further compounded by aberrant
growth factor signalling, which can alter enzyme activity through post-translational covalent
modiﬁcations, and by changes to nutrient availability in the tumour microenvironment, which
can result in changes to intracellular metabolite pools.
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1.2 Metabolite-autonomous allosteric regulation of pyruvate ki-
nase
Mammalian glycolysis involves the conversion of the six-carbon sugar glucose into the three-
carbon keto-acid pyruvate, through a series of ten enzyme-catalysed reactions (Fig. 1.2).
In addition to providing cellular energy in the form of adenosine triphosphate (ATP) and
pyruvate, which can be further oxidised to form acetyl-CoA that enters into the TCA-cycle,
glycolytic intermediates also provide precursors for biomass production. Regulation of gly-
colytic ﬂux plays an important mechanistic role in mammalian physiology, contributing not
only to circulating glucose homeostasis and providing ATP, but also to the provision of biomass
building blocks in contexts such as cell proliferation, immune activation and angiogenesis.
Glucose-utilising pathways are, in turn, coupled to the interconversion of several co-factors
including NAD(P)H that contribute to reduction-oxidation homeostasis.
Regulation of glycolysis is principally achieved through allosteric regulation of several allosteric
enzymes including hexokinase (HK), phosphofructokinase (PFK-1) and pyruvate kinase (PK).
Pyruvate kinase exists as one of four mammalian isoforms (PKM1, PKM2, PKL and PKR), all
of which catalyse the interconversion of PEP and pyruvate in the terminal step of glycolysis.
Diﬀerential splicing produces L- and R-type PK mRNA from the pkl gene. The expression
of PKL is limited to liver and some cells of the pancreas, intestine and kidney, and PKR
is expressed in erythrocytes. The human pkm gene has 12 exons with either the 9th or the
10th alternatively spliced to generate the PKM1 or PKM2 transcripts, respectively. Both the
PKM1 and PKM2 transcripts are identical in length but encode a 56-amino acid region that
diﬀers at 22 residues. This localised diﬀerence in the primary sequence forms an allosteric
pocket in the C-domain of PKM2 to which an activator fructose 1,6-bisphosphate (FBP) can
bind.
In contrast to the M1 isoform, which is thought to be constitutively active in cells17, the
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catalytic activity of PKM2 can be modulated by several endogenous metabolites that bind to
one of two identiﬁed allosteric pockets. Allosteric activators include the up-stream glycolytic
intermediate FBP18; two amino acids L-serine (Ser)19 and L-histidine (His)20; and SAICAR21,
an intermediate in purine synthesis. Conversely, the enzyme activity of PKM2 can be in-
hibited L-tryptophan (Trp)20, L-alanine (Ala)20, L-phenylalanine (Phe)22, a phosphotyrosine
peptide23 and T3 hormone24. Expression of the M2 isoform is dominant in many adult tissues,
and is also expressed in healthy proliferative tissues such as embryonic tissue, lymphocytes
and intestinal epithelial cells25. Additionally, PKM2 is highly expressed in tumour cells26,
and the observation that elevated expression of PKM2 correlates with a poor clinical prog-
nosis27,28 precipitated eﬀorts to inhibit the activity of PKM2 in an attempt to reduce the
elevated glycolytic ﬂux seen in many tumours29,30. A landmark study by Christofk et al.
(2008)26, however, revealed that PKM2 over-expression could promote metabolic adaptations
to nutritional stress in cell culture and increase tumour growth. This led to the prevailing view
that lower PK activity, through the enhanced expression and regulation of the M2 isoform, is
beneﬁcial for anabolic metabolism and thus for cell proliferation and tumour growth25,31–35.
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Figure 1.2: Allosteric regulation of glucose metabolism. PKM2 is allosterically regulated by D-
fructose-1,6-bisphosphate (FBP; an up-stream glycolytic intermediate) and by L-serine (Ser). Increased
glucose uptake results in an accumulation of up-stream glycolytic intermediates. From the current
paradigm it follows that accumulation of FBP leads to enhanced allosteric activation of PKM2, through
a feed-forward mechanism [i]. Decreased serine uptake due to nutrient deprivation results in reduced
binding of serine to PKM2, and hence reduced allosteric activation. This spares glucose carbons for de
novo serine synthesis and one-carbon metabolism.
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1.2.1 Evidence for the involvement of PKM2 regulation in supporting pro-
tumourigenic growth
A number of studies have revealed several mechanisms by which allosteric regulation of PKM2
activity contributes to tumour physiology. Growth-factor signalling pathways have been shown
to play a major role in programming metabolic pathways in cells by mediating acute as well
as long-term changes in cell metabolism. Activation of protein tyrosine-kinases had previously
been shown to result in a decrease in the enzyme activity of PKM2. Christofk et al. (2008)23
elucidated the mechanism by which protein-tyrosine kinases acutely regulate the activity of
PKM2, ﬁnding that aberrant phosphorylation of proteins at tyrosine residues inhibits PKM2
enzyme activity by precipitating the release of the allosteric activator FBP23. To examine
the eﬀect of phosphotyrosine protein binding on FBP-bound PKM2, the authours obtained
a peptide binding motif for PKM2 by screening a phosphotyrosine-enriched peptide library
matrix to identify novel phosphotyrosine (pTyr)-binding proteins from cell lysates. Christofk
et al. then synthesized both the phosphorylated and unphosphorylated versions of the optimal
peptide: P-M2tide (GGAVDDDpYAQFANGG) and NP-M2tide (GGAVDDDYAQFANGG),
respectively for in vitro experimentation resembling the domain of a protein tyrosine-kinase
with the capacity to bind to PKM2. Moreover, PKM2 inhibition via a signalling-induced pro-
tein phosphotyrosine-binding event led to the diversion of glucose carbons away from energy-
producing pathways and into lactate and lipid production23.
Additional environmental conditions associated with the tumour microenvironment such as
hypoxia, matrix detachment and inﬂammation can all lead to excess production of reactive
oxygen species (ROS)36–38, which at suﬃciently high concentrations can damage cellular com-
ponents and compromise cell viability39. In this context, regulation of PKM2 has been shown
to bestow cells with pro-tumourigenic survival advantages. Oxidation of PKM2 at C358 in-
hibits enzyme activity, promoting the utilisation of glucose carbons through the pentose phos-
phate pathway to sustain suﬃcient reducing potential for the detoxiﬁcation of ROS40.
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Allosteric inhibition of PKM2 activity can facilitate the utilisation of glucose carbons for
de novo serine synthesis and one-carbon metabolism. Though generally classiﬁed as a nu-
tritionally dispensable amino acid, serine plays an essential role in a number of metabolic
processes including the synthesis of other amino acids, lipogenesis and methylation reactions
that occur via the generation of S-adenosylmethionine41. Furthermore, the folate cycle, a
serine-catabolising process, can regenerate essential cofactors such as NAD(P)H and ATP.
As tumour growth supersedes its vascular support, uptake of serine becomes necessary for
cancer cell survival. The transfer of human colon cancer cells from culture conditions con-
taining serine to serine-deprived media was found to suppress aerobic glycolysis and enhance
the utilisation of glucose carbons in energy producing metabolic pathways42. The preference
for high-ﬂux aerobic glycolysis in the context of enhanced serine uptake is, in part, driven
by allosteric regulation of PKM2. Serine is an allosteric activator of PKM219, and reduced
activation of PKM2 enables cancer cells to adapt to life under limiting nutrient conditions
by allowing for the accumulation of glycolytic intermediates, which are subsequently diverted
into serine metabolism through phosphoglycerate dehydrogenase (PHGDH). This mechanism
ensures that rapidly proliferating cells to sense and respond to availability of serine, thereby
retaining a reserve pool of an important biosynthetic precursor.
In addition to ﬂuctuations in extracellular concentrations of serine due to limited nutrient
supply in poorly vascularised tumors, serine availability can also be limiting due to en-
hanced activity of enzymes involved in one-carbon metabolism. Rapidly proliferating can-
cer cells demonstrate an enhanced requirement for nucleotides, resulting from DNA replica-
tion stress43. Mitochondrial serine hydroxymethyltransferase 2 (SHMT2) catalyses the con-
version of serine to glycine, while simultaneously hydrolysing tetrahydrofolate (THF) into
5,10-methylenetetrahydrofolate, a co-factor used in purine biosynthesis (Fig. 1.2). An in-
vestigation into the role of serine metabolism within the ischaemic zones of gliomas found
that high SHMT2 facilitates a cross-talk between nucleotide biosynthesis and glycolysis by
sequestering serine, FBP and SAICAR; thereby reducing oxygen consumption and eliciting a
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metabolic state that confers a survival advantage to cells in hypoxic tumor regions44. Fur-
ther in support of this hypothesis, deletion of PKM2 in non-immortalized primary cells from
PKM2-conditional mice45 lead to impaired DNA synthesis and cell cycle progression, result-
ing from severe thymidine depletion46. Limiting nucleotide biosynthesis in PKM2-null cells
could be rescued by supplementation with exogenous thymidine, suggesting that expression
of PKM2, and regulation of its enzyme activity, is required to support DNA synthesis in the
context of exponential cell growth46.
The mechanistic link between low pyruvate kinase activity and cancer cell proliferation pro-
moted drug-discovery eﬀorts, which identiﬁed several small-molecule activators that selectively
target PKM247–49. Exogenous PKM2 activators were found to bind to an allosteric pocket,
distinct from other binding pockets for FBP and amino acids, and resulted in an increased
aﬃnity for the substrate PEP17. An investigation into potential in vivo therapeutic eﬀects of
the PKM2 activators found that the treatment of mice baring H1299 tumour xenografts with
one of the activators Tepp-46, resulted in an inhibition of the xenograft tumors relative to the
vehicle-treated control animals17. Impaired tumour growth was accompanied by decreased lev-
els of serine, lactate and ribose phosphate (an intermediate of the pentose phosphate pathway)
and increased acetyl-CoA, suggesting that activation of PKM2 resulted in metabolic changes
that were incompatible with pro-tumourigenic growth17,50.
Taken together, these observations demonstrate that expression of PKM2 aﬀords cancer cells
the increased metabolic plasticity to respond to varying environmental conditions that a consti-
tutively high or low activity PK enzyme would not readily allow. Nevertheless, the diﬀerential
requirements of cancer cell metabolism, and how this is supported by pyruvate kinase expres-
sion, remain under investigation. Israelsen et al. (2013)45 generated mice with a conditional
allele that abolished PKM2 expression without disrupting PKM1 expression, which were then
crossed with a Brca1 -loss-driven breast cancer mouse model. Intriguingly, mice without expres-
sion of PKM2 showed an accelerated tumour-associated mortality compared to the wild-type
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control, suggesting that expression of PKM2 is not required for cancer cell growth and indeed
its loss may promote tumour progression under certain conditions. Germline PKM2-null mice
were found to spontaneously develop multiple macroscopic liver tumours51. More recently,
Morita et al. (2018)52 reported novel engineered mouse models that express either PKM1 or
PKM2, at protein levels equivalent those found endogenously in tissues. The authors found
that, across numerous cancer models, expression of PKM1 promoted and PKM2 inihibited
tumourigenesis relative to the wild-type control52.
The studies by Israelsen et al. (2013)45, Dayton et al. (2016)51 and Morita et al. (2018)52
highlight a potentially complex relationship between PK expression and cell proliferation. The
use of genetic tools to study the role of a metabolic gene in a complex disease are, however,
limited in by their binary nature (i.e. comparing a phenotype produced by the knock-out of a
single gene with that of wild-type gene expression). In contrast, metabolism, a product of the
complex interaction between many genes and the nutritional environment, constitutes a quan-
titative continuum of phenotypes. Furthermore, spontaneous development of hepatocellular
carcinoma in PKM2−/− models is characterised by the depletion of the nucleotides guanosine
and cytidine51, which may suggest impaired DNA replication resulting from decreased glucose
utilisation in nucleotide biosynthesis. This, in addition to high systemic inﬂammation and
metabolic changes reported by Dayton et al. (2016)51, may explain why the mice develop
tumours in old age.
While the metabolic conditions under which PKM2 exerts pro-tumourigenic eﬀects are con-
troversial, allosteric regulation of PKM2 activity remains an important feature of glycolytic
control. Crucially, expression of the M2 isoform enables cells to undergo dynamic metabolic
changes, which support pro-tumourigenic growth in a number of contexts. Nevertheless, the
ﬁndings presented by Morita et al. (2018)52 suggest that the metabolic outcome of cells may
not necessarily map to a single enzyme activity status, but rather that both enhanced and
decreased pyruvate kinase activity can promote or suppress tumorigenesis, depending on the
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environment and status of all the other genes in the metabolic network53. Therefore, an un-
derstanding of the molecular basis of PKM2 regulation is critical, though this remains largely
elusive both in terms of how conformational changes are induced following the binding of
allosteric ligands and how PKM2 is able to integrate activating and inhibitory signals after
binding to a litany of endogenous allosteric eﬀectors. In this context, the structural and
biophysical aspects of PKM2 regulation are reviewed in the following section.
26
J.A.S MACPHERSON CHAPTER 1
1.2.2 PKM2 protein structure
Mammalian PKM2 is a homo-tetrameric protein, each protomer containing four structural
domains: the A-, B-, C- and N- domains (Fig. 1.3). The protomers within the tetrameric
assembly of PKM2 are associated with 222 symmetry. The 222 symmetry is exact only for the
A- and C-domains, whereas the B-domains of subunits 1 and 2 are not related to each other by
exact two-fold axes because of their diﬀerent orientations. The A-domain is the largest of the
four, spanning from residues N44 to G116 and P219 to I389, and forms a symmetric α8β8 TIM
barrel. The active site is located within the A-domain, underneath the B-domain cap (Fig.
1.3). The B-domain, consisting of a stretch of residues between P117 and L218 forming eight
antiparallel β-sheets, is mobile and closes on the active site upon binding of the Mg2+-ADP
substrate complex54. The C-domain is composed of residues 390-531 and forms ﬁve α helices
and ﬁve β sheets. A linear sequence diagram showing the positions of the domains is shown in
Fig. 1.4. The two-fold symmetry of the homo-tetramer gives rise to two unique protomeric
interfaces: the A-A’ and the C-C’ interfaces. The A-A’ interface is formed from the A-domains
of two adjacent protomers, consisting of a total of 75 residues with a total surface area of 2.7
nm2. There are an estimated 34 hydrogen bonds and 14 salt-bridges that span across the A-A’
interface forming contacts between the adjacent protomers. The C-C’ interface is less than
half the size of the A-A’ interface, and is formed of the C-domains of two adjacent protomers in
the tetramer assembly, with a total surface area of 1.1 nm2. An estimated 17 hydrogen bonds
and 11 salt-bridges are formed across the C-C’ interface. FBP binds to a pocket within the
C-domain of PKM2 (Fig. 1.3), proximal to the C-C’ interface and forms interactions with
W482, R489, K433, T432, S434, S437, G520 and F52155. The N-domain is composed of the
ﬁrst 46 residues in the protein that form a helix-loop-helix, connected to the A-domain by a
ﬂexible linker between L33 and G46. The N-domain forms an apolar allosteric pocket to which
the small molecule synthetic activators bind, forming contacts with F26, Y390 and L39417.
A number of amino acids competitively binding to an allosteric pocket, which is sandwiched
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Figure 1.3: A cartoon representation of the three-dimensional structure of PKM2. The
tetrameric structure of PKM2 is shown above with subunits 1, 2, 3 and 4 of the homotetramer coloured
in blue, red, orange and green, respectively. The structure of one of the four monomers within the
tetrameric PKM2 complex is shown below. Each PKM2 monomer consists of four structural domains,
which are coloured in the cartoon structure. The N-terminal helix-loop-helix is shown in blue, the A-
domain is shown in grey, the B-domain is shown in red and the C-domain is shown in green. The
C-domain contains the binding pocket for fructose 1,6-bisphosphate, which is shown in an orange space-
fill representation. Locations of the active site, the amino acid binding pocket and the small-molecule
activator binding pocket are indicated.
between the A- and C-domains20 (Fig. 1.3). Co-crystal structures of PKM2 in complex with
either L-histidine (His), L-serine (Ser), L-alanine (Ala), L-tryptophan (Trp) or L-phenylalanine
28
J.A.S MACPHERSON CHAPTER 1
Figure 1.4: A linear sequence diagram of PKM2. The full primary sequence of human PKM2
is annotated with the domain composition and the predicted secondary structure of the protein. The
domain composition of the primary sequence is indicated by coloured bars above the protein sequence;
the N-terminal helix-loop-helix is indicated with a blue bar, the A-domain with a grey bar, the B-domain
with a red bar and the C-domain with a green bar. The predicted secondary structure is shown below
the primary sequence; helices are indicated with cylinders and sheets are indicated with thick arrows.
(Phe), found similar binding poses for each ligand20. All amino acid ligands form charged in-
teractions between their carboxyl-groups and the Nδ group of H464. The diverse side-chain
group chemistry of the amino acid ligands is accommodated by a cavernous pocket at the
interface between the A- and C-domains.
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PDB ID Isoform Ligands† Citation
3SRD M2 FBP,GOL,K,MG,OXL Morgan et al. (2013)22
3U2Z M2 FBP,DZA Anastasiou et al. (2012)17
4JPG M2 FBP Guo et al. (2013)56
4B2D M2 FBP,SER Chaneton et al. (2012)19
4G1N M2 MG,NZT,OXL Kung et al. (2012)50
4RPP M2 FBP Wang et al. (2015)57
4QG8 M2 GOL,K,MG,MLI Wang et al. (2015)57
6B6U M2 B3P,CL,K,MG,OXL,PEG,SCN Srivastava et al. (2017)58
4QGC M2 GOL,K,SO4 Wang et al. (2015)57
4FXF M2 FBP,K,MG,OXL Morgan et al. (2013)22
4QG9 M2 ACT,MG Wang et al. (2015)57
3BJT M2 MG,OXL Christofk et al. (2008)23
1T5A M2 FBP,GOL,K,MG,OXL,PO4 Dombrauckas et al. (2005)55
6GG4 M2 CSO,K,PHE,PO4 Yuan et al. (2018)20
3BJF M2 FBP,K,MG,OXL Christofk et al. (2008)23
4QG6 M2 PRO Wang et al. (2015)57
Table 1.1: Structures of human PKM2 deposited on the Protein Data Bank. †Ligand
acronyms: D-fructose-1,6-bisphosphate (FBP), glycerol (GOL), potassium (K), oxalate (OXL), 1-(2,3-
dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[(4-methoxyphenyl)sulfonyl]piperazine (DZA), L-tartaric acid
(TLA), L-serine (SER), N-(4-[4-(pyrazin-2-yl)piperazin-1-yl]carbonylphenyl)quinoline-8-sulfonamide
(NZT), magnesium (MG), chloride (CL), malonate (MLI), pyruvate (PYR), di(hydroxyethyl)ether
(PEG), L-phenylalanine (PHE), acetate (ACT), sulfate (SO4), phosphate (PO4), S-hydroxycysteine
(CSO), unidentified atom (UNX).
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1.2.3 Kinetics of ligand binding and regulation
Allosteric regulation of PKM2 acts over long distances to aﬀect the aﬃnity of the enzyme
for its substrate phosphoenolpyruvate. The apo-form of the enzyme is reported to have a
Michaelis-Menten constant for PEP (KPEPM ) of approximately 2.0 mM
19,55,59. Activation of
PKM2 by FBP is associated with a decreased KPEPM of 0.2 mM, while the rate of product
turnover (kcat) remains unchanged19,48,55,60. Some studies, however, have additionally re-
ported an elevated kcat subsequent to FBP binding20,22,61 and the reason for this discrepancy
remains unresolved. The KM for adenosine diphosphate (ADP; the second substrate) is re-
ported as approximately 0.4 mM and remains unchanged upon allosteric ligand binding19,55,59.
The reported apparent binding aﬃnity of PKM2 for FBP varies considerably between 210
nM62 and 7.6 µM22. Curiously, isothermal titration calorimetry measurements of FBP binding
by Yan et al. (2016)62 found a sub-stoichiometric association of FBP with PKM2, evidenced
by an estimated 0.54 binding sites per PKM2 monomer, despite a reported 1.0 stoichiom-
etry found in several FBP-bound PKM2 crystal structures17,19,23,55. This result could be
explained by the ﬁnding that puriﬁcation of recombinant PKM2 from an E. coli expression
vector is found to have sub-stoichiometric amounts of co-puriﬁed FBP despite extensive dial-
ysis22,23,63, supporting the notion that FBP binds tightly to PKM2.
Several amino acids including Ser, His, Phe, Ala, Trp, Val and Pro have been shown to regu-
late the activity of PKM2, though the reported eﬀects of the amino acids on PKM2 enzyme
kinetic constants vary. Eigenbrodt et al. (1983)64 ﬁrst showed that PKM2 was susceptible to
pronounced activation by Ser and inhibition by Ala, achieved through a positive or negative
eﬀect on the enzyme’s aﬃnity for its substrate PEP. More recently, Chaneton et al. (2012)19
reported the binding mode for Ser in the amino acid allosteric pocket with an apparent aﬃnity
of 810 µM, acting to decrease the KPEPM from 1.9 mM to 0.19 mM in the absence and in the
presence of saturating amounts of Ser, respectively. Taken together, this led to the prevailing
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view that amino acids act as K-type eﬀectors, and that the rate of product turnover does
not change upon ligand binding. Nevertheless, a recent contradictory study, reporting four
co-crystal structures of PKM2 bound to Ser, Phe, Trp or Ala, purported to show that amino
acids have eﬀects on the kcat20.
In addition to the eﬀects of individual ligands on PKM2 activity per se, the multiplicity of
distinct allosteric binding pockets on the surface of PKM2 may facilitate concurrent binding
of ligands. Therefore, changes to PKM2 enzyme activity are exerted through changes in the
concentrations of the metabolite ligands that regulate PKM2. Physical and temporal com-
partmentalisation of these metabolites may necessitate that PKM2 only responds to speciﬁc
stimuli, however, it is likely that at any given time several ligands are available to bind to and
regulate PKM2.
1.2.4 Concurrent regulation of PKM2 activity by multiple ligands
PKM2 can bind to multiple allosteric ligands in vitro that might either reciprocally inﬂuence
each other’s action, or exert independent eﬀects on enzyme activity. Yet, very little is report-
edly known about how PKM2 responds to the simultaneous binding of multiple ligands. A
single-point mutation at the FBP binding pocket S473Y prevents FBP binding, though this
mutant variant can still be activated by Ser19. Conversely, H464A abolishes Ser binding but
can be activated by FBP19, suggesting that Ser activation could work independently from
FBP activation. Inhibitory amino acids that bind to the same pocket as Ser, however, fail
to inhibit enzyme activity in the presence of FBP18,20. The apparent dominant eﬀect of FBP
activation may suggest that inhibition by amino acids is blocked by FBP binding, through
the promotion of an alternate conformation, or that FBP reduces the binding aﬃnities of the
amino acids through a cross-talk between the two binding pockets. Similarly, FBP binding
can overcome the inhibition of PKM2 by T3 by sequestering PKM2 away from the monomeric
species, to which T3 binds24,65.
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An alternative explaination for how PKM2 is able to integrate multiple regulatory ligands
is, rather than a competitive response, through a synergistic response. This might manifest
as two activators (eg. FBP and Ser binding) resulting in supra-activated enzyme activity,
or alternatively, an activator and an inhibitor displaying a complex non-competitive kinetic
phenotype. In support of the latter, Ashizawa et al. (1991)65 found that FBP addition altered
the inhibition of PKM2 activity by Ala, producing only a 30 % inhibition compared to a 97
% inhibition of activity in the absence of FBP. Positive synergism has been experimentally
found not to occur between Ser and FBP, and between SAICAR and FBP19,21. Interestingly,
Zhong et al. (2017)66 recently reported that adenosine monophosphate (AMP) and glucose-6-
phosphate (G6P) synergistically activate M. tuberculosis pyruvate kinase. The authors found
that binding of G6P increased the apparent aﬃnity of the protein for AMP, and conversely,
that AMP binding increased the binding aﬃnity of G6P66. While the binding of AMP occurs
at a pocket equivalent to that of human PKM2 for FBP, G6P binds to a diﬀerent pocket
that is also distinct from the equivalent amino acid interaction site on human PKM2, and it
is intriguing to speculate whether a similar cooperative mechanism occurs between FBP and
amino acid binding to human PKM2. Moreover, a recent modelling study purportedly found
a synergistic eﬀect of concurrent FBP and Ser binding67. The authors performed molecular
dynamics simulations of monomeric PKM2 and found that the predicted free energy of bind-
ing to the substrate PEP changed from -48 kJ/mol (either FBP or Ser bound) to -57 kJ/mol
(FBP and Ser). Nevertheless, the free energies reported by Yang et al. (2016)67 translate into
a substrate binding aﬃnity of between 10−42 M−1 and 10−35 M−1 - a very signiﬁcant departure
from the reported experimental substrate aﬃnity of 1.5 mM. The question of whether binding
of allosteric ligands promotes a synergistic eﬀect, therefore, remains unresolved.
The problem of how PKM2 is concurrently regulated is particularly pertinent in an intra-
cellular context, where multiple allosteric ligands co-exist at varying concentrations and bind
to PKM2 with a range of aﬃnities. Notably, the intracellular concentrations of the PK cat-
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alytic substrate PEP measured in human colorectal carcinoma cells is less than 10 µM and
only accumulates to 80 µM upon stable silencing of both PKM1 and PKM2 expression19. Low
intracellular substrate concentrations suggest that the substrate is limiting for the catalysed
conversion into pyruvate. Moreover, the intracellular concentration of FBP has been reported
as ≃ 0.5 mM across a panel of cancer cell lines68, which would represent a 2500-fold excess
relative to the reported 200 nM binding aﬃnity to PKM262. Taken together, evidence from the
existing literature suggests that concurrent binding of multiple allosteric ligands may be feasi-
ble under certain cellular metabolic conditions, and that there is a selective pressure towards
a signiﬁcant fraction of PKM2 remaining constitutively bound to FBP in order to sustain ﬂux
through the PK reaction, which is reported to be high relative to other rate-limiting enzymes
in glycolysis69. Therefore, the interaction between PKM2 and its various allosteric ligands
warrants further investigation in order to discern the detailed molecular mechanisms involved
in the regulation of this complex glycolytic node, with roles in supporting cancer cell prolifer-
ation.
Question 1: To what extent do cellular metabolic conditions exist under which PKM2
is likely to be bound to multiple allosteric eﬀectors? And how are the eﬀects of concur-
rently bound ligands, with opposing functional signals, integrated by PKM2 to regulate
enzyme catalysis?
1.2.5 Regulation of PKM2 structure and oligomerisation
PKM2 molecules form in an equilibrium of monomers and tetramers, with some studies re-
porting the existence of dimers62,63,70, in which the tetramer has high enzymatic activity
whereas monomers and dimers display basal activity71. Many of the PKM2 allosteric lig-
ands have been shown to modulate PKM2 activity by changing the equilibrium between the
monomer, dimer and tetramer. The binding of FBP promotes, whereas T3 prevents, tetrameri-
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sation17,22,62,63,71. The eﬀect of amino acids on the monomer-dimer-tetramer equilibrium,
however, remains controversial. Some reports suggest that Ala promotes the formation of
inactive PKM2 dimers18,70, whereas others have shown that inhibition by Phe, Ala and Trp
stabilises an inactive T-state tetramer by forming hydrogen bonds with the carbonyl oxygen
atom from R43, and thus repelling the N-terminal helix-loop-helix20,22.
In addition to ligand-dependent oligomerization, evidence suggests that allosteric ligand bind-
ing promotes subtle conformational changes within the tetramer. Crystal structures of L.
mexicana and T. cruzi pyruvate kinase isoforms revealed a rigid-body rocking motion of the
A- and C-domains, reorienting them within the tetramer, in the T- to R-state transition72–74.
Hydrogen-deuterium exchange experiments reported an increase in global ﬂexibility in E. coli
type 1 pyruvate kinase upon binding of FBP, and proposed that destabilisation of β-strands
within the TIM-barrel core resulted from ligand binding75. Further attempts to gain insights
into the dynamic mechanism of human PKM2 and M. tuberculosis pyruvate kinase regulation,
found that allosteric activator binding causes R342 on the Aα6-helix to reach across the A-A’
interface of the tetramer, forming a stabilising hydrogen bound with the backbone carbonyl
group of G271 on the adjacent protomer22,66.
Ligand-induced conformational changes are likely to be limited to subtle backbone changes
and side-chain motions, evidenced by the lack of FBP-driven changes to the radius of gyration
of human PKM2 tetramers in small-angle X-ray scattering experiments62. A whole-protein
mutagenesis study of the human liver isoform of pyruvate kinase (PKL) reported by Tan and
Fenton (2017)76, found that approximately 30 % of residues, when mutated to alanine, per-
turbed allosteric activation by FBP. The authors concluded that a signiﬁcant proportion of
the protein contributes to allosteric regulation. In the same study, Tan and Fenton (2017)76
found that perturbing mutations were dispersed across the structure, rather than localised to
domain-domain boundaries, suggesting that large scale domain reorientations are not exclusive
to the allosteric mechanism of PKL.
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The relative contributions of tetramerisation and local structural changes to the mechanism of
allosteric activation is disputed. Molecular dynamics simulations of human PKM2 and L. mex-
icana pyruvate kinase have revealed that allosteric activation by D-fructose-1,6-bisphosphate
(human) and D-fructose-2,6-bisphosphate (L. mexicana) result in the closure of the B-domain
over the active site74,77, consistent with ﬂexible A/ B - inter-domain motions reported in the
crystal structure55,58. The observation by Gehrig et al. (2017)77 that FBP binding reca-
pitulates some of the experimentally described dynamic changes to the structure, within the
monomeric species, argues that the allosteric content of the protein is encapsulated within
the protomeric unit. Christofk et al. (2008)23 published the ﬁrst atomic structure of human
PKM2 in the apo-form, showing that ligand binding is not required for tetramer formation.
It is not clear, however, whether apo-tetramer formation is an artefact of the high protein
concentration used for crystallisation (80 mg/mL), as polymer self-assembly is inherently a
concentration-dependent process. Moreover, PKM2 has been shown to form a mixture of
oligomeric states, in solution22 and in the gas phase63, though since FBP is known to remain
bound to preparations of puriﬁed recombinant PKM2, and it is unclear whether the observed
tetramers are simply a result of residual FBP.
The apparent dichotomy between protomer-speciﬁc conformational and oligomeric eﬀects of
allosteric ligand binding on PKM2 activation raises important and fundamental questions
about the structural basis of its regulation. In addition to allosteric eﬀectors, covalent post-
translational modiﬁcations (PTMs) have been suggested to inﬂuence the oligomerisation of
PKM2 protomers23,40, although the eﬀects of PTMs on the enzyme mechanism remain elu-
sive. Nevertheless, PKM2 activity in cells is frequently inferred from the oligomeric state that
the protein is found to adopt17,26,40,78–82. Collectively, current evidence suggests that a link
between enzyme activity and the oligomeric state exists and, while not well understood, it
may play a role in PKM2 regulation.
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Question 2: What are the contributions of ligand-induced conformational and
oligomeric changes to PKM2, and what are the relationships between these allosteric
eﬀects and PKM2 activity?
Many of the current insights into metabolic dependencies in cancer are derived from anal-
yses of developed tumours and so it is unclear whether observed metabolic changes reﬂect
late adaptive events, or a cumulative agglomeration of metabolic adaptations that have been
gradually emerging depending on the needs of cancer cells along the various stages of tumour
development83. Nevertheless, PKM2, and other allosterically regulated metabolic proteins
with roles in disease progression, show that genome-encoded and therefore stably propagated
metabolic changes in tumourigenesis are potentiated through protein allostery83. Therefore,
metabolic ﬂexibility may confer advantages suitable for surviving the varying extracellular con-
ditions cancer cells are subjected to during tumourigenesis, so tools that aid the identiﬁcation
of such mechanisms could hold signiﬁcant power for discovery.
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1.3 Investigating the role of protein dynamics in allosteric reg-
ulation
Characterising allosteric mechanisms of enzyme regulation oﬀers several advantages for thera-
peutic interference with the metabolism of cancer cells. Despite the importance of allostery in
regulating numerous aspects of cellular physiology, the investigation of the underlying mech-
anisms remains a challenge for conventional structural approaches and therefore necessitates
multi-disciplinary strategies. A critical obstacle in characterising protein allosteric mecha-
nisms is the inherent ﬂexibility of protein structures, which can result in the emergence of
latent allosteric pockets84,85. Once an allosteric pocket has been identiﬁed, understanding
how information is propagated the active site is confounded by the involvement of protein
structural motions on a variety of time scales86. Furthermore, as exempliﬁed in the case of
PKM2, many proteins contain several allosteric pockets that facilitate the simultaneous bind-
ing of several ligands. Concurrent binding of multiple allosteric ligands can modulate the
functional response of a protein through the action of multiple allosteric pathways87. It re-
mains unclear, however, whether such allosteric pathways operate independently, or integrate,
either synergistically or antagonistically, to control protein function.
1.3.1 Enzyme regulation can involve structural or vibrational motions
Static model representations of proteins are so prevalent that it is easy to misconstrue these
dynamic machines for rigid aperiodic crystals. In addition to the process of protein-folding
where a protein reaches its native state through a funnel of energetic intermediates (Fig.
1.5 A), folded proteins are soft materials with a complexity, due to the absence of periodicity
conditions, forcing the macromolecule to assume a single unique structure. Folded proteins can
adopt a variety of diﬀerent structural and energetic conﬁgurations that give rise to an ensemble
of isoenergetic ground states, referred to here as conformational sub-states (Fig. 1.5 B). The
amplitudes of the structural motions are determined by the physical and chemical nature of
the transient bonded interactions that are broken and made in the transitions between sub-
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states, and are characterised by a hierarchy of vibrational and conﬁgurational motions (Fig.
1.5 B).
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Figure 1.5: The energetic landscape of protein folding and native protein dynamics. (A) A
cartoon representation of the energetic landscape of protein folding. (B) The native state of a protein
consists of an ensemble of conformations, which are termed conformational sub-states. The transitions
between conformational sub-states are characterised by a hierarchy of protein dynamics including (i)
side-chain motions, (ii) protein backbone conformational changes, (iii) secondary structural changes
(iv) inter-domain motions and (v) oligomerisation of multi-meric proteins. Each respective motion
necessitates that the protein overcomes energy barriers, the heights of which are determined by the free
energy required for a specified motion.
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Initial evidence for conformational sub-states of a protein came in the early 1970s from mea-
surements of the rate of carbon monoxide (CO) re-association to the heme centre of myoglobin
(Mb) following photolysis88–90. The ﬁrst crystal structures published in 1960 by Kendrew et
al. (1960)91 had shown that Mb does not have a permanent channel through which CO can
exit, suggesting that the exit must proceed through a transient channel caused by dynamic
ﬂuctuations of the protein. It was therefore hypothesised that the study of ligand escape
from its binding to the heme centre as a function of external parameters such as temperature,
pressure and solvent viscosity, would yield information on the ﬂuctuations that underpin the
protein dynamics of myoglobin92.
In a seminal paper by Austin et al. (1975)90 the Mb-CO bonded interaction was photol-
ysed with a laser pulse, allowing the CO ligand to migrate within the protein and then ﬁnally
escape into the bulk solvent. The rate of CO exit (kexit) determined over a range of tempera-
tures is plotted in Fig. 1.6, along with typical rate constants of ﬂuctuations of bulk solvent
(kβ) and ﬂuctuations of the ﬁrst hydration shell of a solvated protein (kα). While the rate of
ﬂuctuations in the bulk solvent were found to follow the Arrhenius law, kα and kexit become
non-exponential at temperatures T < 220K. This revealed the existence of a glassy state
adopted by proteins at very low temperatures, in the absence of protein conformational ﬂexi-
bility. Protein ﬂexibility was found to be restored around 220 K, allowing for an exponential
rate of reversible binding of the CO ligand to the heme centre of Mb. The transition of solvated
proteins from a glass-like to a soft-matter is thought to be coupled with interactions between
the protein and hydration water in the ﬁrst solvation shell. This explains the observation
that the rate of ﬂuctuations of the solvation shell (kα) undergoes a similar non-exponential to
exponential transition around 220 K, as does the rate of CO exit from myoglobin. Subsequent
experiments measuring the rate of CO exit under varying solvent compositions, found that
the protein must overcome distinct free energy barriers as the CO moves within the protein
towards its binding site, providing the ﬁrst evidence for a hierarchy of protein dynamical
motions88–90. This theory implied that a molecular system of N components (amino acids)
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Figure 1.6: Typical rate coefficients as a function of temperature. The rate constant kβ rate
of fluctuations in the bulk solvent, kα is the rate constant of fluctuations in the first hydration shell
and kexit is the rate constant of CO exit from myoglobin. All rate constants are determined over a
range of temperatures. This figure is reproduced from Figure 4 in Frauenfelder et al. (2007)93.
has approximately eN states with energies close to that of the ground state and experiences
sizeable ﬂuctuations in its internal energy.
Experimental evidence for the existence of multiple protein sub-states prompted the inves-
tigation of the structural-basis of protein dynamics by temperature-dependent X-ray crystal-
lography. Two consecutive papers by Artymiuk et al. (1979)94 and by Frauenfelder et al.
(1979)95 provided the ﬁrst direct experimental evidence for the notion that protein adopt
dynamic structures. In the former publication, authors computed the mean-squared displace-
ment of backbone atoms within human lysozyme and found that the residue displacements
constitute a characteristic rigid-body motion94. Displacements were found to be smaller within
the core of the protein and greater on solvent-exposed loops of both lysozyme and myoglobin,
due to charge ﬂuctuations in the solvent and the hydration shell94. Moreover, Artymiuk et al.
(1979)94 found that the catalytic pocket underwent a signiﬁcant conformational change upon
substrate binding, concluding that "...protein mobility may play a signiﬁcant part in biological
activity...".
Allostery had originated from experiments performed by Changeux and co-workers96–98, and
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for decades the two dominant models for allostery were the ’sequential’, or KNF (Koshland-
Nemethy-Filmer) model99 and the ’symmetric’ or MWC (Monod-Wyman-Changeux) model98,
both of which still contribute to the abstraction of complex allosteric mechanisms100. The two
essential features of the MWC model were that an equilibrium was proposed to exist between
two conformational states, usually known as the R (’relaxed’) and T (’tense’) states, in the
absence of any ligand, and that symmetry is maintained, so that all subunits in a oligomeric
protein change between the R and the T states in a concerted manner101. Conversely, the
sequential model did not require conformational symmetry but instead necessitated a strict
application of induced ﬁt, with one conformation existing only when the ligand is not bound101.
While both the MWC and KNF models agreed on the importance of structural transitions
between two pre-deﬁned conformational states whole equilibrium was shifted by the binding of
a ligand, both were phenomenological and consequently did not answer the fundamental ques-
tion of how the binding of a ligand potentiated an allosteric eﬀect at an atomic level of detail102.
The subsequent accessibility of experimental methods capable of determining protein struc-
ture gave rise a stereochemical model of allostery, ﬁrst proposed by Max Perutz, whereby
allostery could be understood in terms of structural changes that could be gleaned through an
inspection of high-resolution structures of proteins in the apo and holo states. In this model,
oxygen binding to the T-state triggers the movement of the ferrous iron into the heme plane,
realignment of the neighbouring helices and breakage of of inter-subunit salt bridges, thereby
shifting the quarternary equilibrium toward the R conformation103. The elucidation of the
initial structures of haemoglobin in two forms (the T- and R-forms) supported the notion that
allostery as a general phenomenon might be understood, perhaps in all systems, if only the
structures of the allosteric states and the transitions between those states could be determined.
Nevertheless, crystal structures are limited in that they provide only a limited snapshot of a
single consensus conformational state.
Moreover, despite the fact that plots of estimated mean-square ﬂuctuations versus residue
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number remain a standard part of the analysis of high-resolution structures, the contribution
of overall translation and rotation as well as crystal disorder to B-factors, continues to be a
source for concern in their interpretation104. It was understood that the best means to study
the structural basis of cooperativity displayed by haemoglobin, and other allosteric proteins,
was to have available a way of calculating the energy of the protein as a function of the atomic
positions. To this end, Gelin and Karplus developed a method for calculating the side-chain
potentials of bovine peptide tripsin inhibitor (BPTI) using an empirical energy function105.
The same approach was applied towards calculating the forces on the atoms of haemogloblin
for the minimisation of its energy in response to ligand binding on the heme group106, provid-
ing the ﬁrst comprehensive description of distal side-chain motions involved in the transition.
Next, Karplus and co-workers used the forces computed from an empirical potential energy
function in Newton’s equation to simulate protein dynamics, which came to be known as
molecular dynamics (MD) simulations. MD simulation methods had already been developed,
prior to the 1970s, for simpler systems such as liquid argon with a soft-sphere (Lennard-Jones)
potential107, followed by simulations of complex ﬂuids108. The ﬁrst MD simulation of bovine
peptide tripsin inhibitor (BPTI) in vacuo performed by McCammon et al. (1977)109, made
clear that proteins are relatively soft polymers and, consequently, have signiﬁcant structural
ﬂuctuations at room temperature; i.e., the static view of the structure of biomolecules had to
be replaced by a dynamic picture.
While allosteric transitions are often accompanied by structural changes, long-range com-
munication between sites can also be mediated by changes in dynamic ﬂuctuations about the
mean conformational state (ie. in the absence of structural changes), which are driven by
entropic changes in the protein. Dryden and Cooper (1984)110 ﬁrst proposed that an allosteric
eﬀector may simply change the broadness of the free energy basin of the protein conforma-
tional state, rather than shifting the basin to a distinctly diﬀerent region. This provided a
plausible model for an entropy-driven allosteric mechanism, in the absence of stereochemical
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conformational changes. Entropy-driven allosteric mechanisms have since been experimen-
tally described. Popovych et al. (2006)111 characterised the negatively cooperative binding of
cAMP to dimeric catabolite activator protein (CAP). Two cAMP molecules bind to dimeric
CAP with negative cooperativity and function as allosteric eﬀectors by increasing the pro-
tein’s aﬃnity for DNA. The authors showed that the binding of the ﬁrst cAMP molecule
had minimal eﬀects on the conformation of the second cAMP binding site, but rather that
distinct change in protein motions between the two sequential cAMP binding steps results in
a large diﬀerence in conformational entropy111. This showed that allostery can be mediated
exclusively by vibrational changes, rather than large-scale conformational changes.
1.3.2 Allostery is an ensemble phenomenon
Just as protein folding can be viewed as a landscape of possible conformational states surround-
ing the native (free energy minimum) state, a folded protein has an ensemble of conformational
sub-states. According to this statistical framework, all possible conformations of a protein are
populated within the ensemble according to their free energies. The free energy landscape of
a folded protein can be smooth with many accessible states, rough with only a few states, or
somewhere in between112. Allosteric ligands can eﬀectively remodel the energy landscape of
proteins, manifesting as enthalpic and/or entropic redistributions within the available conﬁgu-
rational space. Therefore, protein function is not determined purely by its static structure but
rather through a redistribution of already existing populations in response to ligand binding.
The energy landscape of a folded protein contains a plurality of functional mechanisms and,
as such, sub-states within the ensemble can be partitioned into conﬁgurations that account
for the active and inactive states of the enzyme. Nevertheless, investigating the relationships
between protein dynamics, activity and structure is hampered by the diﬃculty in observ-
ing all three characteristics simultaneously. A landmark study by Volkman et al. (2001)113,
used nuclear magnetic resonance (NMR) spectroscopy to correlate the structural states of
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the nitrogen regulatory protein C (NtrC) and its interconversion dynamics directly with its
biochemical activity. Phosphorylation of NtrC causes the displacement of several structural
elements resulting in the exposure of a hydrophobic patch on one side of the molecule, enabling
NtrC dimers to self-associate to form oligomers that regulate the transcriptional activity of
a number of genes involved in nitrogen metabolism in enteric bacteria. In order to probe µs
- ms time-scale dynamics, Volkman et al. (2001)113 measured the chemical shifts of protein
backbone atoms and found that the dynamics of various NtrC mutants correlated with their
activity, supporting the idea of a population shift between two pre-existing conformations.
The propensity of an allosteric transition to stabilise a particular sub-state within the con-
formational landscape, and hence the probability that a protein will exert a given function,
is determined by the free energy barrier between the diﬀerent sub-states. Indeed, within the
boundaries of the protein’s primary sequence, the free energy between all of the accessible sub-
states constrains the landscape of a protein and encodes the structure and function. Yao et al.
(2008)114 used solution NMR measurements to quantify the free energy of the light-sensitive
LOV2 (light, oxygen and voltage) domain-Jα-helix binding equilibrium following light stimu-
lation. Blue light absorption of the LOV domain induces the formation of a covalent adduct
between a conserved cysteine residue in the LOV domain and the C4a carbon of the isoallox-
azine ring of FMN, leading to a light-dependent enhancement of phototropin kinase activity.
Yao et al. (2008)114 found that this light-sensitive switch is mediated by an equilibrium be-
tween two conformations, determined by the positioning of the Jα helix between a bound
conformation (dark; inactive) and a dissociated state (lit; active). NMR relaxation experi-
ments found that photo-excitation resulted in a redistribution between the bound-dissociated
Jα equilibrium from 98:2 in the dark state to 9:91 in the light state, with an associated free
energy diﬀerence of 3.8 kcal mol−1. The authors noted that the free energy barrier of the
allosteric transition was small relative to the energy of the blue light photons being absorbed
by the ﬂavin chromophore (≃ 64 kcal mol−1). Thus, the bonded and non-bonded interactions
that make up the protein core fold are generally modest, suggesting that no single state will
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necessarily dominate the ensemble. As such allosteric mechanisms are likely to be controlled
by statistical equilibria and less deterministic than was suggested by classical discrete-state
models.
As exempliﬁed by NtrC and LOV2, allosteric regulation of proteins can involve transitions
between sub-states with unique physical and biochemical properties. Therefore, the role that
structural dynamics of a protein play in biological processes can only be understood by char-
acterizing all thermally accessible protein conformations and their populations. Since the free
energy landscape of a folded protein contains many conformational sub-states, any macro-
molecular observable A can be described as an ensemble average over microscopic sub-states
given by:





where xλ is the sub-state of the λth member of the ensemble. In reality, experimental mea-
surements are made only on a single system and all the microscopic detailed motion is present.
As such, one observes an averaged observable over time of the detailed motion, which sup-
presses the microscopic details. Thus, the time average and the ensemble average should be
equivalent:







It is often straightforward to determine 〈a〉 from an experiment, while the underlying distribu-
tion of a(x) is experimentally inaccessible since the experiment is a time- and ensemble-average
over molecular conformations115. A common approach to dynamic interpretation of NMR re-
laxation experimental data is to use NOE data and s2 order-parameters as constraints for
molecular dynamics simulations to simulate a conformational ensemble in agreement with ex-
perimental data116. Such approaches are limited in their application due to complications in
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performing measurements in a suﬃciently diverse combination of alignment media117. Never-
theless, molecular dynamics simulations can provide a direct sampling of microscopic sub-states
a(x) and, as such, present a powerful tool for investigating allosteric transitions of proteins.
1.3.3 Identification of allosteric pathways from molecular dynamics simu-
lations
Empirical evidence suggests that subsequent to ligand binding to an allosteric site, a network
of residues mediates the communication between the allosteric site and the functional centre
of the protein (catalytic pocket in the case of enzymes). Communication across the protein,
through so-called allosteric pathways87, is mediated by networks of residues that exhibit spatial
and/or temporal correlations. It was therefore hypothesised that measuring correlated motions
within a protein structure during allosteric transitions, observed from simulated trajectories of
the protein conformational ensemble, would lead to the identiﬁcation of the residues involved
in propagating information along allosteric pathways.
Covariance measurements of residue correlation
Long-range positional correlations were ﬁrst observed in molecular dynamics simulations of
bovine trypsin inhibitor (BTPI) and hen white lysozyme (HEWL) by Huenenberger et al.
(1995)118. The authors measured correlated motions by computing the normalised covariance






where xi and xj are the vectorial positional ﬂuctuations of atoms i and j, respectively. As noted
by Ichiye and Karplus (1991)119 correlations measured of the form in Equ. 1.4 assumes that xi
and xj are co-linear vectors, since Cij depends on the angle between both vectors. Moreover,
the use of the covariance matrix implies a Gaussian approximation of the underlying conﬁg-
urational space density, and therefore this approach treats correlations in a quasi-harmonic
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approximation120. The quasi-harmonic approximation of the Hamiltonian implies that the po-
tential energy surface of a protein is parabolic, which is irreconcilable with empirical ﬁndings
showing that proteins have an ensemble of conformational sub-states (Section 1.3.2).
Mutual information
Rather than measuring co-linear motions, mutual information presents a more physically faith-
ful method for computing correlated motions from protein dynamics. The ﬂuctuations of each
atom are considered to have a given distribution, and the correlations between distributions
are calculated by the joint probability distribution. The ﬂuctuations of two atoms are con-






where p(x) is the canonical ensemble density p(x) = Z−1exp
(
− 1kBT V (x+ 〈r〉)
)
, with par-
tition function Z, temperature T , Boltzmann constant kB, potential energy V and marginal
probability density pi(xi). The idea behind this analysis to calculate those correlations that
violate Equ. 1.5 using the Shannon mutual information:




where H is the entropy of the random variables deﬁned as: H[x] = − ∫ p(x) log p(x) dx.
Focusing on correlations between pairs of atoms:
I[xi,xj] = H[xi] +H[xj]−H[xi,xj] (1.7)
The mutual information between pairs of ﬂuctuating atoms was ﬁrst used by Lange and Grub-
mueller (2006)120 to measure correlated motions from molecular dynamics simulations of the
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B1 domain of G protein and T4 lysozyme. The authors noted that a linear covariant qual-
iﬁcation of the covariance matrix missed more than 50 % of the correlations, attributed to
a dependence on mutual orientations of the atomic ﬂuctuations and non-linear correlations
that emerged in the dynamics120. As such, linear mutual information between distal pro-
tein motions has subsequently emerged as a commonly used method for computed correlated
motions121,122, and is not susceptible to the problematic assumptions of covariance measures
previously highlighted.
Discrete-state mutual information
More recently, the use of mutual information to measure correlated motions that underpin
allosteric communication was further developed by Kleinjung, Fraternali, and co-workers123,124
using a discrete-state formalism for the mutual information calculation. The authors deﬁned
a collection of 24 four-residue fragments, which comprised the so-called M32K25 structural
alphabet125. Each fragment provides a simple and explicit description of four successive Cα
atoms along the backbone of a protein and deﬁned by three internal angles. While limited to
describing positions of Cα atoms, and not considering other ﬁne-grained features of protein
structure, the M32K25 structural alphabet (SA) was eﬀective in encoding the structure of all
experimental protein structures deposited in the Protein Data Bank, and could therefore be
used as a coarse graining method to deﬁne the local orientation of a protein backbone in a
simulated ensemble (Fig. 1.7 A). In this context, the local orientation of a protein backbone
is deﬁned as the vectorial position of successive Cα atoms within a protein structure, which
is discretised into overlapping four-residue long segments. Insofar as the M32K25 SA maps
the vectorial position of successive Cα atoms, and thereby changes to the positions of these
segments that result from simulated or experimentally obtained protein dynamics, the detected
changes are localised to the aﬀected regions of the protein backbone. This makes the analysis
of a molecular dynamics trajectory with the M32K25 SA particularly sensitive to backbone
conformational changes (e.g. secondary structure transitions) and rather insensitive to side-
chain ﬂuctuations. Rather than a vectorial deﬁnition of atomic ﬂuctuation, the discrete-state
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mutual information between locally-encoded fragments was computed in order to determine





where the columns of the structural fragment alignment are given by Ci and Cj , I(Ci;Cj) is
the mutual information, ǫ(Ci;Cj) is the expected ﬁnite size error and H(Ci, Cj) is the joint







where the two columns in the structural alphabet alignment Ci and Cj are random variables
with a joint probability mass function p(ci, cj), and marginal probability mass functions p(ci)
and p(cj). The joint entropy H(Ci, Cj) is deﬁned as
H(Ci;Cj) = −
∑∑
p(ci, cj) log2 p(ci, cj) (1.10)
The discrete mutual information calculated for ﬁnite state probabilities can be signiﬁcantly
aﬀected by random and systematic errors. In order to account for this, an error term ǫ(Ci;Cj)
was subtracted from the mutual information I(Ci;Cj) in Equ. 1.8 given by
ǫ(Ci;Cj) =
B∗CiCj −B∗Ci −B∗Cj + 1
2N
(1.11)
where N is the sample size and B∗CiCj , B
∗
Ci
and B∗Cj are the number of states with non-zero
probabilities for CiCj , Ci and Cj , respectively.
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Figure 1.7: The M32K25 structural alphabet as a fragment-based representation of protein
structure and dynamics. (A) An illustration of the fragment-encoding procedure, whereby a protein
is encoded with the M32K25 structural alphabet. Each sequential four-residue stretch is encoded with
one of 25 fragments, previously defined by Pandini et al. (2010)125. (B) Multiple conformational
snapshots, derived from a molecular dynamics trajectory, are encoded with a string of fragments giving
a multiple sequence alignment of the conformational state of each snapshot in the trajectory. The
mutual information between each fragment in the protein is then determined by calculating the marginal
probabilities and the paired probabilities for each combination of columns in the alignment. This figure
is partially reproduced with permission of Dr. Alessandro Pandini.
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Pandini et al. (2012)123 used the M32K25 structural alphabet to encode the ensemble
of structures calculated from molecular dynamics simulations of the bacterial two-component
system NtrC, as a basis for computing the mutual information between distal fragments in
the protein. The authors found that the transmission from the phosphorylation site to the
signalling surface of the receiver domain NtrC was mediated by a layer of hub residues123.
Moreover, the location of the hubs preferentially connected to the allosteric site was found
to be in close agreement with key residues experimentally identiﬁed as involved in the signal
transmission.
A recent investigation of the allosteric mechanism of a myosin small-molecule activator ome-
camtiv mecarbil (OM) binding to cardiac myosin, used the discrete-state mutual information
approach developed by Pandini et al. (2012)123 to investigate the mechanism of action of
myosin activation. Hashem et al. (2017)126 found that OM binding to an allosteric pocket
both increased coupling of the motions of the converter and lever arm subdomains to the rest of
the protein, and established allosteric communication pathways between the OM binding site
and the functional regions in the U50K subdomain. This case-study, and others123,124,127–130,
demonstrates the utility of discrete-state mutual information as a predictor of allosteric path-
ways.
An important distinction between the method developed by Pandini et al. (2012)123 and
the linear mutual information method developed by Lange and Grubmueller (2006)120, is that
the Pandini et al. method normalises the mutual information between fragments by the com-
bined entropies. Determining the positional entropies of fragment-encoded structures is trivial
with a discrete-state model (see Equ. 1.10), and can therefore easily be computed over each
fragment in the structural alignment. Conversely, the method by Lange and Grubmueller cal-
culates the mutual information in Cartesian space. Therefore, it would be necessary to assume
the quasi-harmonic approximation in order to compute the positional entropy, oﬀsetting the
advantages of mutual information as a statistical framework. Normalising for the combined
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entropy of each combination of fragments has the presumed eﬀect of reducing false-positives
by normalising for random entropic motions, though a robust comparison between the two
methods is lacking. Nevertheless, due to the ease of normalising the correlations for random
thermal ﬂuctuations within a discrete-state model, the method developed by Pandini et al.
(2012)123 holds particular promise for revealing allosteric communication pathways.
Computer simulations of protein dynamics, including molecular dynamics (MD) stochastic
dynamics (SD) and Monte Carlo (MC) simulations, continue to provide a powerful toolbox for
the investigation of allosteric transitions. An ensemble view of protein allostery86 predicates
that proteins sample an ensemble of conformations and that the conﬁgurational landscape is
modiﬁed by allosteric ligand binding. This landscape reconﬁguration is achieved by pathways
of correlated residues, which can be accurately determined by computing the mutual infor-
mation between distal residues. Nevertheless, each minima in the conﬁgurational landscape
accessible to a protein gives rise to unique structural and dynamic properties, and therefore
measurements of correlated motions should account for this sampling of phase space, though
no methods to this end exist. Given the power of trajectory methods for elucidating allosteric
transitions, the present work makes use of molecular dynamics simulations to probe the con-
formational dynamics of PKM2.
Question 3: To what extent can networks of correlated motions, extracted from de-
ﬁned conformational sub-states, be used as a means of predicting protein residues that
propagate the energetic eﬀects of allosteric ligands?
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1.4 Summary of research questions and the contribution of this
thesis
Understanding the molecular basis for how PKM2 catalytic activity is regulated is critical to-
wards investigating its role as a disease target. This thesis follows on from work by Christofk
et al. (2008)26, Anastasiou et al. (2011)40 and Anastasiou et al. (2012)17 detailing how re-
duced PKM2 catalytic activity favours pro-tumorigenic cell growth. The prevailing view that
allosteric regulation of PKM2 promotes its disease-associated functions was subsequently sup-
ported by the a number of compound screens that led to the identiﬁcation of small molecule
activators of PKM2, which were found to alleviate tumour progression by stabilising the highly
active tetrameric form of PKM217. Additional work by Chaneton et al. (2012)19, and oth-
ers, established a cross-talk between glycolysis and de novo serine biosynthesis, orchestrated
by allosteric regulation of PKM2 by serine and SAICAR. Moreover, work by Morgan et al.
(2013)22 and more recently by Yuan et al. (2018)20 found that PKM2 acts as a nutrient
sensor for a number of amino acids, which can activate or inhibit enzyme activity by binding
to a common allosteric pocket. Taken together, these studies led us to hypothesise that the
cellular activity of PKM2 is regulated by numerous allosteric ligands, and that this may be
relevant for metabolic phenotypes associated with cancer cell growth. Allosteric regulation of
PKM2 activity by numerous endogenous ligands may occur either in isolation; or concurrently,
resulting from the multiplicity of distinct allosteric pockets on the surface of PKM2. While
the mechanisms of how PKM2 responds to ligands per se has been carefully investigated, very
little is understood about how PKM2 responds to simultaneous binding of multiple allosteric
eﬀectors with opposing functional signals. This led to the ﬁrst research question: Do cellular
metabolic conditions exist under which PKM2 is likely to be bound to multiple allosteric effec-
tors? And if so, how are the effects of concurrently bound ligands, with opposing functional
signals, integrated by PKM2 to regulate enzyme catalysis? To this end, Chapter 3 investigates
possible functional mechanisms of allosteric regulation by a number of ligands, both alone and
in combination, on PKM2 enzyme activity.
55
J.A.S MACPHERSON CHAPTER 1
Regulation of PKM2 enzyme activity has been suggested to involve oligomeric changes and
possible subtle conformational rearrangements. Early investigations of PKM2 regulation by
Hofmann et al. (1975)70 suggested that the oligomeric structure of the protein can alternate
between lower-order oligomers and tetramers. Subsequent work by Kato et al. (1989)24, Anas-
tasiou et al. (2012)17, Morgan et al. (2013)22 and Yan et al. (2016)62 found that stabilisation of
PKM2 tetramers resulted in high enzyme activity. Nevertheless, the monomer-dimer-tetramer
distribution of PKM2 in the absence of any allosteric ligands, and the subsequent eﬀects of
various ligands on this distribution, is disputed. Moreover, if multiple ligands concurrently reg-
ulate PKM2, under cellular metabolic conditions, the necessary relationship between enzyme
activity and oligomerisation remains to be determined. It may, for example, be the case that
a molecule of PKM2 is bound to both FBP (an activator; reportedly promotes tetramerisa-
tion) and alanine (an inhibitor; reportedly destabilises tetramers). Given the current available
knowledge in the literature, it is unclear how ligands alone, and in combination, determine
the oligomeric state of PKM2, and whether this is linked to the prevailing level of enzyme
activity. This led to the second research question, which will be addressed herein: What are
the contributions of ligand-induced conformational and oligomeric changes to PKM2, and what
are the relationships between these allosteric effects and PKM2 activity? The relationship be-
tween PKM2 activity and its oligomeric state is of greater biological interest given that PKM2
activity in cells is often inferred from the its oligomeric state17,26,40,78,79,81,82. To this end,
Chapter 4 presents an investigation of the oligomeric and structural conformation of PKM2,
and how this changes in response to concurrent allosteric ligand binding, using native mass
spectrometry and ion mobility. Chapter 5 builds on the experimental ﬁndings of the previous
chapter, and presents details about the conformational dynamics of PKM2 in response to al-
losteric regulation, gleaned from molecular dynamics simulations.
The previous ﬁnding by Anastasiou et al. (2012)17 that allosteric activation of PKM2 al-
leviates some of its pro-tumourigenic functions, suggests that genome-encoded, and therefore
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stably propagated, allosteric eﬀects can contribute towards disease progression. Allosteric
pockets are subject to less evolutionary pressure and hence are more sequence variable than
orthosteric sites131, aﬀording exogenous allosteric ligands greater target speciﬁcity. Therefore,
methods which [i] identify putative allosteric pockets and [ii] elucidate networks of protein
residues involved in the propagation of allosteric signals, would hold great power for drug
discovery. Particularly successful has been the use of analysis methods such as those de-
veloped by Pandini et al. (2012)123 and Lange and Grubmueller (2006)120 used to identify
distally correlated motions in the backbone of proteins in order to elucidate allosteric path-
ways. Nevertheless, work by Volkman et al. (2001)113, Lindorﬀ-Larsen et al. (2005)116, Yao
et al. (2008)114, Guerry et al. (2013)117 and many others, has shown that protein dynamics
results in an ensemble of pre-existing conformations that determine the physico-chemical and
functional properties of enzymes. In this respect, ensemble-averaging of any dynamic time-
resolved observable is required. Additional methods are required to predict the network of
residues involved in protein allostery, with a consideration for the ensemble nature of protein
dynamics. This led to the third and ﬁnal research question: To what extent can networks of
correlated motions, extracted from defined conformational sub-states, be used as a means of
predicting protein residues that propagate the energetic effects of allosteric ligands? To ad-
dress this question, Chapter 5 presents the development of a AlloHubMat, a novel method and
stand-alone software package used to predict allosteric hub residues from molecular dynamics
simulations using tools from information theory. AlloHubMat is applied towards the analysis
of molecular dynamics simulations of PKM2 and predicts a network of residues involved in
propagating the eﬀects of FBP-induced activation. These in silico predictions are tested in
Chapter 6 using single-point mutant variants of PKM2, designed to abrogate the allosteric
pathways induced by FBP activation.
In addition to various biophysical and analytical methods, molecular dynamics simulations
are used as a detailed statistical-mechanical technique for investigating the conformational
dynamics of PKM2 in response to allosteric regulation. Moreover, the simulated trajectories
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generated from MD calculations are used as an input for AlloHubMat, to predict allosteric
pathways. Given the importance of molecular dynamics as an in silico tool for this work,
and the immense power it presents for the study of protein dynamics, the mathematical and
physical principles of MD simulations are detailed in the following Chapter.
Figure 1.8: Time line of historical discoveries in the fields of protein dynamics and al-
lostery, and PKM2 biology and biophysics. Historical discoveries relating to the fundamental
concepts of protein dynamics and allostery, with a focus on molecular dynamics simulation methods,






2.1 Theoretical principles of molecular dynamics simulations
[Anfinsen] showed a film of the folding of a protein with "flickering helices form-
ing and dissolving and coming together to form stable substructures". Of course,
the film was purely imaginary, but it led to my asking him whether he had thought
of taking the ideas in the film and translating them into a quantitative model. He
said that he did not really know how he would do this, but to me it seemed clear
that such a model could be based on straightforward physical concepts.132
Martin Karplus
The aim of a molecular dynamics (MD) simulation is to compute the equilibrium and transport
properties of a classical many-body system. The term classical means that the interaction be-
tween particles and their movement is studied over a given time t through a classical statistical
mechanical treatment of the constituent particles. The real power of MD simulations in study-
ing protein dynamics is in the ability to complement experimental studies. MD simulations can
act as a ﬁgurative microscope aﬀording the investigator high spacial and temporal resolution
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in the study of macromolecular dynamics. Given that most current applications of molecular
dynamics simulations of large proteins use a classical statistical mechanical framework due
to the enormous computational cost associated with solving the time-dependent Schroedinger
equation for biologically interesting molecules, the Hamiltonian of a classical system will be
introduced in the following section. This will be followed by a discussion of how molecular
forces are computed in an MD simulation, a consideration for how dynamics is calculated in
diﬀerence physical ensembles and ﬁnally, a brief description of the potential energy function
used to represent the atomic interaction energies in an MD simulation.
2.1.1 The Hamiltonian of a classical mechanical system
The Hamiltonian (H) can be used to describe a classical system of particles i with coordinates
r and momenta p. The Hamiltonian is equal to the total energy if the potential energy function
is independent from time and velocity:






where K is the kinetic energy, U is the potential energy and m is the mass. A classical system
can therefore be deﬁned by the set of values r,p, which corresponds to a point in phase space
deﬁned by the internal coordinates of the system and their momenta.
In order to measure thermodynamic averages over a micro-canonical ensemble of states char-
acterised by the macroscopic variables (N,V,E), it is necessary to determine the probability
distribution of ﬁnding the system at each point in phase space (ρ(r,p)). With a knowledge of
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where H is the Hamiltonian of the system, β = 1kBT and tr is the trace of the operator. With
this it is assumed that each quantum state of a many-body system with energy E is equally
likely to be occupied. The same thermodynamic observable can be calculated for all quantum








Unfortunately computing thermal averages for a many-body system by solving the Schroedinger
equation and then computing the expectation value of the operator A for all quantum states
that have a non-zero statistical weight is not possible for macromolecular systems. The number
of quantum states contributing to the operator A in Equ. 2.3 would be so large (1010
23
) that a
numerical evaluation of the system would be impractical. For this reason the basic assumption
of statistical mechanics is made, whereby it is assumed that a system with ﬁxed number of
particles (N), volume (V ) and energy (E) is equally likely to be found in any of its quantum
states. Such an average over all quantum states of an N-body system in Equ. 2.2 is called an
ensemble average. Nevertheless, in order to compare an observable computed from a simula-
tion with that derived from an experiment, it is desirable to study the time-evolution of that
system. Thermal averages can be computed by following the motion of the system through the
phase space as a function of time (t) by integrating the system’s equations of motion, taking
the averages only over those points that are visited along the trajectory. Provided that the
initial coordinates and momenta of all atoms are deﬁned (rN ,pN ), the time-averaged density










The ergodic hypothesis states that when t tends towards inﬁnity and that the trajectory
samples the entire phase space, the time average does not depend on the initial conditions.
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Therefore, averaging over all initial phase space coordinates is equivalent to averaging over the
time-evolved space coordinates:
ρi(r) = 〈ρi(r)〉NV E (2.5)
Generally the above is not true due to the ﬁnite length of molecular dynamics simulations,
which is constrained by computer processing speed. As such, ergodicity is unattainable for
simulations of macromolecules in the vast majority of cases. The ideal simulation length
depends primarily on the time-scale of the phenomena of interest. Taking the intrinsic dynamic
motion of protein atoms as an example, diﬀerent atomic and molecular motions are dispersed
across a wide range of time scales. The positions of amino acid side chains may ﬂuctuate with
a relatively with relatively high frequency (on the ps time scale), whereas large inter-domain
tertiary structural rearrangements of the entire protein may occur on much longer time scales
(approaching the µs to ms time scales). In reality, the time scales of these motions largely
varies from protein to protein and may depend on the physical and chemical properties of the
polypeptide chain. Nevertheless, slow structural dynamics and hence long time scales, still
represent a signiﬁcant computational cost. Apart from using a ’brute-force’ approach, this can
be overcome by decreasing the number of degrees of freedom of the system, or by biasing the
energetic landscape such that the protein is able to traverse free energy barriers and explore
conformational space otherwise inaccessible. Neither of these approaches are the subject of
this thesis and, as such, will not be reviewed here.
2.1.2 The force calculation and integrating the equations of motion
To start a molecular dynamics simulation, it is ﬁrst necessary to assign the initial positions
and velocities to all particles of the system. Following this initialisation step, the forces on
each particle within the system can be calculated and Newton’s equations of motion can
be solved. The positions of the atoms are adjusted such that steric clashes between the
composite particles are minimised. Additionally, prior to the start of the simulation, velocities
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are assigned to each particle such that the total momentum is zero and that the instantaneous







Next, the forces acting on each of the particles in the system are computed. The forces are
subsequently used, along with the positions of the particles at the current and at the previous
step, in order to predict the positions at the next step. If a given pair of particles are close
enough to interact, the forces along the x-direction between these particles are derived from




The potential energy between each interacting particle in the system is deﬁned by empirically-
deﬁned force ﬁeld potentials. The functional form of these potentials will be described later. It
is worth mentioning here that the force evaluation is the most time-consuming step of a molec-
ular dynamics simulation, as it is necessary to consider the contribution to the force on particle
i due to all its neighbours. Considering only the interaction between a particle and the nearest
image of another particle, it is necessary to evaluate N ·N−12 pair distances, which scales as N2.
Having computed all the forces for each of the constitutive particles of the system, New-
ton’s equations of motion can be integrated. The simplest way to construct an integrator is
through a Taylor expansion of the positions and velocities:
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r(t+∆t) ≃ 2r(t)− r(t−∆t) + f(t)
m
∆t2 (2.10)
These equations have been modiﬁed to make them time-reversible133, thus increasing the
accuracy and robustness of the integration.
2.1.3 Molecular dynamics in various ensembles
Until this point, concepts for simulating a system in the microcanonical (NVE) ensemble have
been introduced. Nevertheless, in order to replicate the conditions of a particular experimental
set-up, it is often desirable to perform molecular dynamics calculations in diﬀerent ensembles
(ie. NVT or NPT). Physical and mathematical considerations for simulating in these ensembles
will be discussed brieﬂy.
Constant temperature (NVT)
A constant temperature can be imposed by bringing the system in thermal contact with a large
heat bath. This allows for the study of diﬀerent molecular systems at diﬀerent temperatures
and sampling of the canonical statistical ensemble. Under these conditions, the probability












We then obtain a simpliﬁed relation between the imposed temperature T and the kinetic
energy for each particle in the system
kBT = m〈v2α〉 (2.12)
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where kB is the Boltzmann constant, m is the mass of the particle and 〈v2α〉 is the time averaged
αth component of its velocity. This equivalence is often used to measure the temperature of a
microcanonical system. Given that the temperature of a system is proportional (though not
directly) to the average kinetic energy of the particles, the temperature can be controlled by
scaling the velocities. If the temperature at time t is T (t) and the velocities are multiplied by


























Multiplying the velocities at each time step by a factor λ =
√
T0/T (t), where T (t) is the
current temperature calculated from the kinetic energy and T0 is the desired temperature pro-
vides the simplest way of keeping a constant system temperature.
A simpler formulation of velocity scaling is given by the Berendsen temperature coupling
algorithm, in which the velocities are scaled at each step such that the rate of change of the






(T0 − T (t)) (2.16)
where τ is a parameter which determines how tightly the system is coupled to the thermal bath.
The Berendsen temperature coupling algorithm gives an exponential decay of T (t) towards
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T0. The coupling parameter τ is given by










In practice the coupling parameter τ is empirical and the choice of its value alters the strength
of coupling between the system and the thermal bath and should be chosen within a reasonable
range. Despite the empirical nature of the Berendsen coupling algorithm, it is very eﬃcient
for converging systems towards a desired temperature and consequently is commonly used in
the equilibration step of an MD simulation134. Nevertheless, to accurately probe the canonical
ensemble, the Extended System approach was ﬁrst proposed simultaneously by Nosé135 and
Hoover136. The premise of the Nosé-Hoover approach is to an extended Lagrangian to consider
the thermal bath as part of the system by adding a dynamic variable s˜ , which has a non-zero
mass and a velocity ˙˜s. In the extended system the atomic coordinates are identical to the
non-coupled system, however the time scale is stretched by the factor s˜ so that
dt = s˜dt (2.18)












where Q is the mass of s˜. The ﬁrst two terms of the extended Lagrangian represent the
potential energy subtracted from the kinetic energy of the real system. The third and forth
terms represent the kinetic energy minus the potential energy assigned to s˜. The energy of the
real system will ﬂuctuate about a mean and accompanying the ﬂuctuations of s˜, heat transfers
occur between the system and the thermal bath, which regulate the system temperature. The





























Many experiments are conducted at a constant pressure, and rather than adjusting the volume
of a simulation box in the canonical ensemble, it is often more convenient to ensure a constant
pressure. Constant pressure simulations can be attained in the isothermal-isobaric ensemble
by considering the volume as a dynamic variable that changes during the simulation. Similar
to Hoover scheme to regulate the temperature of the water box, the volume parameter is




















where N is the number of particles; the thermostat variable, its momentum and mass are
given by ξ1, pξ1 and Q1, respectively. This is similar to the thermostat in the Nosé-Hoover
chain algorithm. Additionally, a barostat is introduced via the variables ǫ, pǫ and W , which
give the additional variable, along with its momentum and mass, respectively. The dynamic
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where V0 is the volume of the system at time t = 0. The corresponding equations of motion














where Pext is the external pressure, which is selected at the outset of the calculation. The
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The Hamiltonian of the extended system is given by:








+ (dN + 1)kBT ξ1 + kBT
∑
i=1
ξi + PextV (2.29)
2.1.4 The functional form of the potential energy
When calculating the forces on each particle i using Equ. 2.7, it is necessary to evaluate the
potential energy of each interaction in the system. The potential energy between each consti-
tutive particle in a system is represented by an empirically-derived force ﬁeld potential, which
describes the interaction energy between atoms in terms of the atom coordinates (r) and the
force ﬁeld parameters (s). The potential energy is written as a sum over diﬀerent contribu-
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tions, which can correspond to physical atomic interactions or to unphysical interactions that
may be applied to the system:
U(r; s) = Uphys(r; s) + U special(r; s) (2.30)
Special unphysical interactions can correspond to restrains to bond lengths and distances, or
additional forces applied to the system, though these will not be described here in any further
detail. The physical interactions within the system can be further sub-divided into bonded
and non-bonded interactions between the composite atoms:
Uphys(r; s) = U bonded(r; s) + Unon−bonded(r; s) (2.31)
The functional form of the bonded interactions of the Gromos force ﬁeld parameter set, used
herein, are the sum of the bond, bond angle, harmonic dihedral angle and trigonometric
dihedral angle terms138:
U bonded(r; s) = U bond(r; s) + U bondangle(r; s) + Uharmonic(r; s) + U trig.(r; s) (2.32)
The non-bonded interactions are a sum over the potential associated with van der Waals and
electrostatic interactions between all pairs of atoms138:
Unon−bonded(r; s) = UvdW (r; s) + U electrostatic(r; s) (2.33)
Bonded interaction potential
The energetic potential of covalent bonded interactions is calculated as the sum over all Nb
bonds and depends on the parameters Kb and b0, which were originally parametrised against
experimental spectroscopic and X-ray diﬀraction data for small molecules. The functional
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form of the bonded potential is:





Kbn [bn − b0n ]2 (2.34)
where bn is the actual bond length, b0 is the optimal bond length and Kb is the bond force
constant. The parameters Kb and b0 vary depending on the nature of the bonded interaction
between given pairs of atoms (Fig. 2.1 A). The potential due to the angle between bonded
interactions is calculated as a sum of all Nθ bond angles and depends on the parameters Kθ
and θ0:





Kbθ [cos θn − cos θ0n ]2 (2.35)
where θn is the actual bond angle, θ0 is the optimal bond angle and Kθ is the bond angle force
constant (Fig. 2.1 B). The harmonic torsion angles are used to maintain a speciﬁc planar
conﬁguration for four speciﬁc atoms (eg. maintaining a tetrahedral conﬁguration about an sp3
hybridised carbon atom). This potential is calculated as the sum over all improper dihedral






Kbξ [ξn − ξ0n ]2 (2.36)
where ξn is the actual harmonic torsion (Fig. 2.1 C). Similarly, the trigonometric torsion
angles are deﬁned as a sum over all Nϕ torsion angles, with parameters Kϕ, δ and m:
U trig.(r;Kϕ, δ,m) =
Nϕ∑
n=1
Kϕn [1 + cos(δn) cos(mnϕn)] (2.37)
where δ is the phase shift, mn is the multiplicity of the torsion angle and ϕ is the actual
trigonometric torsion angle (Fig. 2.1 D).
70
J.A.S MACPHERSON CHAPTER 2
Figure 2.1: Examples of bonded interaction potential energies for arbitrarily selected
atoms. (A) The interaction potential for a C-O bond length. (B) The interaction potential for a
H-N-C bond angle. (C) The harmonic torsional potential energy for a tetrahedral centre. (D) The
trigonometric torsional potential energy for a -C-C- torsion.
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Non-bonded interactions
In the GROMOS force ﬁeld parameter set, the non-bonded interactions are calculated as the
potential between all atoms that are not involved in a covalent (ie. bonded) interaction.
There are a number of exceptions to this collection of interactions, including those that fall
outside of a deﬁned inter-atomic cut-oﬀ range. Two principle non-bonded interaction types
are considered: van der Waals interactions and electrostatic interactions. The non-bonded van
der Waals potentials are calculated as a sum over all interacting non-bonded atom pairs i, j
using a Lennard-Jones 12/6 interaction function with parameters C12 and C6:










Electrostatic interaction potentials are deﬁned as three separate terms: a Coulomb interac-
tion potential, a distance-dependent reaction-ﬁeld contribution and a distance-independent
reaction-ﬁeld term. The Coulomb potential is given as a sum over all interacting pairs UC ,









where the dielectric permittivity of a vacuum and that of the solvent in which the atoms are
embedded is given by ǫ0 and ǫ1, respectively. In addition to the direct Coulomb interactions,
a reaction-ﬁeld URF is determined, which represents the interaction of atom i with an induced
dielectric ﬁeld outside a deﬁned cut-oﬀ distance RRF in the presence of atom j. Finally, a
distance-independent reaction-ﬁeld term is given as a constant contribution to the potential
for every pair of atoms taken into account.
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Evaluating long-range electrostatic interactions
Increasing computational power has allowed for the simulation of ever larger molecular sys-
tems. Nevertheless, it is crucial that the computation of all pair interactions is avoided, as
otherwise the time complexity of a molecular dynamics algorithm would be proportional to
the square of the number of particles. The expense of a molecular dynamics simulation could
be reduced rather drastically by truncating the potential of long-range electrostatics, thus
assuming that the long-range part of the potential is unimportant. Truncation of long-range
electrostatics removes the expensive part of the calculation but introduces serious inaccura-
cies. Other techniques are available for handling long-range electrostatic interactions and,
while more expensive than a simple truncation, have the advantage that they more faith-
fully respect the long-range character of the forces between a charge-charge pair of atoms.
Of the techniques available to evaluate long-range electrostatics, the so-called particle-mesh
Ewald summation is often used for biomolecular systems and scales with a time complexity of
O(n log n).
The particle-mesh Ewald scheme is used as a numeric approximation to Ewald summation. In
the Ewald summation method, long-range electrostatic interactions are split into two parts: a
short-range contribution and a long-range contribution. The short-range contribution is solved
in real-space, whereas the long-range contribution is calculated using a Fourier transform. The
time complexity for a fully optimised Ewald summation scheme scales to the number of par-
ticles as O(n2/3), due to the expense of the reciprocal-space part of the Ewald sum. For the
simulation of systems where the number of particles is of the order of 105 it is necessary to
have a scheme that handles the Fourier part of the Ewald summation more eﬃciently. To
this end, particle mesh Ewald methods allow for the eﬃcient evaluation of the Fourier part of
the Ewald summation scheme by using a so-called Fast Fourier Transform139. First, charged
particles are assigned to discrete points on a lattice. Next, a Fast Fourier Transform method
is used to compute the Poisson equation for the discrete charge distribution on the deﬁned
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lattice. Once Poisson equation has been computed to give the electrostatic energy, the forces
are calculated and assigned back to the particles on the system.
2.2 Parameters used for molecular dynamics simulations of PKM2
Molecular dynamics (MD) simulations were used throughout this study to characterise the
functional dynamics of PKM2 in explicit solvent and in vacuo.
2.2.1 Molecular dynamics simulations in explicit solvent
MD simulations of monomeric and tetrameric human PKM2 were performed with the GRO-
MACS 5.2 engine140, in SPC-E water141. Interactions between protein atoms and solvent
were modelled using the Gromos 53a6 force ﬁeld parameter set138. The input coordinates for
monomeric PKM2 in the apo form (mPKM2apo) were extracted from the Protein Data Bank
crystal structure structure 3bjt23. Coordinates for mPKM2Phe were extracted from 4fxj22;
mPKM2FBP , tPKM2FBP and mPKM2Tepp−46 from 3u2z17; and coordinates for tPKM2FBP+Phe
and tPKM2FBP+Ser were extracted from 4b2d19. Missing residues were modelled using holo-
mogy modelling within the Modeller suite142. The force-ﬁeld parameters for FBP and Tepp-46
were determined using a quantum mechanical assignment of the partial charges using the ATB
server143. Structures were solvated in a dodecahedral period box, such that the distance be-
tween any protein atom and the periodic boundary was a minimum of 1.0 nm. The system
charge was neutralised by adding counter ions to the solvent (Na+ and Cl−). Equations of
motion were integrated using the leap-frog algorithm with a 2 fs time step. The system was
equilibrated for 5 ns in the NVT ensemble at 300 K and 1 bar. This was followed by a further
5 ns equilibration in the NPT ensemble. Following equilibration, multiple replicate production
run simulations were performed for 400 ns under constant pressure and temperature condi-
tions, 1 bar and 300 K. Temperature was regulated using the velocity-rescaling algorithm,
with a coupling constant of 0.1. Covalent bonds and water molecules were restrained with
the LINCS144 and SETTLE145 methods, respectively. Electrostatics were calculated with the
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particle mesh Ewald method139, with a 1.4 nm cut-oﬀ, a 0.12 nm FFT grid spacing and a
four-order interpolation polynomial for the reciprocal space sums.
2.2.2 Molecular dynamics simulations in vacuo
Structural models of the 15+ monomer, 23+ A-A’ and C-C’ dimers and 33+ tetramers were
generated from the PDB crystal structure 3bjt23 by randomly assigning positive charges to
histidine residues distributed throughout the protein. Models were simulated in vacuo using
the OPLS- AA/L force-ﬁeld parameter set146. Systems were minimised using the Steepest
Descent algorithm for 5 x 106 steps, with a step size of 1 J mol−1 nm−1 and a maximal force
tolerance of 100 kJ mol−1 nm−1. Next, systems were equilibrated at consecutively increasing
temperatures (100 K, 200 K and 300 K) each for 5 ns, with the Berendsen temperature coupling
method and an integration step size of 1 fs. Production run simulations were performed for
10 ns with an integration step size of 2 fs in the canonical ensemble. Pressure coupling and
electrostatics were turned oﬀ. Temperature was held constant at 300 K using the Berendsen
coupling method. The most prevalent structures were extracted using the GROMOS clustering
algorithm147. Theoretical collision cross sections were calculated for each clustered structure,
using the projection approximation method, as outlined by Ruotolo (2008) et al.148, and using
the exact hard-sphere scattering model, as implemented in the EHSSrot software149.
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2.3 Protein biophysics
2.3.1 Recombinant protein expression and purification
PKM2 single-point mutant plasmids were generated through a single-step PCR reaction us-
ing hot-start KOD polymerase (Merck Millipore; Burlington MA, USA) and a pET28a-His-
PKM2(WT) template plasmid (plasmid no. 42515 AddGene; Cambridge MA, USA). Plasmids
were sequence-veriﬁed by Sanger Sequencing (Source Bioscience; Nottingham, UK). Expres-
sion of plasmids was achieved by transforming 40 ng pET28a-His-PKM2 into 40 µL E. coli
BL21(DE3)pLysS (60413; Lucigen, Middleton WI, USA). Colonies were inoculated in LB
media at 37 °C and grown to an optical density of 0.8 AU (600 nm). After bacteria had
reached exponential growth, expression of the N-terminal His6-PKM2(WT) was induced with
0.5 mM isopropyl b-D-1 thiolgalactopyranoside (Sigma Aldrich, St. Louis MS, USA) at 24
°C for between 16 and 18 hours. The pellet was harvested and re-suspended in a lysis buﬀer
consisting of 50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 200 mM NaCl, 100 KCl and 10 mM
imidizole, with the EDTA-free Complete protease inhibitor cocktail (Sigma Aldrich, St. Louis
MS, USA). Cells were lysed by sonication at 4 °C. DNase was added at 1 µL/mL prior to
centrifugation of the lysate at 20000 xg for 1 hour at 4 °C. The supernatant (the water-soluble
cell fraction) was loaded onto a HisTrap HP nickel-charged IMAC column (GE; Boston MA,
USA) and was washed with ﬁve column-volumes of wash buﬀer [10 mM HEPES pH 7.5, 10
mM MgCl2, 100 mM KCl, 10 mM imidazole and 0.5 mM tris-2-carboxyethyl phosphine hy-
drochloride (TCEP; Sigma Aldrich, St. Louis MS, USA)]. After consecutive wash steps, the
protein was eluted from the IMAC column with elution buﬀer buﬀer (10 mM HEPES pH
7.5, 10 mM MgCl2, 100 mM KCl, 250 mM imidazole and 0.5 mM TCEP). The N-terminal
His6-epipope tag was cleaved with at 4 °C for 18 hours in cleavage buﬀer (50 mM Tris-HCl pH
8.0, 10 mM CaCl2) with recombinant bovine thrombin, immobilised on agarose beads. Puri-
ﬁed recombinant PKM2 was eluted from the thrombin-agarose column. Aﬃnity puriﬁcation
was followed by size-exclusion chromatography on a HiLoad 16/60 Superdex 200 pg column
(28-9893-35; GE, Boston MA, USA) at 500 mL/min ﬂow rate with protein storage buﬀer (10
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mM HEPES pH 7.5, 10 mM MgCl2, 100 mM KCl, and 0.5 mM TCEP) at 4 °C. Eluted PKM2
was collected and concentrated to a ﬁnal protein concentration of 7 mg/mL with centrifugal
concentrating ﬁlters (Vivaspin 20, 10 kDa molecular-weight cut-oﬀ, 28-9323-60; GE, Boston
MA, USA). Protein purity was assessed by SDS-PAGE. The ﬁnal concentration of the protein
was obtained by measuring the ﬂuorescence absorbance spectrum between 240 nm and 450


























†Identiﬁer: JM.<single point mutant substitution>.<forward (F) / reverse (R)>
Table 2.1: Forward primer sequences for single-point mutants of PKM2
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†Identiﬁer: JM.<single point mutant substitution>.<forward (F) / reverse (R)>
Table 2.2: Reverse primer sequences for single-point mutants of PKM2
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2.3.2 Spectrophotometric assay to determine molar amounts of fructose
1,6-bisphosphate
Puriﬁed recombinant PKM2 was heat-precipitated at 90 °C and supernatant was carefully ex-
tracted. The supernatant was subsequently analysed for amounts of fructose 1,6-bisphosphate
(FBP) using an assay with three coupled enzymatic steps. The reaction mixture contained
20 mM Tris-HCl pH 7.0, 150 µM NADH, 0.7 U·mL−1 glycerol 3-phosphate dehydrogenase
(G-3-PDH), 7 U·mL−1 triose phosphate isomerase (TPI) and the supernatant of 5-50 µM
puriﬁed recombinant PKM2 after heat-precipitation at 90 °C. Reactions were initiated by
adding between 0.008 and 0.016 U·mL−1 to a total reaction volume of 100 µL. The enzymes
rabbit muscle TPI and G-3-PDH were purchased as a mixture from Sigma (50017, Sigma
Aldrich; St. Louis MS, USA). Rabbit muscle aldolase was also purchased from Sigma (A2714,
Sigma Aldrich; St. Louis MS, USA). For each molecule of FBP consumed in the reaction,
two molecules of NADH are oxidised. Therefore, FBP amounts were quantiﬁed by monitoring
NADH oxidation over time at 25 °C in a 1 mL quartz cuvette (1 cm path-length) by measuring
the NADH absorption signal at 340 nm using a Jasco V-550 UV-Vis spectrophotometer. For
the assay calibration, known amounts of FBP from a powder stock were used instead of the
heat-precipitated PKM2 supernatant.
2.3.3 Measurement of PKM2 steady-state enzyme kinetics
Initial velocities for the forward reaction of pyruvate kinase [phosphoenolpyruvate (PEP) and
adenosine diphosphate (ADP) conversion to pyruvate and adenosine triphosphate (ATP) (Fig.
2.2)] were measured using a reaction coupled to rabbit muscle lactate dehydrogenase. The
reaction monitored the oxidation of NADH (ǫ340nm = 6220 M−1 cm−1) at 37 °C in a buﬀer
containing 10 mM Tris-HCl pH 7.5, 100 mM KCl, 5 mM MgCl2 and 0.5 mM TCEP. Initial
velocity versus substrate concentrations for PEP were measured in the absence and in the
presence of allosteric ligands, in a reaction buﬀer containing 180 µM NADH and 8 U·mL−1
rabbit muscle lactate dehydrogenase (Sigma; St. Louis MS, USA). Reactions were initiated
by adding PEP at the desired concentration, with ADP at a constant concentration of 5 mM.
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A total protein concentration of 5 nM PKM2 was used for all enzyme reactions, in a total
volume of 100 µL per well in a 96-well plate. Apparent kinetic constants KM and kcat were
determined by ﬁtting initial velocity curves to Michaelis-Menten steady-state kinetic models.
Figure 2.2: The catalytic mechanism of the pyruvate kinase-catalyzed conversion of phos-
phoenolpyruvate and ADP to pyruvate and ATP. 1. A phosphoryl group is transferred from
phosphoenolpyruvate (i) to ADP (ii) by an apparent SN2 mechanism, to yield the enolate of pyruvate
(iii) and ATP (iv). 2. A water molecule at the active site protonates the enolate (iii) at the 2-si
face of the double bond to form keto pyruvate (v.). 3. the hydroxide is reprotonated by the active site
residue His-78. Divalent cations Mg2+ or Mn2+ are thought to enhance the acidity of the solvent
molecule150. K+ does not directly contact the substrate or intermediate, but instead is thought to
influence the structure of the active site through interactions with R72, R119 and K269 55.
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2.3.4 Analysis of the steady-state kinetics of PKM2 enzyme activity inhi-
bition by Phe
The dependence of the PKM2 enzyme kinetic constantsKM , kcat and kcatKM on the concentration
of Phe were determined, in order to assign the mechanism by which Phe inhibition of PKM2 oc-
curs in the absence and in the presence of FBP. Steady-state measurements of PKM2 enzyme
activity (as described in Section 2.3.3) were performed by titrating the substrate phospho-
enolpyruvate at several diﬀerent concentrations of phenylalanine and a constant concentration
of 5 mM adenosine diphosphate. In order to investigate the allosteric K-type eﬀect of Phe on
enzyme aﬃnity for its substrate PEP, a single-substrate-single-eﬀector paradigm was assumed.
Under prevailing equilibrium conditions the rate equation of the general modiﬁer mechanism



























where [E]t is the concentration of enzyme active sites, X is the inhibitor (Phe), S is the
substrate, KX is the dissociation constant of the speciﬁc component of the enzyme mechanism,
α is the reciprocal allosteric coupling constant and β is the factor by which the inhibitor
aﬀects the catalytic constant k2. It then follows that the dependence of the equilibrium





)app on the concentration of a modiﬁer (X) (the allosteric
inhibitor phenylalanine) are written as follows151:
kappcat = k2 ·
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1 + β [X]αKX
1 + [X]KX
(2.44)
Rate curves measuring the dependence of [Phe] on the three kinetic constants were ﬁt to the
equations above to solve for Ks, Kx, α and β. The kinetic mechanism was assigned based on
the topology of rate-modiﬁer mechanisms detailed by Baici (2015)151.
2.3.5 Measurement of the allosteric coupling co-efficient
PKM2 initial velocities were measured at 37 °C using a lactate dehydrogenase assay over a
range of phosphoenolpyruvate concentrations with a constant concentration of 5 mM ADP,
as previously described in Section 2.3.3. Activity measurements were repeated following pre-
incubation of the PKM2 variant with saturating concentrations of FBP (2 µM for all variants,
with the exception of R489L which was incubated with 50 mM FBP to saturate this variant).
The allosteric coupling constant (Q) was calculated to determine the coupling between FBP





where Kia and Kia/x are equilibrium dissociation constants for the binding of the substrate
(a) in the absence or presence, respectively, of the allosteric eﬀector (x). Q > 1, indicates
positive allosteric coupling between the binding of x to the protein and the binding of a to the
substrate binding pocket. Conversely, where Q < 1, negative coupling exists between the a
and x sites. Measurements were repeated after addition of 400 µM Phe to the protein variants
that had been pre-incubated with FBP, and activity was measured over a range of substrate
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concentrations.
2.3.6 Circular dichroism spectroscopy
A JASCO J-815 spectrometer was used to record far-UV circular dichroism (CD) spectra
(Jasco; Oklahoma City, OK USA) from 200 nm to 260 nm with 300 µL of 0.2 mg/mL PKM2
ion a quartz cuvette with a path length of 0.1, at a temperature of 20 °C. Raw data in units of
mdeg were converted to extinction co-eﬃcient of the mean residue CD extinction co-eﬃcient,
in units of M−1 cm−1:
∆ǫmrw =
S ·MRW
32980 · c · L (2.46)
where c is the molar concentration of the protein, L is the path length, S is the raw mea-
surement of CD intensity (in units of mdeg) and MRW is the molecular weight of the protein
divided by the number of amino acids in the protein.
To measure the thermal stability of recombinant protein, the CD intensity at 222 nm was
monitored over a range of temperatures. Melting curves were ﬁt to a two-state equilibrium
model, which assumes that the protein is either folded or unfolded and that there is no inter-





where N is the native state, U is the unfolded state, Ku is the unfolding constant and Kn is











The CD absorbance signal at 222 nm over a range of temperatures, starting from the folded
and ending in the unfolded state, is assumed to reﬂect a linear combination of detected optical
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signals from the folded and the unfolded species in solution:











where S is the signal and F is the fractional content of either species. Substituting for ∆G




























where Tm is the melting temperature, ∆HTm is the enthalpy change at T = Tm and ∆Cp is
the heat capacity change.
2.3.7 Measurements of FBP binding to PKM2
PKM2 binding to FBP was measured by titrating a concentrated solution stock solution of
FBP into 5 µM PKM2 in a buﬀer containing 10 mM HEPES pH 7.0, 100 mM KCl and 10 mM
MgCl2 at 20 °C. Intrinsic ﬂuorescence emission spectra of PKM2 were recorded using a Jasco
FP-8500 ﬂuorescence spectroﬂuorometer with an excitation wavelength of 280 nm (bandwidth
of 2 nm) and emission scanned from 290 nm to 450 nm (bandwidth of 5 nm) in a 0.3 cm
path length quartz cuvette (Hellma Analytics; Muellheim, Germany). A ratio of the emission
intensities at 325 and 350 nm was plotted against the concentration of the titrant. Binding
curves were ﬁt to a model assuming a 1:1 binding stoichiometry (1 FBP molecule per monomer
of PKM2) with a non-linear least squares regression ﬁt of the following:
Sobs = SPP0+SLL0+(SPL−SP−SL)· (KD + P0 + L0)−
√
(Kd + P0 + L0)2 − 4(P0L0)
2
(2.51)
where the spectral signal Sobs is the ratio of ﬂuorescence emissions at 325 nm and 350 nm; SP ,
SL, and SPL are the spectral signals of the free protein, the free ligand and the protein-ligand
complex, respectively. The apparent dissociation constant is given by KD. The free protein
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concentration ([P0]) was corrected by subtracting the percentage of protein pre-bound to co-
puriﬁed FBP, as determined from the aldolase-coupled assay.
To automate the solution of Equ. 2.51 for binding data, an R package ligBind was writ-
ten. The package consists of two simple functions 1. to ﬁt binding data to Equ. 2.51
and 2. to plot the binding curve along with the raw data and the residuals of the ﬁt
to Equ. 2.51. A brief description of ligBind is given here, which will provide a tutorial
for how to use the package to estimate the binding aﬃnity for a ligand-receptor interac-
tion. ligBind can be compiled from source and is freely available to download at https:
//github.com/jamieAmacpherson/ligand_binding/tree/master/ligBind. Once ligBind has
been compiled, the user can ﬁt binding data to estimate the aﬃnity and visualise the binding
curve, in an automated manner. For the purposes here we will use test data that is shipped
with the package.
After the package has been compiled, the user can calculate the binding aﬃnity of the protein-
receptor interaction using the function ﬁt.binding(). The ﬁtting function requires as inputs:
(1) a data-frame with two equal columns containing the ligand concentration and the bind-
ing response, (2) a predicted binding aﬃnity and (3) the protein concentration used in the
experiment. The function ﬁt.binding() prints the calculated binding aﬃnity along with the
associated error. The function also returns a four-element list containing the summary of the
ﬁtting procedure, the raw binding data, the ﬁtted binding model and the residuals between
the ﬁtted model and the raw data. This list can be used as a direct input for the plotting
function ligBind::plt.binding.curve() to visualise the binding data and the predicted model.
An example output of the plotting function in ligBind is shown in Fig. 2.3.
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Listing 1: Use of ligBind to calculate binding affinity and visualise ligand-
receptor binding data.
## Load ligBind package
library(’ligBind ’);
## Initialise the test data
test_data = dat;
## Calculate the binding affinity of the protein -receptor
## interaction.
test_data_fit = ligBind ::fit.binding(bindingdat = test_data ,
kd_pred = 3000,
prot_conc = 5);
## Visualise the binding curve
ligBind ::plt.binding.curve(test_data_fit );
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Figure 2.3: Visualisation of a ligand-receptor binding curve fitted using the ligBind pack-
age. The output of ligBind::plt.binding.curve() function shown above in Listing 1.
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2.3.8 Microscale thermophoresis measurements of phenylalanine and serine
binding
Microscale thermophoresis (MST) is an experimental technique that is used to measure protein-
ligand binding. In this technique, a protein-ligand mixture is prepared in a buﬀered solution
and is loaded into a glass capillary. During the MST experiment, a temperature gradient
is induced by an infrared laser, which induces protein-ligand molecules to disperse from the
focal point of the laser. The directed movement of the protein-ligand molecules is detected by
monitoring the ﬂuorescence absorption or emission properties at a deﬁned wavelength using
either covalently attached ﬂuorophores or the intrinsic ﬂuoresence of either the protein or the
ligand. The thermophoretic properties of a protein is strongly dependent on its size, charge,
hydration shell and conformation. Therefore, protein-ligand binding which perturbs any of
these biomolecular properties can be detected using MST.
The binding of Phe and Ser to PKM2 was measured using MST on a Monolith NT.115 in-
strument (Nanotemper Technologies; Munich, Germany). PKM2 was ﬂuorescently labelled
with an Atto-647 ﬂuorescein dye (NT-647-NHS; Nanotemper, Munich, Germany). 250 µL of
20 µM recombinant PKM2 was labelled with 250 µL of 60 µM dye in a buﬀer containing 100
mM bicarbonate pH 8.5 and 50 % DMSO for 30 minutes at room temperature in the dark.
Free dye was separated from labelled PKM2 using a NAP-5 20 ST size-exclusion column (GE;
Boston MA, USA). The stoichiometry of labelled- to unlabeled-PKM2 was determined by
measuring the ﬂuorescence absorbance ratios at 647 nm (labelled; PKM2-NT495NHS) and
280 nm (unlabeled PKM2). Thermophoresis measurements of labelled PKM2 were obtained
using a Monolith NT.115 instrument (Nanotemper; Munich, Germany). Labelled PKM2, at
a constant concentration of 30 nM, was titrated with either Phe (up to 5 mM) or Ser (up to
10 mM) in a buﬀer containing 10 mM HEPES pH 7.5, 100 mM KCl, 5 mM MgCl2, 0.5 mM
TCEP and 0.1 % tween-20. Prior to each thermophoresis measurement, capillary scans were
obtained to determine sample homogeneity. Apparent binding curves were ﬁt assuming a 1:1
stoichiometry.
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2.4 Native mass spectrometry
Micro Bio-Spin 6 chromatography colums (Bio-Rad Laboratories, Hercules, CA, US) were used
to buﬀer-exchange PKM2 samples into 200 mM ammonium acetate (Fisher Scientiﬁc, Lough-
borough, UK). Protein samples were diluted to a concentration of 5 µM - 20 µM. Ligands
were dissolved in 200 mM ammonium acetate and added to the protein prior to MS analysis.
Three separate instruments were used for native mass spectrometry experiments: an Ultima
Global (Micromass, UK) extended for high mass range, a modiﬁed Synapt G2 (Waters; Wilm-
slow, UK) where the triwave assembly was replaced with a linear drift tube and a Synapt
G2-Si. Positive ionisation mode was used in analysing samples. Nano-electrospray ionisation
was applied from borosilicate glass capillary tips, pulled in-house on a Flaming/Brown P-1000
micropipette puller (Sutter Instrument Company, Novato CA, USA). A platinum wire was
inserted inside the tip after the protein solution had been loaded, to allow the application of a
positive voltage. All voltages were kept as low as possible to achieve spray while keeping the
protein in a native-like state. Typical conditions used were a capillary voltage of ≃ 1.2 kV, a
cone voltage of ≃ 10 V and a source temperature of 40 °C.
2.4.1 Mass-deconvolution of native spectra
The mass-deconvolved spectrum o was estimated from protein spectra y by maximising the
conditional probability P (o|y) using the Bayes Rule:
P (o|y) = P (y|o)P (o) (2.52)
The prior probability of the mass spectrum P (o) is given by:
P (o) =
N !
o1!, o2!, ..., ok!
Zo11 Z
o2
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where Z is deﬁned by an initial guess of the parent mass spectrum. The probability for the











2.4.2 Ion mobility mass spectrometry
An in-house modiﬁed Synapt G2 was used for IM-MS measurements, in which the original
triwave assembly was replaced with a linear drift tube with a length of 25.05 cm. Drift times
were measured in a helium buﬀer gas at a temperature of 298.15 K and a pressure of 1.99 -
2.00 torr. Motilities for all charge states were converted into rotationally averaged collision




















where K is the measured mobility, q is the charge of the analyte ion, N is the density of
the buﬀer gas, m is the mass of the analyte ion, M is the mass of the buﬀer gas, kB is
the Boltzmann constant, T is temperature and Ω is the rotationally-averaged collision cross
section. The collision cross sections of each charge-state species were further converted into
a single collision cross section distribution in which all charge states contribute towards the
overall distribution, in proportion to their intensity in the mass spectrum153.
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2.5 Measurement of metabolite concentrations in human cell
lines
2.5.1 Liquid chromatography-mass spectrometry (LC-MS) detection of metabo-
lites
Samples were injected into a Dionex UltiMate liquid chromatography system (Thermo Sci-
entiﬁc; Waltham MA, USA) with a pHILIC (150 mm x 4.6 mm, 5 µm particle size) column
(Merk Sequant; Millipore Sigma, Burlington MA, USA). An elution gradient was used with
a 80:20 solvent mixture composed of 20 mM ammonium carbonate (solvent A) and acetoni-
trile (solvent B). The elution gradient was run over 15 minutes, followed by a 5 minute wash
with a solvent mixture of 95:5 solvent A to solvent B. Additional parameters: 10 µL injec-
tion volume; auto-sampler temperature 4 °C; ﬂow rate 300 µL min−1; column temperature 25
°C. Positive/negative polarity switching was performed using a Q Exactive Orbitrap (Thermo
Scientiﬁc; Waltham MA, USA) with a HESI II (Heated electrospray ionisation) probe. The
following mass spectrometry parameters were used: spray voltage 3.5 kV (positive mode) and
3.2 kV (negative mode); probe temperature 320 °C; sheath and auxiliary gases 30 and 5 art-
ibrary units, respectively. A full scan range between 70 m/z to 1050 m/z with settings of AGC
target (3× 106) and a mass resolution setting of ’Balanced and High (70,000). The Xcalibur
3.0.63 software suite (Thermo Scientiﬁc; Waltham MA, USA) was used for data acquisition.
Prior to data analysis, a Thermo Scientiﬁc Calmix solution was used as a standard to perform
mass calibration in both electrospray ionisation polarities and ubiquitous low-mass contam-
inants were used to apply lock-mass correction to each analytical run in order to enhance
calibration stability. Parallel reaction monitoring (PRM) acquisition parameters: resolution
17,500 (ion count), auto gain control target 2×105, maximum isolation time 100 ms, isolation
window m/z 0.4. The collision energies were set individually in the high-energy collisional
dissociation mode. In order to assess the stability and performance of the system, quality
controls were performed by extracting an equal volume of each sample and pooling them.
This quality control mixture was subsequently analysed throughout the run. Data analysis
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was performed using the Xcalibur Qual Browser and Traceﬁnder 4.1 software suites (Thermo
Scientiﬁc; Waltham MA, USA).
2.5.2 Metabolite extraction and cell volume calculations
Cells were seeded in 6 cm dishes in RPMI media containing 10 % dialysed foetal calf serum, 24
hours prior to the start of the experiment. An hour prior to treatment of cells, the media was
refreshed and then changed again at the start of the experiment to RPMI with or without 11
mM glucose; or to Hank’s Balanced Salt Solution (HBSS) with or without supplemented amino
acids as described in the text. Four technical replicate plates were used for each condition,
and 2-4 plates for each cell line were used to count cells and measure mean cell diameter.
This was then used to determine the intracellular volume of the cells, and subsequently the
intracellular concentrations of the detected metabolites. Media treatments were performed for
1 hour, after which plates were washed twice with ice-cold 120 mM phosphate buﬀer saline
(PBS), and 725 µL of ice-cold methanol was used to quench the cells. The cells were scraped
from the plates and were transferred into 180 µL H2O and 160 µL CHCl3. A further 725 µL
methanol was used in a second scraping of each plate. The ﬁnal methanol-chloroform-water
mixtures containing the cells were vortexed and sonicated in a sonicating water bath at 4 °C.
Extraction of the metabolites was allowed to proceed at 4 °C for 16 hours, before sedimenting
precipitated material and then drying down the supernatant. Polar and apolar phases were
separated by re-suspending the dried metabolites in a 1:3:3 mixture of chloroform-to-methanol-
to-water, with a total volume of 350 µL. Polar metabolites were then analysed by LC-MS (as
detailed above). For absolute quantiﬁcation of the metabolites of interest, known quantities of
13C-labelled versions of those metabolites were spiked into lysates. Amounts of the unlabelled
compounds could then be determined as a proportion of the intensity given by the labelled
compound. Previously determined cell numbers and volumes were then used to determine the
intracellular concentrations of each of the metabolites of interest.
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2.6 Absolute quantitation of intracellular PKM2 amounts using
targeted proteomics
The absolute amounts of trypsin-digested PKM1 and PKM2 peptides, isolated from four cancer
cell lines (MCF7, LN229, SN12C and HCT116), were measured using a targeted proteomics
approach. The cell lines used for these experiments have previously been shown to highly
express PKM2. The exon-9/10 splicing event of the pkm transcript is mutually exclusive
and so either PKM1 or PKM2 is expressed by a given cell. Nevertheless, to control for
amounts of both PKM1 and PKM2 protein in the cells, proteotypic peptides for both isoforms
were synthesised, along with several peptides that mapped to both the PKM1 and PKM2
primary sequences. A pilot experiment identiﬁed ﬁve peptides to be used for the quantitation
of PKM2/1. These peptide standards were synthesised by the Crick Proteomics STP with







All peptides were synthesised with arginine and lysine heavy labelling (Arginine: 13C6, 15N4;
and Lysine: 13C6, 15N2).
Table 2.4: Proteotypic peptide standards used for absolute quantification of PKM2 in cell lysates.
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2.6.1 Trypsin digestion
Cell lysates containing a total of 50 µg of protein content were precipitated by adding ice-cold
acetone. Samples were centrifuged at 8000 xg for 10 minutes at 4 °C, following overnight
incubation at -20 °C. The supernatant was removed and any residual acetone was evaporated
at room temperature. The pellet was dissolved in 50 mM TEAB, reduced with 10 mM DTT
and alkylated with 20 mM iodoacetamide. Next, protein was digested with 1 µg of trypsin
overnight at 37 °C, after which each sample was spiked with a mixture of the ﬁve heavy-labelled
peptide standards (Table 2.4). For mass spectrometry analysis, 1 µg of peptide was loaded
onto a 50 cm Easy Spray C18 column (Thermo Scientiﬁc; Waltham MA, USA).
2.6.2 Analysis of peptides by LC-tandem MS (LC-MS/MS
A Dionex U3000 system (SRD3400 degasser, WPS-3000TPL-RS autosampler, 3500RS nano
pump) coupled to a QExactive electrospray ionisation hybrid quadruole-orbitrap mass spec-
trometer (Thermo Scientiﬁc; Waltham MA, USA) was used for mass spectrometic analysis.
Reverse-phase chromatography with a buﬀer of 5 % DMSO in 0.1 % formic acid (mobile phase
A) and 5 % DMSO, 80 % acetonitrile in 0.1 % formic acid (mobile phase B) was used at a ﬂow
rate of 250 nL·min−1. Digested samples were run of linear gradient of mobile phase B in 90
minutes, giving a total run time (including column conditioning) of 120 minutes. The nanoLC
was coupled to a QExactive mass spectrometer using an EasySpray nano source (Thermo Sci-
entiﬁc; Waltham MA, USA), with a spray voltage of +2.1 kV, a capilary temperature of 250
°C an an S-lens radio-frequency level of 55 AU.
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Enzyme kinetics and ligand binding
biophysical studies reveal a combined
role for multiple allosteric ligands in
the regulation of PKM2.
3.1 Introduction
PKM2 enzyme activity is regulated by a number of intracellular metabolites. The upstream
glycolytic intermediate fructose 1,6-bisphosphate (FBP) stimulates PKM2 catalysis by binding
to an allosteric pocket in the C-domain of the protein55,65,70,71. Additionally, serine (Ser) and
histidine (His) increase; whereas phenylalanine (Phe), alanine (Ala), tryptophan (Trp), valine
(Val) and proline (Pro) inhibit PKM2 enzyme activity by binding to a common pocket, sand-
wiched between the A- and the C-domains19,20,22,64,65. Crystallographic structures of PKM2
showing that the FBP- and amino acid binding pockets are physically and chemically distinct,
suggests that PKM2 can concurrently bind to both FBP and an amino acid19. What remains
unclear, however, is how simultaneous binding of multiple ligands with, opposing functional
eﬀects, control PKM2 enzyme activity.
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The following chapter investigates the functional consequences of allosteric regulation by a
number of regulators, both alone and in combination, on PKM2 enzyme activity. In support
of in vitro ﬁndings, we explore cellular metabolic conditions required for concurrent allosteric
regulation of PKM2.
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3.2 Characterising the kinetics of FBP binding to and activa-
tion of PKM2
Activation of PKM2 by FBP is a prototypical and long-studied example of feed-forward reg-
ulation in cellular metabolism154. Nevertheless, the mechanism of PKM2 activation is dis-
puted; some studies have reported an increased aﬃnity for the substrate phosphoenolpyruvate
(PEP)19,47–49 and others reporting changes to the rate of substrate turnover20,22. To reconcile
the diﬀering results in the literature, and to characterise PKM2 regulation at the basal level,
we started by investigating the kinetics of FBP binding and regulation of PKM2 activity.
3.2.1 FBP binds to PKM2 with nanomolar affinity
PKM2 contains three tryptophan residues, two of which (W482 and W515) are proximal to
the FBP binding pocket55. Previous studies have reported that addition of FBP leads to
changes to the intrinsic ﬂuorescence emission spectrum of PK155, likely resulting from side-
chain conformational changes to W482 and W515 upon FBP binding22. Therefore, FBP
binding to PKM2 was measured by monitoring tryptophyl ﬂuorescence (λEX = 280 nm,
λEM = 350 nm).
Measurements of PKM2 fluorescence suggested sub-stoichiometric FBP binding
We found that titrating PKM2 with a stock solution of FBP resulted in a ligand concentration-
dependent excitation and red-shifting of the protein emission spectrum (Fig. 3.1 A). The
eﬀect of FBP on the ﬂuorescence of PKM2 was suﬃciently large to allow for a determination of
the dissociation constant from titrations of the ﬂuorescence change. Nevertheless, an inspection
of the ﬂuorescence spectra revealed that full saturation of the PKM2 ﬂuorescence response to
FBP addition occured at ligand concentrations less than the concentration of protein used in
the titration (Fig. 3.1 A), suggesting sub-stoichiometric binding despite a 1:1 stoichiometry
reported in several crystal structures17,19,55. We therefore hypothesised that puriﬁcation of
recombinant PKM2 may co-purify residual amounts of FBP produced by the E. coli expression
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vector, which had been previously reported22,23,63.
Sub-stoichiometric amounts of FBP are co-purified with recombinant PKM2
Preparations of puriﬁed recombinant PKM2 were assessed for their content of co-puriﬁed FBP
using a three-step aldolase assay156, which couples the conversion of FBP into glyceraldehyde
3-phosphate (GA-3-P) and dihydroxyacetone phosphate (DHAP) with the oxidation of NADH
by glycerol 3-phosphate dehydrogenase (G-3-PDH), requiring the conversion of GA-3-P to
DHAP by triosephosphate isomerase (TPI) as an intermediate step (Fig. 3.1 B). The assay
was calibrated by quantifying molar amounts of FBP from a known solution of the compound
made up from powder (Fig. 3.1 C). Subsequent quantitation of FBP in several independent
preparations of puriﬁed PKM2, following heat-precipitation of the protein, revealed that up to
77.5 % of puriﬁed PKM2 was pre-bound to FBP (Fig. 3.1 D and E), consistent with previous
reports of FBP co-puriﬁcation with PKM223,63. Many attempts to purify recombinant PKM2
under denaturing conditions, and thereby remove co-puriﬁed ligand, were unsuccessful (data
not shown). Therefore, all subsequent experiments were performed with preparations of PKM2
with less than 25 % of the protein pre-bound to FBP, so that experimental data could be
interpreted consistently. Experiments performed on puriﬁed PKM2 in the absence of any
added ligands, though containing quantiﬁed sub-stoichiometric amounts of FBP, are denoted
with an asterisk (Apo∗).
Determination of the free protein concentration was used to calculate the KFBPD
Quantiﬁcation of the FBP-PKM2 saturation status using the aldolase assay allowed for an
estimate of the concentration of free protein in the puriﬁed PKM2 sample, which was essential
for accurately calculating the binding constant in the ligand titration experiment because the
ﬂuorescence signal is produced by the free protein P0 upon association with the free ligand L0 in
solution. A variable proportion of the total PKM2 (Ptotal) was sequestered in a protein-ligand
complex PL and would therefore not produce a ﬂuorescence change upon further addition of
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the ligand. Therefore, the free protein concentration of a given preparation of PKM2 could
be calculated:
P0 = Ptotal − PL (3.1)
It was unclear, however, whether sub-stoichiometric pre-occupancy of FBP meant that ligand
binding was distributed amongst the protomers, producing a mixed population of tetramers
with varying FBP-binding stoichiometries (0:4, 1:4, 2:4, 3:4 and 4:4), or whether a ﬁxed
percentage of PKM2 tetramers were fully bound to FBP. The distribution of stoichiometries
in the starting material was likely determined by the cooperativity of FBP binding to PKM2; in
an inﬁnitely cooperative system, binding of a limiting pool of ligand to a multi-site oligomeric
protein would be expected to be all or none. Nevertheless, it was assumed that the binding
aﬃnities of FBP to each of the four structurally identical pockets in the PKM2 homo-tetramer
was identical, and produced equivalent ﬂuorescence spectral changes upon ligand binding.
Moreover, it was posited that the PKM2 ﬂuorescence change was a result of ligand binding
only, and that any potential oligomeric changes would not contribute to the emission spectrum.
Therefore, the changed PKM2 ﬂuorescence signal, observed upon addition of FBP, is given by
a mixture of ﬂuorescence signals from P0 and PL:
Sobs = SP · [P0] + (SPL − SP ) · [PL] (3.2)
where SP and SPL are optical properties of P0 and PL, respectively. The concentration of
PL at equilibrium is given by:
[PL] =
(KD + [P0] + [L0])−
√
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where KD is the dissociation constant of the FBP-PKM2 interaction. Substituting the ex-
pression for [PL] back into Equ. 3.2:
Sobs = SP [P0]+(SPL−SP ) · (KD + [P0] + [L0])−
√
(KD + [P0] + [L0])2 − 4([P0][L0])
2
(3.4)
After correcting for the partial pre-occupancy of FBP, a solution for the quadratic function
Sobs(SP , SL, SPL, P0, L0,KD) (Equ. 3.4) was calculated using a non-linear least squares pro-
cedure to provide an estimate of the dissociation constant KD. The calculation of the binding
aﬃnity of a protein-ligand interaction was automated in an R package ligBind (see Methods
section 2.3.7 for details and software tutorial). An average apparent KFBPD of (21.4 ± 9.0)
nM was estimated from a total of six replicate FBP binding measurements (Fig. 3.1 F).
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Figure 3.1: FBP binds to PKM2 with nano-molar affinity. (A) Fluorescence spectra of human
PKM2 in 10 mM HEPES pH 7.5, 100 mM KCl, 10 mM MgCl2 at 20 °C. A protein concentration of 5
µM was used for all curves and the concentration of FBP is specified in the legend. (B) Molar amounts
of FBP co-purified with recombinant PKM2 were quantified using a three-step enzymatic assay, as
described in the text. (C) Calibration of the aldolase assay to estimate the sensitivity for measuring
amounts of co-purified FBP. The assay was tested by adding 4 µM or 10 µM purified FBP. (D)
Preparations of 5 µM (green), 19 µM (blue) and 40 µM (red) of purified PKM2 were heat-precipitated at
90 °C to release any co-purified FBP. The supernatant was subsequently analysed for its molar contents
of FBP, as previously described in (B). (E) Quantitation of the percentage saturation of PKM2 with
FBP in six independent preparations of purified recombinant PKM2. (F) Binding was monitored from
spectroscopic measurements of PKM2 fluorescence emission with increasing concentrations of FBP.
The relative changes to emission at 325 nm and 350 nm is plotted against the concentration of added
FBP. The binding affinity was calculated, as described in the text. Means and standard deviations from
six separate experiments are plotted.
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3.2.2 Technical note: the protein concentration determines the error asso-
ciated with the KD of PKM2-FBP binding
Experimental measurements of PKM2 ﬂuorescence in Section 3.2.1 were necessarily performed
at a protein concentration of 5 µM because of the limited quantum-yield of tryptophan. As
such, P0 was approximately 220-times greater than the estimated KFBPD . Measurements of
ligand binding are known to be increasingly imprecise under conditions where [P0] >> KD be-
cause small additions of L are sequestered into the PL complex (i.e L0 << Ltotal ≃ PL)157,158,
which was accounted for in our numerical treatment of the binding data (see Section 3.2.1).
We therefore questioned to what extent using a protein concentration orders of magnitude in
excess of the binding constant would contribute the imprecision of the aﬃnity estimate.
To this end, a numerical approach was employed whereby theoretical ligand-protein bind-
ing data were simulated using the ligBind::simtitr() function within a new R package ligBind
(see Methods section 2.3.7). Binding data were simulated over a range of increasing P0 and
a deﬁned theoretical KD of 1 µM. The simulated binding data were subsequently ﬁt using
Equ. 3.4 to estimate a calculated KD, which was compared to the initialised theoretical KD
to determine the percent error of the aﬃnity calculate for a given P0. Where the theoretical
KD >> P0, the transition between unbound and fully bound is achieved over a gradient of
ligand concentrations (Fig. 3.2 A). In contrast, where KD << P0, the resulting quadratic
function Sobs(SP , SL, SPL, PL,KD) has a sharp apex, leading to a higher percent error (Fig.
3.2 B).
Next, the KD was calculated for simulated binding data over a range of [P0] up to 250 µM. We
found that, where [P0] ≤ 50 ·KD the calculated binding aﬃnity was approximately equivalent
to the true binding aﬃnity when ﬁtted with the quadratic function Sobs(SP , SL, SPL, PL,KD)
(Fig. 3.2 C), resulting in a negligible percent error of the apparent aﬃnity. As the free
protein concentration was increased such that P0 ≥ 50 ·KD, we observed a non-linear increase
in the calculated binding aﬃnity (µKD) (Fig. 3.2 C).
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similar to other classical ﬁtting methods, where binding is expressed as a function of the total
ligand concentration ([Ltotal]), but does not account for the concentration of the three species
present at equilibrium (P0, L0 and PL). Fitting simulated binding data over a range of P0
using a classic graphical approach in Equ. 3.5, high P0 leads to an unacceptable percentage
error of > 10000 % (Fig. 3.2 D), which dwarfs the relatively moderate error we obtain by
ﬁtting with the quadratic function in Equ. 3.4 (Fig. 3.2 C).
Therefore, given the experimental limitations (outlined above) that precluded us from us-
ing PKM2 concentrations close to the KD, the ﬁt of the quadratic equation permitted the use
of our binding data to determine KDs. Importantly, Fig. 3.2 C suggests that at higher P0,
the calculated KFBPD reported in Section 3.2.1 is likely higher than the theoretical KD (i.e.
FBP binds even tighter than our data suggest).
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Figure 3.2: Simulated protein-ligand binding data show that the measured binding affin-
ity is over-estimated when high concentrations of protein are used in the experiment.
(A) Binding data (open circles) were simulated with a defined theoretical KD of 1 µM and a protein
concentration (P0) of 0.1 µM (i.e KD >> P0). A binding curve was calculated from the simulated
data (red curve), using the quadratic function Sobs(SP , SL, SPL, PL,KD) described in Equ. 3.4. (B)
Binding data were simulated as in (A) with a defined theoretical KD of 1 µM and a protein concen-
tration (P0) of 250 µM (i.e KD << P0). (C) Binding affinities were calculated for simulated binding
data with a theoretical KD = 1 µM over a range of P0 concentrations, using the quadratic function
Sobs(SP , SL, SPL, PL,KD) (Equ. 3.4) or (D) using the hyperbolic function Sobs(KD) (Equ. 3.5).
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3.2.3 FBP binding leads to an increase in the affinity of PKM2 for its
substrate
To investigate the mechanism of FBP-induced activation, steady-state kinetic parameters of
PKM2 were determined in the presence and absence of FBP. In the absence of any added
FBP, the KPEPM was (1.22 ± 0.02) mM with a kcat of (349.3 ± 40.9) s−1 (Fig. 3.3 A and B).
Addition of saturating concentrations of FBP resulted in a six-fold reduction in the KPEPM to
(0.23 ± 0.04) mM, without a signiﬁcant change in kcat (Fig. 3.3 A and B). The activation
constant (ACFBP50 ) for FBP was measured as (118.1 ± 19.0) nM (Fig. 3.3 C), in excess of our
previously measured KFBPD . Taken together, steady-state measurements of PKM2 catalysis
suggested, consistent with previous ﬁndings, that FBP acts as a K-type activator to increase
the binding aﬃnity of the catalytic substrate PEP, without changing the rate of substrate
turnover (kcat).
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Figure 3.3: Addition of FBP results in an increase in the substrate affinity of PKM2
for phosphoenolpyruvate. (A) Specific activity of 5 nM PKM2 was measured using an LDH-
coupled spectrophotometric assay (see Methods Section 2.3.3) in the absence (black) and in the presence
(green) of 2 µM added FBP. A constant concentration of 5 mM ADP was used, while varying the
concentration of PEP. Measurements were performed at 37 °C. Rate curves were fitted using Michaelis-
Menten kinetics. Means and standard deviations from four separate experiments are plotted. (B)
Kinetic parameters were quantified from activity measurements of PKM2 in the absence (black) and in
the presence (green) of 2 µM FBP. Significance was assessed using a Wilcoxon rank-sum test. Asterisk
(*) marks significant changes (p-value < 0.05). (C) Specific activity of 5 nM PKM2 was measured
at 1.5 mM PEP and 5 mM ADP, varying the concentration of FBP. A binding curve was fitted to
the resulting rate curve assuming a 1:1 stoichiometry, to estimate the apparent activation constant
(ACFBP50 ). Means and standard deviations of four separate experiments are plotted.
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3.2.4 A phosphotyrosine peptide binds competitively with FBP to PKM2
Given the ﬁnding that FBP binds to PKM2 with nano-molar aﬃnity in vitro (Section 3.2.1),
consistent with previously reported KFBPD measurements
59,62,63, we sought to investigate pos-
sible mechanisms by which the aﬃnity is reduced by competition with other ligands. Growth
factor signalling mediated by phosphorylation of proteins at tyrosine residues, which is often
upregulated in cancer, inhibits PKM2 activity by outcompeting FBP with a phosphotyrosine
peptide motif23. The mechanism of PKM2 phosphotyrosine peptide regulation, however, and
the kinetics of its competition with FBP have not been characterised. We therefore sought
to investigate the kinetics with which the phosphotyrosine peptide (M2tide) identiﬁed by
Christofk et al. (2008)23 displaces FBP.
M2tide binds to PKM2 with an apparent affinity of 150 µM
To this end, competition binding experiments between FBP and M2tide were performed by
measuring the ﬂuorescence anisotropy (λEX = 494 nm, λEM = 518 nm) of a ﬂuorescein-
labelled M2tide variant (ﬂuor-M2tide)159,160. The sequence of ﬂuor-M2tide is given: Fluorescein-
GGAVDDD(PTyr)AQFANGG-COOH.
Preliminary experiments found that addition of PKM2 resulted in an increase in the anisotropy
of ﬂuor-M2tide (data not shown). Subsequent titrations of ﬂuor-M2tide with PKM2 resulted
in a concentration-dependent increase in the anisotropy of the peptide, which were used to
calculate an apparent binding constant [Kfluor−M2tideD = (153 ± 19) µM] (Fig. 3.4 A).
Measurements were repeated with a single-point mutant PKM2(K433E), previously shown to
disrupt phosphotyrosine binding to PKM223. Consistent with this, we found that ﬂuor-M2tide
did not bind to PKM2(K433E), though a linear increase in the ﬂuorescence anisotropy of the
ﬂuorescein probe was observed, likely a non-speciﬁc concentration-dependent eﬀect of the la-
belled peptide (Fig. 3.4 B). The notion that the linear ﬂuorescence signal of the peptide
arose from a non-speciﬁc eﬀect, was supported by the observation that titrating the peptide
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with puriﬁed bovine serum albumin (BSA) resulted in a similar linear ﬂuorescence anisotropic
signal (Fig. 3.4 B).
M2tide and FBP competitively bind to PKM2
To investigate the competitive binding kinetics between ﬂuor-M2tide and FBP, ﬂuorescence
measurements of FBP-PKM2 binding were performed (as previously in Section 3.2.1) in the
presence of increasing concentrations of ﬂuor-M2tide. We found that addition of the peptide
was accompanied by a linear increase the apparent KFBPD (Fig. 3.4 C), suggesting that the
peptide and FBP competitively bind to PKM2. Conversely, while the K433E mutant abolished
binding of ﬂuor-M2tide, FBP binding was maintained albeit with a lower aﬃnity [KD = (6.46
± 1.46) µM] (Fig. 3.4 D). Taken together, these results suggest that ﬂuor-M2tide binds
adjacent to the FBP pocket and that residue K433 provides a critical charged interaction for
its binding, which would imply that the binding pockets for ﬂuor-M2tide and FBP partially
overlap.
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Figure 3.4: Fluor-M2tide competes with FBP for binding to PKM2. (A) Fluorescence
anisotropy measurements of a fluorescein-labelled peptide (fluor-M2tide) were performed at increasing
concentrations of recombinant PKM2. The apparent binding affinity was estimated from a non-linear
least squares regression of the binding curve. (B) Fluorescence anisotropy measurements of fluor-
M2tide were acquired, titrating the concentrations of either PKM2(K433E) (blue) or bovine serum
albumin (black). Anisotropy measurements were fitted with a linear regression. (C) Fluorescence
emission measurements of PKM2 were performed to estimate the binding affinity of FBP at vary-
ing concentration of the fluor-M2tide peptide. Means and standard deviations from three independent
titrations are plotted. (D) Fluorescence emission spectroscopy measurements of PKM2(K433E) were
performed over a range of FBP concentrations. (E) A structural view of residue K433 relative to FBP
bound in the crystal structure. Structural coordinates were extracted from the PDB accession code
3u2z.
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3.3 FBP binding to PKM2 induces inter-protomeric coopera-
tivity
Consistent with previous reports of FBP-induced activation of PKM255,59,161, the previous
Section found a K-type mechanism whereby FBP binding increases the eﬀective aﬃnity of
the protein for the substrate phosphoenolpyruvate. The reciprocal relationship between FBP
binding and enzyme activation, however, is further complicated by the reported association
of monomers and/or dimers into stable tetramers, which may invoke ligand-induced commu-
nication pathways between the four active sites in the tetramer forming the basis of inter-
protomeric cooperativity. Alternatively, enzyme catalysis and subsequent activation of PKM2
protomers may act in isolation within the purported tetramer assembly.
3.3.1 Titrating PKM2(WT) with the catalytically-dead PKM2(R72A) re-
sults in a non-linear decay in enzyme activity
A mutant-doping assay can be used to quantify inter-subunit cooperativity of a
hetero-oligomeric protein
In order to test the hypothesis that FBP-induced allosteric activation promotes inter-subunit
co-operativity, we sought to monitor the kinetics in the decay of PKM2 activity as PKM2(WT)
was titrated with a catalytically-inactive mutant variant of PKM2, in a so-called mutant doping
assay162–165. In this assay, PKM2(WT) was titrated with a catalytically-inactive mutant
variant of PKM2 to form hetero-oligomeric species with deﬁned stoichiometric ratios of WT
subunits and inactive subunits. The enzyme activity of each mixture is measured, which
decreases with increasing concentrations of the inactive species in the mixture. For proteins
with a cooperative dependence on the adjacent subunits in an oligomeric assembly, the decrease
in activity is non-linear. Conversely, for proteins where the subunits function independently
of their neighbouring subunits within an oligomeric assembly, the activity decay is linear.
Therefore, the inter-subunit of an oligomeric protein can be quantiﬁed by ﬁtting the decay in
enzyme activity as the WT protein is doped with an inactive variant.
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PKM2(R72A) is inactive and hetero-oligomerises with PKM2(WT)
To ﬁrst identify a single-point mutant that depleted PK phosphotransferase activity, the en-
zyme activity of three active site mutants [PKM2(R72A), PKM2(R120A) and PKM2(K270A)]
were measured. Initial velocity curves revealed that, compared to PKM2(WT) [kcat = (538.4±
18.0)s−1] the rate of product turnover was decreased by approximately 1.7-fold for PKM2(R120)
[kcat = (308.4±5.7)s−1] and PKM2(K270A) [kcat = (270.8±5.3)s−1] (Fig. 3.5 A). Moreover,
activity of PKM2(R72A) was almost entirely abolished, evidenced by a 63-fold decrease in the
apparent rate of substrate turnover [kcat = (8.5± 1.4) s−1] (Fig. 3.5 A).
To measure the inactivating eﬀect of introducing catalytically inactive protomeric units into a
hetero-oligomeric assembly with PKM2(WT), it was ﬁrst necessary to establish that PKM2(R72A)
did not disrupt oligomerisation. First, microscale thermophoresis (MST) measurements of
ﬂuorescein-labelled PKM2(WT) were performed with titrated amounts of unlabelled PKM2(WT),
to measure PKM2(WT) oligomeric association. A concentration-dependent change in PKM2
thermophoresis was detected, from which an apparent oligomerisation constant (KoligoD ) of
(90.8 ± 5.7) nM was estimated for PKM2(WT) (Table 3.1). The apparent oligomerisation
constant of PKM2(WT) was found to be unchanged upon addition of saturating concentra-
tions of FBP, yielding a KoligoD of (97.9 ± 1.8) nM (Table 3.1).
MSTmeasurements of labelled-PKM2(WT) were repeated with titrated amounts of PKM2(R72A),
revealing a 4-fold increase in the KoligoD both in the absence [(410 ± 20) nM] and presence
[(390 ± 40) nM] of saturating concentrations of FBP (Fig. 3.5 B) and Table 3.1). Despite
the reduction in the apparent KoligoD for [WT]PKM2 and PKM2(R72A) association, a similar
maximal thermophoretic behaviour of the labelled-PKM2(WT) at high concentrations of the
mutant suggested that the catalytically-dead variant formed hetero-oligomeric assemblies with
the wild-type, albeit with marginally weaker binding.
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Titrant Ligands KoligoD (nM)
PKM2(WT) None 90.8 ± 5.7
PKM2(WT) 2 µM FBP 97.9 ± 1.8
PKM2(WT) 2 µM Tepp-46 54.6 ± 2.1
PKM2(WT) 5 mM ADP 75.8 ± 6.4
PKM2(WT) 10 mM PEP 52.1 ± 10.1
PKM2(R72A) None 410.0 ± 20.0
PKM2(R72A) 2 µM FBP 390.0 ± 40.0
Table 3.1: Dissociation constants for PKM2 self-association and hetero-association with
PKM2(R72A), under various liganded conditions. All measurements were made by titrating
fluorscein-labelled PKM2(WT) with either unlablled PKM2(WT) or unlabelled PKM2(R72A).
Titration of PKM2(WT) with PKM2(R72A) results in a non-linear decay in en-
zyme activity
Next, the mutant doping assay was performed whereby stoichiometric mixtures of PKM2(R72A)
and PKM2(WT) were assayed for pyruvate kinase activity. PKM2(WT)-PKM2(R72A) mix-
tures were prepared at a total protein concentration of 5 µM, an order of magnitude in excess
of the measured KoligoD , thereby circumventing the reduced aﬃnity of the mutant for the wild-
type. A linear decay in activity was observed over a range of substrate concentrations, with
increasing [PKM2(R72A)][PKM2(WT )] , in the absence of added FBP (Fig. 3.5 C). Conversely, addition
of saturating concentrations of FBP resulted in a non-linear decay in enzyme activity of the
[PKM2(R72A)]
[PKM2(WT )] mixtures (Fig. 3.5 D), suggesting an FBP-induced cooperative eﬀect between
the PKM2 subunits.
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Figure 3.5: A mixture of wild-type and catalytically-dead PKM2 has a non-linear decay
in activity. (A) Initial velocity measurements were recorded over a range of PEP concentrations
at a constant concentration of 5 mM ADP at 310 °C for PKM2(WT) (black) and active-site mutant
variants PKM2(R72A) (teal), PKM2(R120A) (orange) and PKM2(K270A) (blue). The mean and
standard deviation of four separate experiments are shown, for each protein variant. Kinetic param-
eters were estimated from Michaelis-Menten fits of the rate curves. (B) Microscale thermophoresis
measurements were acquired for titrations of fluorescein-labelled PKM2(WT) with PKM2(R72A). (C)
Mixtures of PKM2(WT) with PKM2(R72A) were assayed for enzyme activity over a range of substrate
concentrations in the absence and (D) in the presence of 2 µM FBP.
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3.3.2 A numerical framework for modelling oligomeric enzyme cooperativ-
ity
The non-linear decay in enzyme activity of mutant-doped PKM2, upon FBP addition (Section
3.3.1), suggested a ligand-dependent inter-subunit cooperativity. To rationalise this observa-
tion, a numerical framework was constructed whereby the inter-subunit cooperativity of a
tetrameric protein could be simulated, and compared to experimental data.
To this end, a model was generated to consider the enzyme activity resulting from the mixture
of active PKM2(WT) oligomers (A) and inactive PKM2(R72A) (I ) oligomers. We assumed
that the measured association between PKM2(WT) and PKM2(R72A) formed tetramers and
that the composition of the tetramers was purely stochastic. Moreover, it was posited that
the mixture of A and I was deﬁned by the ratio of the concentrations of A and I.
Given the above assumptions, ﬁve conﬁgurations of hetero-tetramers resulting from the mix-
ture of PKM2(WT) and PKM2(R72A) are possible, not counting permutations under the
assumption of a stochastic association: AAAA, AAAI, AAII, AIII, IIII. The concentration of






The total concentration is trivially given by:
C = a+ i (3.7)
A ﬁnal assumption made in this model was that the enzyme activity of A is 1 AU (activity unit)
and that the corresponding activity of I is equal to 0 AU. Additionally, under conditions where
A and I catalytic sites function in complete isolation (ie. no inter-subunit cooperativity), the
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From this, the probability of observing a fully active tetrameric species from a sequential









where AC is the allosteric coeﬃcient, an added exponential term, deﬁned by the strength
of inter-protomeric cooperativity between individual subunits in the tetramer assembly (Fig.
3.6 A).
The mixture model in Equ. 3.10 was simulated over a range of increasing values of AC.
Where AC = 1, a linear decrease in activity was observed (Fig. 3.6 B). Conversely, where
AC > 1 a non-linear decay in activity of the model was observed (Fig. 3.6 C). The magni-
tude of the non-linear decrease in activity was found to be enhanced, with greater pre-deﬁned
values for AC (Fig. 3.6 C).
3.3.3 FBP binding induced inter-subunit cooperativity under conditions of
limiting substrate concentrations
The mixture model of enzyme activity was applied towards analysing initial velocity measure-
ments resulting from ratio-metric mixtures of PKM2(WT) and PKM2(R72) by performing a
non-linear regression of the activity data to Equ. 3.10. Solutions for the allosteric coeﬃcient
(AC) were computed using a non-linear least squares procedure, as a means of quantifying
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the strength of inter-protomeric cooperativity within hetero-oligomeric assemblies of PKM2.
The linear decay in enzyme activity, in the absence of any added FBP, supported the hy-
pothesis that protomers within PKM2 oligomers were acting largely in isolation, with no
detectable cooperativity between the individual catalytic pockets. This expectation was re-
ﬂected in the solution to the AC, which was found to be ≃ 1 (Fig. 3.6 D). In contrast,
the observed non-linear decay in enzyme activity, upon addition of saturating concentrations
of FBP resulted in an increase in the solution for the allosteric coeﬃcient. Moreover, this
non-linear eﬀect, and as such the allosteric coeﬃcient strength, was found to increase at con-
centrations of substrate below the KPEPM (Fig. 3.6 D). The correlation of the AC with the
concentration of phosphoenolpyruvate suggested a mechanism whereby FBP binding acts to
increase the cooperativity between individual subunits under conditions where the substrate
is limiting. Conversely, when the substrate concentrations are near-saturating, FBP-induced
inter-subunit cooperativity is diminished, regulate the activity of PKM2.
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Figure 3.6: FBP binding results in inter-subunit cooperativity as defined in a numerical
model. (A) A probability distribution for the five model hetero-oligomers AAAA, AAAI, AAII, AIIII
and IIII over a range of mixtures of active and inactive protein (i). (B) Simulation of the decay in
enzyme activity of a non-cooperative system. (C) Simulation in the decay in enzyme activity for a
cooperative system, where increasing allosteric coefficients (AC) model the magnitude of inter-subunit
cooperativity. (D) Solution for the allosteric cooperativity coefficient for WT:R72A mixtures in the
absence of any added FBP (empty) and in the presence of 2 µM FBP (solid).
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3.4 FBP and amino acids combinatorially regulate PKM2 ac-
tivity
In addition to the functional eﬀects of FBP on PKM2, demonstrated here, several amino
acids compete for a common allosteric pocket19,20,22 to regulate PKM2 enzyme activity. The
regulatory eﬀects of amino-acid binding per se is disputed; some studies have reported al-
losteric eﬀects on substrate aﬃnity18,19,59,71, while others report eﬀects on the rate of sub-
strate turnover20,22. Moreover, little is known about how simultaneous binding of FBP and
amino acids concurrently regulate PKM2.
3.4.1 Phe and Ser per se are K-type modulators of PKM2 catalytic activity
To this end, we started by measuring the functional eﬀects of an activating amino acid (L-
serine; Ser) and an inhibitory amino acid (L-phenylalanine; Phe) on PKM2 enzyme catalysis
per se. Phe and Ser were chosen because their binding had been structurally resolved19,22,
though at the time of writing a subsequent study by Yuan et al. (2018)20 reported further
structures of PKM2 in complex with Ala, Trp and His. PKM2 enzyme activity was measured
in the absence and in the presence of Ser and Phe. Consistent with previously published
ﬁndings, we found Phe addition to increase the Michaelis-Menten constant for the substrate
KPEPM to (7.09 ± 1.58) mM, without a detectable eﬀect on the product turnover number [kcat
= (324.7 ± 23.0) s−1] (Fig. 3.7). Conversely, addition of Ser resulted in a decrease in the
KPEPM to (0.22 ± 0.03) mM, without a signiﬁcant change in the rate of product turnover (Fig.
3.7). These results show that, in agreement with several existing studies18,19,59,71, Ser and
Phe regulate PKM2 in a K-type manner per se by modulating the apparent substrate aﬃnity
for PEP, without changing the apparent rate of substrate turnover.
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Figure 3.7: FBP and amino acids have distinct combined roles in regulating PKM2 activ-
ity. Steady-state kinetic parameters of recombinant PKM2 were measured with a spectrophotometric
assay coupled to lactate dehydrogenase over a range of concentrations of the substrate phosphoenolpyru-
vate at 37 °C. Kinetic parameters KM and kcat were estimated in the absence of added ligands (empty
green bars) and in the presence of 2 µM FBP (solid green), 400 µM Phe (empty orange), 400 µM
Phe and 2 µM FBP (solid orange), 200 mM Ser (empty blue) and 200 mM Ser and 2 µM FBP (solid
orange). Measurements were independently repeated four times. Significance was assessed using a
Wilcoxon rank-sum test. Asterisk (*) marks significant changes (p-value < 0.05). Data are shown in
a tabular form in Table 3.2.
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3.4.2 The mechanism of phenylalanine inhibition of PKM2 catalysis is dis-
tinct depending on FBP binding.
In order to investigate the inter-dependence between amino acid and FBP regulation, PKM2
enzyme activity was measured following addition of FBP and either Ser or Phe. Addition of
Ser, subsequent to FBP did not produce detectable changes to the KPEPM and the kcat (Fig.
3.7), showing that FBP and Ser do not synergistically activate PKM2.
In the presence of FBP, Phe reduces the substrate affinity and the maximal ve-
locity of PKM2 catalysis
Next, PKM2 activity was measured in the presence of FBP and Phe. We found that in the
presence of FBP, Phe signiﬁcantly decreased the kcat of PKM2 in a dose-dependent manner
by 57 % from 349.3 s−1 at [Phe] = 0 µM, to 222.8 s−1 at [Phe] = 400 µM. In contrast,
no Phe-dependent change to the kcat was detected in the absence of FBP (Fig. 3.7). In
addition to the observed reduction in the product turnover number, Phe addition reduced the
operational substrate binding aﬃnity from 0.22 mM, in the absence of Phe and saturating
FBP, to (0.65 ± 0.03) mM at [Phe] = 400 µM (Fig. 3.7. Taken together, these data revealed
that Phe addition, in the presence of FBP, produces a distinct inhibitory eﬀect on PKM2
activity compared to the eﬀects of Phe addition per se.
Phe per se acts as a hyperbolic specific inhibitor of PKM2
In order to assign the mechanism of Phe inhibition per se, the dependence of the enzyme
kinetic constants KM , kcat and (kcatKM )
app on the concentration of phenyalanine were analysed
(as described in Methods Section 2.3.4) (Fig. 3.8 A-C). Phenylalanine was found to act
as a hyperbolic speciﬁc inhibitor of PKM2 in the absence of FBP (Fig. 3.8 D). Formation
of the enzyme-eﬀector (EX) complex was favoured over the enzyme-substrate complex (ES)
due to an aﬃnity of the enzyme for Phe (KX = 0.019 mM), which was approximately 14-
times greater than the measured eﬀective substrate aﬃnity (KS = 0.250mM). However, the
aﬃnity of the substrate for the EX complex was found to be very weak (αKS > 20 mM),
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thus sequestering the enzyme in the EX complex, leaving less enzyme available for the ES
and ESX complexes, to facilitate turnover of the product. Notably, increasing concentrations
of phenylalanine had little eﬀect on the coeﬃcient β and so the rate of product turnover (k2)
between the ES and ESX complexes remained unchanged.
In the presence of FBP, Phe per se acts as a hyperbolic mixed inhibitor of PKM2
The dependence of the enzyme kinetic constants KM , kcat and (kcatKM )
app on the concentration
of phenyalanine was next analysed in the presence of saturating amounts of FBP (Fig. 3.8
E-G). In the presence of saturating FBP, the eﬀective substrate binding constant to FBPE
(KS = 0.170 mM) was found to be approximately three-times greater than the eﬀector bind-
ing constant (KX = 0.540 mM), marginally favouring the formation of the FBPES complex
over the FBPESX complex (Fig. 3.8 H). Nevertheless, Phe was found to have a signiﬁcant
eﬀect on the eﬀective substrate aﬃnity of the FBPEX complex (αKS = 1.130 mM), compared
to substrate binding to FBPE, thereby acting to sequester a fraction of FBP-bound enzyme
away from substrate binding. Moreover, Phe addition was found to signiﬁcantly reduce the
β coeﬃcient resulting in a reduction of the rate of product turnover from the FBPESX com-
plex (βk2 = 174.4 s−1), compared to the rate of product turnover from the FBPES complex
(βk2 = 459.0 s−1). Therefore, the inhibitory eﬀect of Phe binding to PKM2FBP could be
accounted for by a mixed mechanism of both reduced substrate binding and reduced prod-
uct turnover, and as such could be assigned as a hyperbolic mixed (predominantly speciﬁc)
allosteric inhibitor of PKM2FBP (Fig. 3.8 H).
Together, these data revealed that FBP mechanistically alters the mode of PKM2 inhibi-
tion by phenylalanine from a hyperbolic speciﬁc inhibitor, to a mixed hyperbolic inhibitor.
When FBP is absent, Phe acts exclusively as a K-type inhibitor whereas, in the presence of
saturating concentrations of FBP, Phe addition acts on both the KPEPM and the kcat, as a
mixed V- and K-type inhibitor.
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Figure 3.8: Phenylalanine inhibition follows one of two distinct mechanisms, depending
on the presence of FBP. Recombinant PKM2 activity was measured at varying concentrations of
PEP and a constant concentrations of 5 mM ADP and 5 nM PKM2, at 37 °C. Initial velocities were
performed in the presence of a range of Phe concentrations between 0.08 mM and 5 mM. Rate curves




were computed for Phe inhibition of PKM2apo∗ (black; A, B and C). (D) The dependence of the




were fit to the steady-state modifier-rate
equations defined in the text. (E-H) An analysis of phenylalanine inhibition was repeated as in (A-D),
in the presence of 2 µM FBP (saturating amounts).
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Apo∗ 1.22 ± 0.02 349.3 ± 40.9 285.6 ± 34.1
Phe 7.08 ± 1.58 324.7 ± 23.9 46.8 ± 6.0
Ser 0.22 ± 0.04 323.1 ± 43.2 1489.8 ± 84.7
FBP 0.23 ± 0.04 356.7 ± 25.7 1540.4 ± 96.9
FBP and Phe 0.65 ± 0.03 222.3 ± 6.3 342.1 ± 11.1
FBP and Ser 0.20 ± 0.04 348.7 ± 44.3 1620.0 ± 253.6
Table 3.2: Steady-state Michaelis-Menten kinetic parameters for PKM2apo∗, and following
the addition of FBP, Phe and Ser.
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3.4.3 Ligand-induced changes in affinity cannot explain the changed phenylalanine-
inhibition of PKM2 by FBP
Results in Sections 3.4.1 and 3.4.2 revealed that FBP addition changes the inhibition kinetics
of Phe. It was unclear whether this was a result of a combinatorial eﬀect of both ligands on
the bind aﬃnity of the other, or whether the result reﬂected a bona fide functional cross-talk
between the two ligands. Indeed, the eﬀective Phe binding constant to PKM2apo∗ [Kapo∗X =
(0.019 ± 0.077) mM] was found to be signiﬁcantly diﬀerent compared to that of Phe bind-
ing to PKM2FBP [KFBPX = (0.540 ± 0.06) mM] (Fig. 3.8 D and H). Nevertheless, since
a simpliﬁed single-substrate-single-enzyme mechanism was assumed, it was unclear whether
the changed (KX) reﬂected a changed binding aﬃnity or whether a more complex interaction
between PKM2, phosphoenolpyruvate and adenosine diphosphate (the second substrate not
considered in the above mechanism) was at play. To this end, the mutual eﬀects of FBP and
amino acids on binding to PKM2 was investigated.
We ﬁrst estimated the apparent aﬃnities of each ligand in the presence of saturating amounts
of the other. In the presence of saturating concentrations of either Phe or Ser, the KFBPD
decreased, however this was found not to be statistically signiﬁcant (p = 0.150 and p = 0.054,
respectively) (Fig. 3.9 A).
Next, the binding of Phe and Ser to PKM2 was measured, in the absence and in the presence
of FBP, using MST. Phe and Ser addition to PKM2 produced dose-dependent changes to the
thermophoresis of labelled PKM2. The estimated binding aﬃnites of Phe [(191.0 ± 86.2) µM)
and Ser [(507.5 ± 218.8) µM) (Fig. 3.9 B), were unaﬀected by the addition of saturating
amounts of FBP (Fig. 3.9 C).
Taken together, these measurements suggested that alteration in the binding aﬃnity of one
ligand by the presence of the other cannot account for the distinct FBP-dependent modes of
PKM2 inhibition by Phe. Rather, the altered mechanism of Phe inhibition upon FBP binding
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may reﬂect a mechanistic dependence between the two allosteric regulators.
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Figure 3.9: Amino acids and FBP do not reciprocally affect binding. (A) FBP binding to
PKM2 was measured using fluorescence emission spectroscopy (as described previously) in the absence
of amino acids (green) and in the presence of 400 µM Phe (orange) and 200 mM Ser. (B) MST
measurements of fluorescein-labelled PKM2 were performed to monitor serine (Ser) and phenylalanine
(Phe) binding to PKM2. Labelled PKM2, at a constant concentration of 30 nM, was titrated with either
Phe or Ser, and the thermophoretic properties of the resulting protein-ligand interaction was measured.
The mean and standard deviations of four separate titrations are shown. (C) MST experiments were
repeated for Phe (orange) and Ser (blue) in the presence of 2 µM FBP. (D) The overlapping modes
of Phe and Ser binding to PKM2 are superimposed from two crystal structures19,22.
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3.5 Simultaneous regulation of PKM2 by multiple ligands is
relevant for enzyme regulation in cells
Results presented in this chapter demonstrate that FBP binds tightly to PKM2 with a high
aﬃnity, and that Phe attenuates FBP-induced activation by stabilising a distinct kinetic state
with a reduced maximal velocity. The fraction of PKM2 bound to allosteric ligands in cells,
and hence the ability of these ligands to exert their respective regulatory eﬀects, is determined
by their intracellular concentrations and their binding aﬃnities. To investigate whether FBP
and amino acids are likely to concurrently bind to PKM2 and whether this is relevant for
PKM2 regulation, we sought to quantify the fractional saturation of PKM2 bound to FBP,
Ser and Phe, in proliferating cancer cells. The cellular fraction of PKM2 bound to allosteric
ligands is given by:
[PL] =
(KD + [Pic] + [Xic])−
√







where [Pic] and [Xic] are the intracellular protein and metabolite concentrations, respectively.
3.5.1 Intracellular FBP binding to PKM2 is constitutive whereas Phe and
Ser bind reversibly
The intracellular concentration of FBP is in excess of its binding affinity to PKM2
To this end, the range of intracellular concentrations of FBP, Ser and Phe in three human
cancer cells lines of diﬀerent tissue origin (HCT116, LN229 and SN12C), cultured in the pres-
ence of physiological (human blood serum) concentrations of glucose (Gluc+). [FBP ]ic varied
between between 240-360 µM across the three cell lines (Fig. 3.10 A). This concentration
range of FBP, under physiological glucose culture conditions, was in excess of the KFBPD be-
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tween 11919- and 17755-fold. The fraction of cellular PKM2 bound to FBP, calculated using
Equ. 3.12, found a fractional saturation of 0.99, which remained unchanged even in cells
cultured in the absence of glucose (Gluc−) (Fig. 3.10 B), despite a marked reduction in the
[FBP ]ic to between 20-70 µM across the three cell lines.
The intracellular concentrations of Ser and Phe constitute a dynamic range around
their respective affinities for PKM2
Next, cells were supplemented with either 100 µM Ser and 500 µM Phe (S100F 500) or 500 µM
Ser and 100 µM Phe S100F 500). Under physiological media concentrations, the intracellular
concentrations varied between 200-320 µM for Phe and 2000-4000 µM for Ser, across the three
cell lines (Fig. 3.10 C). The measured [Phe]ic and [Ser]ic were close to the apparent binding
aﬃnities for PKM2 [KPheD = (191.0 ± 86.3) µM and KSerD = (507.5 ± 218.2) µM]. The asso-
ciated fractional saturation of PKM2 with Phe was between 0.53-0.75, and between 0.81 and
0.92 with Ser. The range of predicted fractional saturations in the complete absence of amino
acids (aa−) or 5x physiological concentrations was 0.05 and 0.18 for Phe and Ser, respectively,
in culture conditions devoid of amino acids (aa−). The fractional saturation of both Phe and
Ser was found to increase to 0.90 and 0.98, respectively, in conditions of S100F 500 and S500F 100
(Fig. 3.10 D).
Estimations for the fraction of PKM2 bound to Ser and Phe did not take into account the fact
that these two ligands compete for binding. Moreover, the calculation assumed that binding
was unaﬀected by other amino acids, which have been shown to bind competitively at the
same allosteric pocket20. As such, the predicted fractional saturation of Phe and Ser is likely
to be an under-estimation of the true cellular value. Conversely, FBP binding was predicted
to be constitutively saturated, evidenced by a predicted binding saturation approaching 1 in
all conditions (Fig. 3.10 D).
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Figure 3.10: Cellular concentrations of PKM2 allosteric effectors reveal a physiological
role for multi-ligand regulation. (A) Intracellular concentrations of FBP were measured using
liquid-chromatography mass spectrometry (LC-MS) from HCT116, LN229 and SN12C cells cultured
in fully-fed conditions (RPMI containing 11 mM glucose; green bars) and glucose-deprived conditions
(RPMI containing 0 mM glucose; purple bars) for 1 hour. (B) A phase diagram for intracellular FBP
binding to PKM2 was computed over a range of [FBP] and [PKM2] values. Saturation of ligand-protein
binding is represented by a colour scale; a fractional saturation approaching 0 indicating conditions
under which PKM2 is fully apo∗ with respect to its interaction with FBP, and a fractional saturation
equal to 1 indicates that each FBP binding site on the cellular pool of PKM2 is occupied. The predicted
fractional saturation for each of the three cell lines (four technical replicates) are shown in the phase
diagram. The intracellular concentration of PKM2 was measured for each cell line using a targeted
proteomics approach (see Methods Section 2.5.2). (C) Intraceullar concentrations of Phe and Ser were
measured in media devoid of amino acids (aa−), containing 500 µM Phe and 100 µM Ser (F 500S100)
or 100 µM Phe and 500 µM Ser (F 500S100). Phase diagrams were computed for phenylalanine (D)
and serine (E), as for FBP above.
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3.5.2 The addition of exogenous FBP does not change PKM2 activity in
HCT116 cell lysates
Under conditions where FBP binding is constitutive, the intracellular activity of PKM2 would
be predicted to be unresponsive to the addition of further amounts of exogenous FBP. To
test this hypothesis, we assayed HCT116 cell lysates for PKM2 activity, following culture in
glucose-fed and glucose-depleted media. Cells were gently lysed in hypotonic lysis buﬀer, in an
attempt to maintain the intracellular FBP-PKM2 stoichiometry. It was observed that, while
addition of 100 µM FBP to recombinant PKM2 had the eﬀect of decreasing the KPEPM by
7-fold, very little change to PKM2 activity was apparent in HCT116 lysates upon addition of
up to 1 mM exogenous FBP (Fig. 3.11 A).
Phe addition reduces the maximal velocity of PKM2 activity in cell lysates
Addition of physiological concentrations of exogenous Phe to HCT116 cell lysates resulted in




3.11 B). It was observed that a Phe dose-depedent reduction in the maximal velocity was
the main kinetic determinant in the inhibition of the kcat
KPEP
M
of PKM2. No detectable change
to the KPEPM , however, was apparent upon addition of Phe to HCT116 lysates, similar to the
observed mechanism of Phe inhibition of recombinant PKM2FBP . Furthermore, the addition
of exogenous molar concentrations of Ser out-competed the inhibitory eﬀect of Phe, restoring
the maximal velocity to ’FBP-bound’ levels (Fig. 3.11 C).
Binding of PKM2 to PEP in cells is predicted to be sub-saturating
Intracellular concentrations of the catalytic substrate phosphoenolpyruvate (PEP) were mea-
sured in the low micro-molar range between (9.6 ± 3.5) µM and (2.3 ± 1.3) µM under glucose-
fed and glucose-deprived conditions, respectively (Fig. 3.12 A). The estimated KPEPA was
therefore between approximately 24-fold and 100-fold in excess of [PEP ]ic, suggesting that a
very low fraction of the protein was bound to its substrate in cells (sPEP < 0.04) (Fig. 3.12
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B). Conditions where the substrate is limiting give further credence to the relevance of Phe
and Ser competitively modulating the rate of product turnover, in the context of constitu-
tive FBP binding. Nevertheless, possible channelling of the substrate and/or diﬀerential PEP
sequestration in diﬀerent cellular compartments, could not be discounted.
Figure 3.11: PKM2 activity from HCT116 lysates is not further activated by addition of
exogenous FBP. (A) PKM2 activity in HCT116 cells cultured under glucose-fed conditions was as-
sayed, in the presence of increasing concentrations of exogenously added FBP. Initial velocities were
measured over a range of PEP concentrations. (B) Activity measurements were repeated in pres-
ence of increasing concentrations of exogenous phenylalanine and (C) serine. The fold-change in the
Michaelis-Menten constants (D) KPEPM and kcat measured from PKM2 activity of recombinant PKM2
(orange) and PKM2 activity in HCT116 cell lysates (teal). The fold-change is plotted between the
’apo∗’ condition and upon addition of either 2 µM FBP or 400 µM Phe.
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Figure 3.12: Intracellular concentrations of phosphoenolpyruvate are predicted to be con-
stitutively limiting for PKM2 binding. (A) Intracellular concentrations of phosphoenolpyruvate
were determined in three cancer cell lines under 11 mM glucose-cultured (teal) and glucose-deprived
(red) conditions. (B) A phase diagram of phosphoenolpyruvate binding to PKM2. A binding constant
of 0.22 mM was used, as determined from PKM2 activity measurements under conditions of FBP
binding.
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3.5.3 High milli-molar phospho-peptide concentrations are required to re-
versibly displace FBP binding
In this chapter, it is shown that competition between Phe and Ser regulating the rate of
PKM2FBP product turnover. The observed V-type eﬀect of Phe and Ser is dependent on
saturating FBP concentrations. We therefore reasoned that the combined regulatory eﬀects
of amino acids and FBP could be perturbed upon phosphopeptide-induced displacement of
FBP binding. Nevertheless, exploring the stoichiometry of peptide binding to PKM2 in cells
is complicated by the likelihood that multiple peptide binding motifs bind with varying aﬃni-
ties. Therefore, an accurate quantiﬁcation of the fraction of PKM2 bound to phospho-peptides
would require a comprehensive phospho-proteomics screen combined with a high-throughput
peptide aﬃnity eﬀort, which was beyond the scope of this thesis.
Instead, to estimate the intracellular concentration of PKM2-binding phosphopeptide, required
to reduce the binding aﬃnity of FBP to levels which facilitate a non-constitutive phenotype,
Equ. 3.12 was computed for a range of simulated phosphopeptide concentrations. It was as-
sumed that all phosphopeptide molecules have the same binding aﬃnity for PKM2, and that
they all displace FBP with the same kinetics as measured in recombinant protein (see Section
3.2.4). We found that phosphopeptide concentrations of approximately 40 mM were required
to reduce the fractional saturation of FBP to 0.5 (Fig. 3.13).
Together, these observations supported the hypothesis that, during steady-state cell prolif-
eration under cell culture conditions, FBP is constitutively bound to PKM2. Under these
conditions, amino acids can reversibly bind and thereby regulate the enzyme activity of PKM2
by modulating its maximal velocity, in the background of post-translational modiﬁcations that
are likely to occur to PKM2 in cells.
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Figure 3.13: Milli-molar concentrations of phosphorylated peptide is required to out-
compete FBP binding in cells. The fraction of PKM2 bound to FBP in HCT116, SN12C, MCF7
and LN229 cell lines was computed over a range of phospho-peptide concentrations.
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3.6 Conclusion
Evidence, presented in this chapter, derived from measurements of PKM2 activity suggests
that allosteric eﬀectors can modulate the velocity and substrate aﬃnity through a complex
series of intra- and inter-protomeric couplings. Moreover, simultaneous regulation of PKM2 by
FBP and amino acids is likely to occur over a large range of cell culture conditions. A major
mechanism that has been suggested to result from allosteric eﬀector binding is the regulation
of the oligomeric state of PKM2. We therefore wanted to understand if, and to which extent,
the ﬁndings of this chapter could be explained by ligand-induced oligomerisation of PKM2.
We next turned to native mass spectrometry to investigate the potential of allosteric regulators
to eﬀect changes in the oligomeric state of PKM2.
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Chapter 4
Native mass spectrometry reveals the
structural basis of distinct ligand
modes of action.
4.1 Introduction
The oligomeric state adopted by PKM2, and how ligand binding aﬀects changes to the
monomer-dimer-tetramer equilibrium, remains controversial. PKM2 forms a homotetrameric
complex in crystal structures, both in the absence and in the presence of various co-crystalised
allosteric ligands and substrates17,19,20,22,23,55. Solution-phase chromatographic measure-
ments of PKM2 size, however, have shown that PKM2 forms an equilibrium of monomers
and tetramers17,20,22,24,70, with some studies reporting the existence of dimers21,62, in which
the tetramer has high enzymatic activity whereas monomers and dimers display lower levels of
activity17,33,65,70,71. Accordingly, the regulation of PKM2 oligomerisation by various allosteric
ligands in solution17,20–22,62,70,71 and in the gas phase63, has been previously reported as a
mechanism by which PKM2 activity can be modulated. In addition to oligomerisation, several
studies of PKM2 and its homologues have implicated ligand-induced conformational changes
as contributing to the inactive-active state transition20,22,55,66,72–74,77. What is unclear, how-
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ever, is the relative contribution of ligand-induced oligomerisation and conformational changes
towards regulation of PKM2 enzyme activity.
Measurements of the steady-state enzyme kinetics of PKM2, in Chapter 3, found that al-
losteric regulators FBP, Ser and Phe act per se in a K-type mechanism to modulate the
eﬀective substrate aﬃnity of PKM2 for PEP. Moreover, it was found that FBP binding alters
the mode of phenylalanine inhibition from a hyperbolic-speciﬁc to a hyperbolic-mixed mech-
anism, suggesting a mechanistic cross-talk between the two ligands. Given that modulation
of the oligomeric state of PKM2 has been previously demonstrated as an important regula-
tory mechanism, we sought to investigate whether ligand-induced activity changes could be
explained by PKM2 oligomerisation and/or conformational transitions.
In this chapter, a characterisation of PKM2 oligomerisation in the gas phase is presented.
Two mass spectrometry techniques, nano-electrospray ionisation mass spectrometry (nESI-
MS) and ion-mobility coupled to nESI-MS (IM-MS), were used to explore the distribution of
PKM2 oligomers and ensemble of conformations, respectively in the native-state.
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4.2 FBP binding regulates oligomerisation of PKM2
4.2.1 PKM2 forms a mixture of oligomeric states
To mass-resolve the oligomeric states of PKM2 in the gas phase, native spectra of PKM2
in the absence of any added ligands were obtained. As was detailed in Chapter 3, prepa-
rations of PKM2 co-puriﬁed with sub-stoichiometric amounts of FBP. All experiments were
performed with a single preparation of PKM2 containing less than 25 % of its sites pre-bound
to FBP. Experiments performed on puriﬁed PKM2 in the absence of any added ligands, though
containing quantiﬁed sub-stoichiometric amounts of FBP, are denoted with an asterisk (Apo∗).
The native spectrum of PKM2 showed a mixture of monomers, dimers and tetramers at
an approximate ratio of 1:7:10 (Fig. 4.1 A). To investigate the concentration-dependence of
PKM2 oligomerisation, additional native spectra of PKM2 were acquired at protein concen-
trations between 1 µM and 70 µM. A concentration-dependent eﬀect on the relative intensities
of the three oligomeric species was observed, favouring a higher proportion of tetramers in the
more concentration protein samples at the expense of the dimeric species (Fig. 4.1 A and
B). Additionally, the relative intensities of the monomeric charged-state species were found to
increase towards higher protein concentrations. This may suggest an inherent instability of the
dimeric species at higher protein concentrations, which pushes the equilibrium of oligomeric
states towards the tetrameric and monomeric states.
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Figure 4.1: The concentration-dependence of PKM2 oligomerisation. (A) Nano-electrospray
ionisation mass spectrometry was used to acquire native spectra of PKM2apo∗. The protein was sprayed
from a 100 mM ammonium acetate solution containing a total PKM2 concentration of 1 µM, 10 µM,
35 µM and 70 µM. (B) The oligomeric state distribution was quantified for each of the concentration
of PKM2 and presented as stacked bars showing the relative intensities of monomers (orange), dimers
(white) and tetramers (blue).
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4.2.2 PKM2 dimers form stably about the A-A’ interface
PKM2 dimers might form two possible assembles about the A-A’ and C-C’ inter-
faces
The inherent two-fold symmetry of PKM2 tetramers may give rise to one of two possible
dimeric assemblies about the A-A’ interface (the A-A’ dimer) or about the C-C’ interface (the
C-C’ dimer) (Fig. 4.2 A). It was unclear whether the PKM2 dimers observed in the native
spectra (Fig. 4.1 A) were of the A-A’ or C-C’ assembles, or a mixture of the two. PKM2
protomers have the same primary structure and hence, identical masses, and so it was not
possible to mass-resolve the two possible species. Nevertheless, an inspection of the overall
shape of in silico models generated of the two dimeric assemblies showed a diﬀerence in shape
between the two possible dimer species (the A-A’ dimer is more globular than the elongated
C-C’ dimer assembly; Fig. 4.2 A). As such, we hypothesised that the two dimer assemblies
could be distinguished by their mobilities in the gas phase.
In silico calculations find that A-A’ and C-C’ dimers have distinct ion mobilities
To this end, we used IM-MS to measure the experimental drift time of selectively activated
PKM2 dimer charge states. The drift time of the ion in a deﬁned buﬀer gas (tD) is proportional
to the rotationally-averaged collision cross section (CCS, Ω), which can be interpreted as the






















where e is the elementary charge, E is the charge carried by the ion, N is the number density,
L is the path length of the drift cell, T is the temperature and kB is the Boltzmann constant.
For comparison with experimental measurements, the CCS of the 23+ A-A’ and C-C’ dimers,
the 15+ monomer and the 33+ tetramer ions were computed from short 10 ns molecular dy-
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namics simulations of A-A’ and C-C’ dimer in silico models (see Methods Section 2.2.2).
The CCS was calculated from the representative clustered structures using a projection-
approximation (PA) approach (PACCS), which has been used for many years to calculate
rotationally-averaged CCS values for molecules166. PA methods, however, fail to account for
long-range interactions and all the physical details of the scattering process between the ion
and the buﬀer gas166. For a more explicit treatment of the scattering process in calculating the
CCS, PACCS was supplemented with additional CCS calculations using an elastic hard-sphere
scattering (EHSS) approach (EHSSCCSHe), in which the CCS is calculated by averaging the
momentum transfer cross section which is related to the scattering angles between the incoming
and departing gas atom trajectory166.
A comparison between theoretical and experimental CCS measurements finds that
dimeric PKM2 forms the A-A’ assembly
The experimentally determined collision cross section for the 15+ monomer ion (DTCCSHe)
was (34.5 ± 9.9) nm2, 3.3 % larger than the theoretical EHSSCCSHe (Fig. 4.2 B). Although
the diﬀerence between the EHSSCCSHe and the experimental DTCCSHe was found to be
signiﬁcant (p-value < 0.001), a more pronounced structural compaction in gas-phase molec-
ular dynamics simulations has been previously reported to manifest in smaller collision cross
sections, relative to the experimental measurements167. The theoretically determined PACCS
was found to further underestimate the experimental DTCCSHe by 10.1 % [PACCS = (31.00
± 1.71) nm2] (Fig. 4.2 B), likely because the PA approach does not account for the eﬀects of
multiple ion-gas collisions, and hence for ions of masses greater than 2 kDa, this method will
underestimate the CCS and is know to be of limited use for the study of larger biomolecules166.
The experimentally measured DTCCSHe for the 33+ tetramer ion [(92.46 ± 2.57) nm2] was
in good agreement with the theoretically-determined CCS as determined using the EHSS-
approach [EHSSCCSHe = (92.98 ± 3.41) nm2] (Fig. 4.2 B). Taken together, the agreement
between theoretically and experimentally determined CCS values for PKM2 monomer and
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tetramer ions suggested that similar measurements of the dimer ion would have predictive
power in elucidating the assembly of dimeric PKM2 in the gas phase.
The C-C’ dimer was found to have a theoretical CCS of [EHSSCCSHe = (61.08 ± 6.73)
nm2], 13 % larger than the A-A’ dimer [EHSSCCSHe = (53.20 ± 2.23) nm2] (Fig. 4.2 B),
suggesting that the two possible dimer assemblies have distinct ion mobilities. Experimental
CCS measurements of the 21+ dimer ion [DTCCSHe = (52.59 ± 9.37) nm2] were in close
agreement with the theoretically-determined CCS of the A-A’ dimer (Fig. 4.2 B). The close
match between the theoretical CCS of the A-A’ dimer and the experimentally-measured CCS
of dimeric PKM2, suggested that PKM2 dimers form the A-A’ assembly in the gas phase.
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Figure 4.2: Ion mobility measurements reveal that PKM2 dimers are stable about the A-A’
interface. (A) Structural models of [i] A-A’ dimers and [ii] C-C’ dimers, shown in cartoon repre-
sentation. (B) The CCS of the 15+ monomeric (orange), 23+ dimeric (white) and 33+ tetrameric
(blue) PKM2apo∗ calculated experimentally by IM-MS (shaded bars) and from MD simulations of
the respective ions using the Projection Approximation (PACCS) and Exact Hard-Sphere Scattering
(EHSSCCSHe) approaches.
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4.2.3 FBP induces PKM2 tetramerisation
Consistent with previous studies19,48,55,60, a characterisation of enzyme kinetics of PKM2 in
Chapter 3 showed that the binding of FBP increases the eﬀective substrate aﬃnity of PKM2
for phosphoenolpyruvate. To explore whether this functional eﬀect of activator binding was
accompanied by an induced change in the oligomeric state, we acquired native spectra of PKM2
titrated with FBP. FBP addition was found to increase the relative abundance of tetrameric
charged-state species in a dose-dependent manner (4.3 A and B). Additionally, an apparent
m/z shift in the tetrameric peaks and a qualitative change to the overall charged-state envelope
was observed (4.3 C). The m/z shift was expected to result from the binding of at least three
molecules of FBP to each PKM2 tetrameric species, given that preparation of protein had
been previously characterised as containing ≃ 23 % of the binding sites pre-occupied with
co-puriﬁed FBP (Section 3.2.1).
145
J.A.S MACPHERSON CHAPTER 4
Figure 4.3: FBP addition induces a dose-dependent tetramerisation of PKM2. (A) Native
spectra were acquired for PKM2 titrated with FBP. The ratio of protein-to-ligand is indicated. (B)
The relative intensities of oligomeric states was determined for each ratio-metric mixture of FBP-
PKM2. (C) Native spectra of the 33+ tetrameric charge state species for each stoichiometric mixture
of FBP-PKM2.
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4.2.4 PKM2Apo∗ tetramers are formed from a mixture of apo and holo pro-
tein
In order to resolve the apparent mass shift of tetrameric PKM2 upon FBP addition, spectra
of PKM2 were acquired under high cone-voltage conditions in order to remove salt adducts
during the ionisation process, which would otherwise add to the overall weight of analyte ions.
Mass-deconvolution of the subsequent spectra (see Methods Section 2.4.1) could thus be com-
pared to the theoretical mass of the PKM2 from its primary sequence.
The mass-deconvolved spectrum of FBP-saturated PKM2 (PKM2FBP ) revealed a single mass
peak at 234.190 kDa (Fig. 4.4) corresponding to the theoretical mass of tetrameric PKM2
bound to four molecules of FBP (234.273 kDa). In contrast, tetrameric PKM2 in the ab-
sence of any added FBP (PKM2apo∗), consisted of ﬁve separate peaks (Fig. 4.4 and Table
4.2). The diﬀerence in mass between the diﬀerent PKM2apo∗ mass peaks were approximately
equivalent to the mass equivalents of a single molecule of FBP (340 Da), suggesting that the
peaks reﬂected tetrameric PKM2 species bound to 0, 1, 2, 3 and 4 molecules of FBP (Fig.
4.4). The intensities of the ﬁve mass peaks of PKM2 in the absence of added FBP, reaﬃrmed
the ﬁnding that considerable molar amounts of FBP are retained during the puriﬁcation of
PKM2 (Section 3.2.1). Additionally, these results show that FBP binding is not required
for PKM2 tetramer formation. Moreover, the relative apex-intensities of the ﬁve mass peaks
of PKM2apo∗ may provide information on the degree of cooperativity associated with FBP
binding. For an inﬁnitely cooperative system, where the concentration of ligand is limiting,
one would expect appreciable quantities of only the apo and holo species. The distribution of
peaks with an approximate ratio of 5:2:2:2:1, however, suggests that FBP binding is weakly
cooperative.
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Tetrameric PKM2 + 1 FBP 233222.6
Tetrameric PKM2 + 2 FBP 233572.6
Tetrameric PKM2 + 3 FBP 233922.6
Tetrameric PKM2 + 4 FBP 234272.6





10 µM PKM2 High voltage 4 232880, 233220, 233580, 233930, 234290
+ 10 µM FBP Native-like 1 235030
+ 10 µM FBP High voltage 1 234190
Table 4.2: Maximum entropy mass estimation of tetrameric PKM2 from nESI-MS m/z spectra under
native-like and high cone-voltage ionisation conditions.
Figure 4.4: The mass-deconvolved spectrum of PKM2apo∗ reveals a mixture of apo and holo
species. Mass-deconvolved spectra were calculated from spectra of PKM2apo and PKM2FBP . Nor-
malised mass spectra of PKM2apo∗ (black) and PKM2FBP (green) are shown. Peaks are annotated
with the corresponding FBP-PKM2 stoichiometric species, as determined from the exact mass of the
measurement.
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4.2.5 FBP binding induces subtle changes to the shape of tetrameric PKM2
Previous studies have suggested that allosteric ligands induce inter-domain conformational
changes within the PKM2 tetramer22,55,62,77 and other pyruvate kinase homologues66,72,74,75.
Therefore, we investigated the possibility that FBP binding induced conformational changes
that could be detected by an altered mobility in the gas phase.
To this end, IM-MS measurements of PKM2 were acquired in the absence and in the presence
of saturating amounts of FBP, from which a global CCS was calculated for each tetramer
(see Methods Section 2.4.2). We found that diﬀerences in the DTCCSHe distribution, which
reﬂects the conformational heterogeneity of proteins, suggested that FBP caused subtle con-
formational changes in the tetramer (Fig. 4.5). The negative diﬀerence in the DTCCSHe
distribution between PKM2apo∗ and PKM2FBP at DTCCSHe > 10000 suggested that FBP
binding marginally reduces the compaction of the tetramer.
Figure 4.5: FBP binding changes the global collision cross section of PKM2 tetramers.
DTCCSHe distribution of PKM2apo∗ and PKM2FBP calculated from analyses of arrival time distribu-
tion measurements of PKM2 tetramer peaks (see Methods Section 2.4.2). Average calculated values are
shown in solid lines and the standard deviations are shown as shaded ribbons. The difference spectrum
between PKM2apo∗ and PKM2FBP is shown as a dashed line.
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4.3 Inhibitory amino acids have distinct effects on tetramerisa-
tion depending on whether FBP is bound
Measurements of the steady-state kinetics of PKM2 in Chapter 3 found that while FBP addi-
tion promoted high substrate aﬃnity, simultaneous addition of phenylalanine (Phe) and FBP
prevented FBP from exerting its maximally activating allosteric eﬀect by reducing the kcat.
nESI-MS experiments supported the hypothesis that FBP activation involves tetramerisation
of PKM2, linking activation to the oligomeric state. Competing views of amino acid inhibi-
tion of PKM2 debate the eﬀects of Phe and Ala binding on PKM2 oligomerisation20,22,70. We
therefore set out to determine the eﬀects of amino acids on the oligomeric state of PKM2, and
to explore whether Phe impedes FBP-induced activation of PKM2 by aﬀecting changes to the
oligomeric state of the protein.
4.3.1 Phe addition does not disrupt FBP-induced PKM2 tetramerisation
Addition either Phe to PKM2 at a protein-to-ligand ratio of 30:1, resulted in an increase in
the relative abundance of dimeric PKM2 charge state species (Fig. 2.1 A and B), suggesting
that Phe addition per se favoured the dimeric form of PKM2. The perference of Phe for
dimerisation is in agreement with previous solution-phase analytical ultracentrifugation stud-
ies70,168. Broadening of the dimeric and tetrameric charge state peaks was observed, likely
due to additional salt molecules binding to the protein upon addition of high concentrations
of the ligand (Fig. 2.1 A and B). The apparent eﬀects of Phe addition in promoting the
dimeric state of PKM2, while signiﬁcant in its magnitude, may have been underestimated due
to the stoichiometry of binding. Considering the measured binding aﬃnities of both ligands,
calculated estimates of the fraction of 10 µM PKM2 bound upon addition of 300 µM Phe is
0.68, leaving a considerable fraction of the unbound protein. Attempts at measuring native
m/z spectra of PKM2 at higher ligand concentrations were unsuccessful due to the unaccept-
ably high salt content of the protein-ligand mixture.
150
J.A.S MACPHERSON CHAPTER 4
Next, native spectra of PKM2 were acquired following pre-incubation with saturating concen-
trations of FBP. As before (Section 4.2.3), FBP addition resulted in PKM2 tetramerisation
(Fig. 4.6 A and B). Addition of Phe subsequent to pre-incubation with FBP did not perturb
the tetrameric state of PKM2, while FBP binding to PKM2 pre-incubated with Phe resulted in
protein tetramerisation, indicating that the dominant eﬀect of FBP on PKM2 tetramerisation
was not eﬀected by the order of ligand addition (Fig. 4.6 A and B).
Figure 4.6: Phe binding does not disrupt FBP-induced PKM2 tetramerisation. (A) Na-
tive spectra of 10 µM PKM2apo∗ and in the presence of 10 µM FBP (PKM2FBP ), 300 µM Phe
PKM2Phe, 300 µM Phe followed by addition of 10 µM FBP PKM2Phe+FBP and 10 µM FBP followed
by addition of 300 µM Phe PKM2FBP+Phe. Relative oligomeric state abundances were calculated and
are shown in (B).
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4.3.2 Phe and FBP synergistically promote PKM2 tetramerisation
It appeared from from the preceding native spectra of PKM2, that Phe had a neutral eﬀect
on the oligomeric state of FBP-bound PKM2 and that their binding was simply a passenger
to FBP-induced tetramerisation. This hypothesis was found not to hold in the context of sub-
stoichiometric FBP addition, where the subsequent addition of either Phe was found to act
synergistically with FBP to promote PKM2 tetramerisation with slow kinetics [ktet = (812.5
± 284.6) s−1] (Fig. 4.7). Conversely, the addition of equivalent half-stoichiometric amount
of FBP in the absence of Phe, were unable to fully convert PKM2 monomers and dimers into
tetramers (Fig. 4.7). The propensity for Phe to enhance FBP-induced tetramerisation im-
plied a functional synergism between the activator and either amino acid inhibitors, favouring
tetramer formation despite to apparent opposing eﬀects of these ligands, individually, both on
enzyme activity and oligomerisation.
Figure 4.7: FBP and Phe synergistically promote PKM2 tetramerisation. The time-resolved
ratio of tetramer-to-dimer charge state intensities of 10 µM PKM2 following pre-incubation with either
(i) 5 µM FBP, or (ii) 5 µM and 400 µM Phe. Time-resolved intensities are fit to a two-state sigmoidal
model.
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4.3.3 Analytical evidence for simultaneous binding of FBP and Phe to
PKM2
The failure of Phe addition to destabilise FBP-bound PKM2 tetramers suggested a dominant
eﬀect of FBP on the oligomeric state of the protein. Moreover, it was predicted that the si-
multaneous addition of Phe and FBP to PKM2 would result in doubly-liganded PKM2, given
the the ﬁnding from ligand binding studies that the binding aﬃnity of Phe was unaﬀected
by FBP binding, and vice versa. Nevertheless, to address the possibility that under ionising
conditions into the gas phase Phe does not bind to PKM2FBP , we sought analytical evidence
for simultaneous binding of Phe and FBP to PKM2.
Evidence for concurrent Phe and FBP binding to PKM2 was provided by the m/z shift pro-
duced by ligand addition to PKM2. Close inspection of the +33 tetramer charge state found
that the PKM2apo∗ spectrum contained a doublet of tetramer peaks: the left portion of the
peak was the fully-apo protein and the right portion resulted from ions of 1, 2, 3 and 4 FBP
molecules bound to PKM2 tetramers (Fig. 4.8 A). Addition of saturating amounts of FBP
resulted in a small m/z shift towards higher CSD values (Fig. 4.8 A). A further shift of the
PKM2FBP 33+ peak was observed upon addition of Phe to FBP-bound PKM2 (Fig. 4.8 A).
The shift towards lower charge-states upon addition of Phe was found to be reversible when the
cone voltage (CV) in the electrospray ionisation source was increased from 10 V to 100 V. In-
creasing the CV had the observed eﬀect of reducing the negative charge of the PKM2FBP+Phe
peaks and converting them to align with the PKM2FBP (Fig. 4.8 A). This was achieved by
displacing Phe molecules bound to PKM2FBP . Conversely, increasing the CV of the ESI source
did not convert the +33 PKM2FBP ion to the ’apo-like’, suggesting that the high FBP-PKM2
binding aﬃnity stabilised the interaction from dissociation even at high ionisation energies.
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Figure 4.8: FBP and Phe can simultaneously bind to PKM2. (A) Mass spectra of PKM2
were acquired in the absence of any added ligands (PKM2apo∗), and following the addition of stoi-
chiometric amounts of FBP (PKM2FBP ); addition of 400 µM Phe to 10 µM PKM2 pre-incubated
with FBP (PKM2FBP+Phe); or addition of 10 µM FBP to PKM2 pre-incubated with 400 µM Phe
(PKM2Phe+FBP ). Spectra were acquired with the cone-voltage of the electrospray ionisation source set
at either 10 V (native-like) or 100 V (collisional activation). Positions of the m/z peaks are shown as
dashed lines. (B) The relative abundances of monomer (orange), dimer (white) and tetramer (blue)
species were quantified from the spectra in (A).
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4.3.4 Phe partially reverses PKM2 to an ’apo-like’ conformation
Previous calculations of the CCS (Section 4.2.5) revealed subtle conformational changes in
PKM2 in response to FBP binding. Given that the subsequent addition of Phe was found
to reduce the kcatKM ratio to apo-like levels (Chapter 3) we questioned whether the apparent
conformational changes might be predictive of the enzyme activity level of the protein. To
this end, IM-MS measurements of PKM2 were repeated following concurrent addition of Phe
and FBP. We found that simultaneous binding of Phe and FBP partially reversed the FBP-
induced shift towards higher DTCCSHe values (Fig. 4.9), suggesting that Phe might reverse
the conformational changes associated with FBP-induced enzyme activation.
Figure 4.9: Phe partially reverses FBP-induced conformational changes. IM-MS measure-
ments of PKM2 in the absence of any added ligands (black) in the presence of stoichiometric amounts
of FBP (green) and in the presence of FBP and 300 µM Phe (orange). A protein concentration of 10
µM was used for all measurements.
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4.4 Conclusion
Collectively, enzymology, biophysics and native mass spectrometry suggest that allosteric reg-
ulators of PKM2 exert distinct eﬀects on PKM2 catalysis by modulating the KPEPM and the
kcat. Furthermore, this diﬀerential eﬀect on alternative aspects of enzyme catalysis is proposed
to be routed in the oligomeric structure of PKM2. A characterisation of amino acid and FBP
binding revealed that the kinetics of ligand binding to these two pockets occcur independently.
The binding of amino acids was found to occur with the same apparent dissociation constant
irrespective of whether or not FBP is bound to its pocket, and vice versa. Concurrent bind-
ing of Phe and FBP to PKM2 was further supported by the ﬁnding that subsequent ligand
addition results in further reversible shifts to the charge-state distribution of PKM2 tetramers.
However, a functional cross-talk between the two binding pockets is proposed. In support
of this hypothesis we have found that the enzyme kinetics of PKM2 are distinct when both
amino acids and FBP are bound simultaneously, compared to their eﬀects per se. Moreover,
the functional synergism between amino acid and FBP binding is manifest by enhanced ki-
netics PKM2 oligomerisation, despite opposing eﬀects of Phe and Ala stabilising dimers and
FBP stabilising the tetrameric state. This suggested a functional cross-talk routed in the
mechanism of allosteric signal transfer from either allosteric pocket to the protomer interfaces
and the active sites, possibly through cooperation between the allosteric pathways connecting
these functional sites.
In order to understand the molecular basis of this functional cooperation between amino
acid and FBP regulation, we sought to model the eﬀect of these allosteric ligands on the
conformational dynamics of PKM2 using molecular dynamics simulations. In addition, we
developed a computational method designed to extract allosteric pathways from molecular




predict hub residues involved in the
allosteric transition of PKM2.
5.1 Introduction
Allosteric ligand binding was shown in the previous two Chapters to aﬀect changes to PKM2
activity by regulating the oligomeric state and the global conformational shape of the pro-
tein. Previous investigations have suggested that human PKM222, and some of its ortho-
logues66,72,75, undergo a concerted rigid-body structural motion in response to FBP binding.
In contrast, very little is known about the ﬁne-grained molecular mechanism by which FBP
and amino acids regulate PKM2; both in terms of the consequent energetic changes (either
enthalpic or entropic) and the amino acid residues involved. Moreover, the structural resolu-
tion aﬀorded by ﬂuorescence spectroscopy and mass spectrometry measurements is limited.
An eﬃcient strategy for probing allosteric regulation with suﬃcient temporal, spatial and
energetic resolution, is the use of molecular dynamics (MD) simulations to model the con-
formational dynamics of proteins83,169,170. Therefore, we sought to investigate the molecular
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mechanism of PKM2 allosteric regulation with a view towards identifying the speciﬁc pro-
tein residues, which are involved in propagating activating or inhibitory eﬀects from distinct
allosteric sites to the catalytic pocket, using MD simulations. In this Chapter, results are
presented from a comprehensive study of the energetics and dynamics of monomeric and
tetrameric PKM2 using computer simulations. Additionally, a novel computational method
AlloHubMat is described and applied towards extracting predicted allosteric hub residues in
PKM2.
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5.2 Molecular dynamics simulations of PKM2 capture ligand-
induced conformational changes
To explore possible protein backbone conformational changes, elicited by allosteric ligand bind-
ing to PKM2, MD simulations of PKM2 were performed in the absence and in the presence
of several allosteric ligands. Given that PKM2 exists as an equilibrium of oligomeric states
(Section 4.2.1), simulations of both monomeric and tetrameric protein were performed to in-
vestigate diﬀerences in the conformational dynamics between the two oligomers. Monomeric
PKM2 was simulated in the apo-form (mPKM2apo), bound to the endogenous inhibitor Phe
(mPKM2Phe), the endogenous activator FBP (mPKM2FBP ) and the exogenous small-molecule
activator Tepp-46 (mPKM2Tepp). Similarly, to investigate the dynamics involved in the ligand-
induced conformational transition of PKM2 (Section 4.2.5), simulations of tetrameric PKM2
were seeded from protein crystal structures in the apo-form (tPKM2apo), bound to FBP
(tPKM2FBP ), concurrently bound to serine and FBP (tPKM2FBP+Ser) and bound to pheny-
lalanine and FBP (tPKM2FBP+Phe).
5.2.1 An integration time step of 2 fs appropriately conserves the energy
in monomeric PKM2 simulations
Prior to production runs in the NPT ensemble, short 40 fs simulations of mPKM2apo were
performed in the microcanonical (NVE) ensemble to evaluate the conservation of total energy
of the system with integration time step sizes of 2 fs, 3 fs and 4 fs.The total energy ﬂuctuations
of the system were compared to those of the potential energy and the kinetic energy:
∆E =
√
(E − 〈E〉)2 (5.1)
where E is either the total, kinetic or potential energies of the system.
Increasing the integration time step of the short NVE simulations resulted in a consider-
able increase in the amplitude of the ﬂuctuations of the potential and kinetic energies (Fig.
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5.1). To reduce errors propagated from integrating the equations of motion, ﬂuctuations of
the total energy should be less than one-ﬁfth of the ﬂuctuations of the kinetic or the potential
energies171. This criteria was not fulﬁlled for simulations using time steps larger than 2 fs
(Table 5.1), and so an integration time step of 2 fs was used in all subsequent simulations of
monomeric and tetrameric PKM2.
Figure 5.1: Energy fluctuations calculated for different integration time-steps. Simulations
with constant energy (NVE) were performed to evaluate how well the total ennergy was conserved for








Table 5.1: Single precision NVE simulation without thermostat or barostat coupling. Quan-
tification of the energy fluctuations in NVE simulations of mPKM2apo, as shown in Fig. 5.1.
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5.2.2 FBP binding causes PKM2 monomers to sample two distinct confor-
mational states
To investigate the mechanical response of PKM2 upon FBP and Phe binding we performed
MD simulations of mPKM2apo, mPKM2FBP and mPKM2Phe at a constant temperature of 300
K and a pressure of 1 atm. To simplify the high-dimensionality of the trajectories and to study
the molecular determinants related to the binding Phe or FBP, principal component analyses
were performed of the positional coordinates of the three simulations. After removing roto-
translational degrees of freedom, the covariance matrix (σ) of the atomic positional ﬂuctuations
was calculated with the elements:
σij = 〈(xi − 〈xi〉)(xj − 〈xj〉)〉 (5.2)
where {x1, x2, x3, ..., x3N} are the Cartesian coordinates of the protein. The covariance matrix
was then trivially expressed in mass-weighted coordinates:
σ′ = Mσ (5.3)
where M is the mass matrix of the protein. From the mass-weighted covariance matrix (σ′),
eigenvalues (λ) and eigenvectors (x) were determined through a linear transformation:
0 = (σ′ − Iλ)x (5.4)
where I is the unit matrix. The eigenvalue problem in Equ. 5.4 was solved for the eigenvalues
and the eigenvectors of the system.
Simulated trajectories of mPKM2FBP were found to sample two discrete conformational states
in eigenvector space over the course of a 500 ns simulation (Fig. 5.2 A). A k-means clustering
of the PCA plot found that two clusters [i] and [ii] explained all of the point variability of
the data set. Transition between clusters [i] and [ii] was dominated by the movement of the
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B-domain into the closed conformation over the substrate-binding pocket, and a change to the
N-terminal helix-loop-helix (HLH) into an alternative, stable conformation (Fig. 5.2 A). The
nature of the B-domain motion led to the annotation of cluster [i] as the open conformation
and cluster [ii] as the closed conformation.
MD simulations of mPKM2apo, mPKM2Phe and mPKM2Tepp−46 were similarly analysed for
positional variance about the ﬁrst two eigenvectors by transforming their positional coordi-
nates into eigenvector space (Fig. 5.2 B). In order to project all four monomer trajectories
into the same eigenvector space, the same rotation matrix was applied to each coordinate
system. Analyses of mPKM2apo and mPKM2Phe trajectories were conﬁned to cluster [i], thus
sampling the open conformation, whereas mPKM2Tepp−46 was found to sample the closed
conformation.
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Figure 5.2: Conformational plasticity and essential dynamics of monomeric PKM2. (A)
PCA projection of a 500 ns MD simulation of PKM2 bound to FBP. Two clusters were found to explain
100 % point variability of the data set. Single most dominant conformations of mPKM2FBP were
extract from clusters [i] and [ii] and are shown in cartoon representation above. The first eigenvector
accounted for 37.5 % of the total variance and the second eigenvector accounted for 13.1 % of the
total variance. (B) Superimposition of eigenvalues from mPKM2apo (black), mPKM2Phe (red) and
mPKM2Tepp−46 (blue) onto the first two eigenvectors determined from an eigenvalue decomposition
of the Cα coordinates of mPKM2FBP (green).
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The open to closed transition of the B-domain in the ﬁrst 300 ns of mPKM2FBP simula-
tions was observed to occur as a single two-state transition, and a re-opening of the B-domain
was not observed within this time scale. To investigate the conformational equilibrium of the
B-domain state transition, MD simulations of mPKM2FBP were extended for a further 200
ns. The resulting B-domain cap dynamics was quantiﬁed by measuring the distance between
the centre of mass of the A- and B-domains. Extended MD simulations of mPKM2FBP
found a reversal between energy minima about the open and closed conformations, with an
intermediate semi-closed conformation additionally detected (Fig. 5.3 A and B).
Taken together, these data suggested that the reversible closure of the B-domain in monomeric
PKM2 was dependent on FBP binding, within the simulated time scales, and that this is a
feature of PKM2 activation. Consistent with this interpretation, mPKM2Apo and mPKM2Phe
were found to same the open conformation, whereas mPKM2Tepp sampled to closed confor-
mation (Fig. 5.3 C-E). It was therefore hypothesised that B-domain closure contributes to
enzyme activation.
165
J.A.S MACPHERSON CHAPTER 5
Figure 5.3: Conformational equilibrium of FBP-induced cap closure from a 500 ns MD
simulation. (A) The distance computed between the centre of mass for the A-domain and the centre
of mass of the B-domain over the course of an MD simulation of mPKM2FBP . Surface distribution
of states plot, with Boltzmann averages of states calculated by B-domain cap distance as a function
of the RMSD of the B-domain for (B) mPKM2FBP , (C) mPKM2Apo, (D) mPKM2Phe and (E)
mPKM2Tepp.
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5.2.3 B-domain closure traps highly resident water molecules in the active
site
previous studies have found that a water molecule is required as part of the catalytic mechanism
of PKM2 to protonate the enolate intermediate150. This is supported by crystal structures
of PKM2 showing a cluster of water molecules proximal to the active site residues T328 and
S36223,55. In light of the observation of ligand-dependent B-domain dynamics aﬀecting the
solvent exposure of the catalytic pocket, we postulated that the closure of the B-domain would
aﬀect the solvent dynamics in the catalytic pocket and that this may play a role in catalysis.
An analysis of water density maps172 calculated from representative structures from MD sim-
ulations of mPKM2FBP in the open and the closed conformations, found that the active site
pocket contained an increased number of highly resident water molecules when the B-domain
cap was closed (Fig. 5.4). Moreover, a cluster of resident water molecules were positioned
proximal to T382 and S362 in the closed state. This would suggest that B-domain closure con-
tributes to catalysis by trapping necessary water molecules, proximal to the substrate binding
pocket.
Figure 5.4: Water residence time at the active site of mPKM2-FBP. Water density was cal-
culated on a 0.5 Å-spaced grid and averaged over snapshots exracted from the mPKM2-FBP simulation
every 0.1 ps for the (A) open and (B) closed conformations of the B-domain cap. The hydration sites
(spheres) are coloured from white to blue according to increased water density.
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5.2.4 B-domain dynamics is correlated with structural changes to catalytic
residues in the active site
To further explore whether B-domain closure was accompanied by other features of PKM2
activation, we investigated the side-chain dynamics at the active site of the protein. A su-
perimposition of PKM2 active site residues from crystal structures deposited in the protein
data-bank, found that the catalytic residue H78 adopts an altered side-chain conformation
when the protein is bound to allosteric activators FBP and Tepp-46 (PDB ID: 3u2z) and
L-serine and FBP (PDB ID: 4b2d), compared to crystal structures of apo PKM2 (PDB ID:
3bjt) and PKM2 bound to the inhibitor phenylalanine (PDB ID: 4fxj) (Fig. 5.5 A). H78 has
been implicated the phospho-transfer reaction of PKM2 as a proton-donor and acceptor in
the catalytic cycle150. In the activator-bound structures, the Nδ1 group was found to be posi-
tioned towards the active site, and was found positioned away from the active site in apo- and
Phe-bound structures (Fig. 5.5 A). Consistent with this change following allosteric activator
binding, the conformation of H78 was proposed to provide a potential read-out for whether
PKM2 was in the active or the inactive states.
To investigate possible changes to the orientation of H78 in the MD simulations of PKM2,
the χ2 torsion angle of H78 was measured in simulations of mPKM2FBP and mPKM2apo.
We found that the closure of the B-domain was accompanied by the catalytic H78 adopt-
ing a χ2 torsion angle of between 100° and 110°, in agreement with the χ2 torsion angles
of the crystal structures of activator-bound PKM2 (108.2° for PKM2FBP+Ser and 103.0° for
PKM2FBP+Tepp; Fig. 5.5 A). Conversely simulations of mPKM2apo and mPKM2Phe dis-
played variable H78 χ2 torsion angles approximately equivalent to that the inhibited crys-
tal structures (≃ −70°; Fig. 5.5 A). This further suggested that the open conformation
corresponds to the inactive state of PKM2 and that FBP-induced closure of the B-domain
contributed to the transition to the active state.
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Figure 5.5: Active site residue H78 adopts a distinct side-chain conformation depending
on the liganded state of the protein. (A) The active site residue histidine 78 (H78) shown in
stick representation for crystal structures of apo- FBP and activator-, phenylalanine-, and serine and
FBP-bound PKM2. Below, 18 evenly spaced snap-shots of the conformation of H78 are shown for a MD
simulated trajectory ofmPKM2FBP in the open and following the transition to the closed states. In the
open state [Cluster (i) in Fig. 5.2 A], the side chain of H78 is flexible and switches into a conformation
seen in that of the active crystal structures following the transition of the simulation into cluster ii
[Cluster (ii) in Fig. 5.2 B]. The time evolution of the dihedral angle of H78 along MD simulations of
mPKM2apo, mPKM2Phe, mPKM2FBP and mPKM2Tepp−46, colour-coded according to the scale
on the right. (B) The PKM2 catalytic pocket, annotated to show the active site residues. (C) Cα
active site corrdinates of the mPKM2apo active site (gold), mPKM2Phe (red), tPKM2apo (orange),
mPKM2FBP (green), mPKM2Tepp−46 (blue) and tPKM2FBP (purple) are projected onto the first
two eigenvectors of mPKM2FBP . This figure is partially adapted from77, which is made available
under a Creative Commons Attribution license (CC-BY).
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While the orientation of H78 correlated with the activity status of the crystal structures,
we could not exclude the possibility that the observed ﬂipping of the imidazole side chain of
H78 was an artefact of the structure-reﬁnement process. Therefore, a PCA analysis of the
positional coordinates was performed for all active site residues (Fig. 5.5 B) in simulations
of mPKM2apo, mPKM2Phe, mPKM2Tepp, mPKM2FBP , tPKM2apo and tPKM2FBP . This
analysis found that the simulations could be separated into two clusters. The ﬁrst cluster [i]
contained coordinates of mPKM2apo, mPKM2Phe and tPKM2apo, while the second cluster [ii]
contained coordinates of mPKM2FBP , mPKM2Tepp and tPKM2FBP (Fig. 5.5 C). Moreover,
crystal structures of PKM2apo (PDB ID: 3bjt) and PKM2FBP (PDB ID: 3u2z) localized to
the ﬁrst and second clusters, respectively. Together, this suggested that side-chain active site
changes were involved in the inactive-active transition. Nevertheless, the partition of active
and inactive simulations into the two clusters observed in the PCA analysis of active site
residues persisted for the entirety of the simulations and transitions between clusters [i] and
[ii] is not observed for simulated trajectories of mPKM2FBP . This suggested that an active-
to-inactive transition, upon B-domain closure, does not completely describe the mechanism of
enzyme activation.
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5.2.5 Comparative dynamics between tetrameric and monomeric PKM2
Investigation of the oligomeric state of PKM2 by native mass spectrometry in Chapter 4 found
that FBP binding results in tetramerisation. Moreover, additional experiments found that Phe
and Ser compete for binding to modulate PKM2 activity, in the context of constitutive FBP
binding.
There are two distinct dimer interfaces within the PKM2 tetramer; the A-A’ interface between
the A- and C-domains of chains 1 and 2 and chains 3 and 4, and the C-C’ domains between
the C-domains of chains 1 and 3, and chains 2 and 4. The C-C’ domain of PKM2 is formed
of adjacent C-domains aligning in a ’tail-to-tail’ fashion and interacts in a four-helical bundle.
Particularly prominent to the C-C’ domain interface is the protrusion of Lys-421 across the
interface and through the loop between residues 399 to 407 on the adjacent monomer. This
loop into which Lys-421 extends has a negative electrostatic potential and thus forms the ba-
sis for several charged interactions with Glu-409 and Try-443. In contrast, the A-A’ interface
largely encompasses several contacts between adjacent A-domains of chains 1 and 3 and chains
2 and 4, with additional bonds formed between the B-domains and N-terminal helix-loo-helix
domains of the adjacent chains. Notably, helix 11 (residues 341-353) protrude into a lipophilic
pocket within the ﬁrst 34 residues of the N-terminal helix-loop-helix domain and the top half
of helix 12 (residues 368-378) of the opposing monomer. The apparent dissociation constant of
PKM2 hetero-oligomerisation measured using MST in Chatper 3 (see Table 3.1) was found
to be 0.9 µM and the concentration of PKM2 in three cultured cell lines was approximately
2 µM. Given that the apparent dissociation constant of PKM2 oligomerisation is similar to
its cellular concentration, PKM2 may undergo reversible oligomerisation in a cellular context.
The monomer-dimer-tetramer equilibrium subsequently described in Chapter 4 is likely per-
turbed in cells by ligands and other interacting partners. Nevertheless, a robust description
of the the cellular nature of the oligomeric equilibrium of PKM2 would necessitate further in
situ experimentation. To provide a more detailed physico-chemical model of PKM2 dynamics,
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tetrameric PKM2 was simulated in the apo-form (tPKM2apo), bound to FBP (tPKM2FBP ),
bound to FBP and Phe (tPKM2FBP+Phe) and bound to FBP and Ser (tPKM2FBP+Ser).
In contrast to MD simulations of monomeric PKM2, analyses of tetrameric PKM2 MD tra-
jectories did not show the same FBP-dependent lateral B-domain closure over the active site,
as for mPKM2FBP . Rather, an inspection of the simulated trajectories of tPKM2FBP found
that a network of inter-protomeric charge-charge interactions was established between R342
and two aspartate residues (D178 and D179) on a ﬂexible loop of the B-domain on the ad-
jacent protomer. This charged interaction was observed to form after approximately 10 ns
of the simulation resulting in a twisting of the B-domain cap (Fig. 5.6 A). The positioning
of the R342 side-chain was such that it blocked the B-domain cap from closing laterally over
the active site, by ﬂipping into the far side of the active site pocket (Fig. 5.6 B). In con-
trast, while the position of R342 and the other residues at the A-A’ interface is largely similar
between the crystal structures of tPKM2apo and tPKM2FBP (Fig. 5.6 A), an inspection
of simulated trajectories of tPKM2apo found that R342 ﬂipped away from the neighbouring
active site pocket and the B-domain of the opposite protomer (Fig. 5.6 B).
The distance between R342 and D179 was quantiﬁed from MD trajectories of tPKM2apo,
tPKM2FBP , tPKM2FBP+Ser and tPKM2FBP+Phe (Fig. 5.6 C). The formation of charged
interactions about the interface of tPKM2FBP was reﬂected in the short inter-atomic distance
between the R342 guanidino group and the acidic side-chain of D177, whereas MD trajecto-
ries of tPKM2apo showed distances out of the range for charged-charged interactions between
these two residues (Fig. 5.6 C [i] and [ii]). A similar molecular behaviour to tPKM2FBP
was observed in simulated trajectories of tPKM2FBP+Ser in the proximity between R342 and
D177, resulting from a lateral twisting of the B-domain cap (Fig. 5.6 C [iii]). Conversely,
the A-A’ interface of tPKM2FBP+Phe was less compact, owing to a greater distance between
R342 and D177, in a manner similar to the dynamics of tPKM2apo (Fig. 5.6 C [iv]).
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Taken together, an analysis of MD simulations of tetrameric PKM2 found that the conforma-
tional dynamics of the B-domain is diﬀerent to that of the monomer due to steric hindrance of
lateral B-domain movement by interface residues. Nevertheless, charged interactions between
R342 and D177 at the A-A’ interface appeared when the tetramer was bound to allosteric
activators FBP and concurrently to FBP and Ser, resulting in twisting of the B-domain and
an observed structural tightening. Conversely, the apo- and FBP and Phe-bound tetramers
did not show this behaviour, suggesting that ligand-dependent conformational changes may
accompany PKM2 regulation.
173
J.A.S MACPHERSON CHAPTER 5
Figure 5.6: Charged-charged interactions at the A-A’ interface prevent lateral B-domain
closure in tetrameric PKM2. (A) Structures of tPKM2apo at 0 ns and 400 ns show that R342
and D177 flip away from the A-A’ interface, breaking a crucial interface charge-charge interaction.
(B) Structures of tPKM2FBP at 0 ns and at 400 ns show a tightening at the A-A’ interface. (C)
The distance between R342 and D177 about the A-A’ interface is quantified for [i] tPKM2apo, [ii]
tPKM2FBP , [iii] tPKM2FBP+Ser and tPKM2FBP+Phe.
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5.2.6 The configurational entropy of PKM2 does not change upon allosteric
ligand binding
Entropy-driven allosteric regulation has been described in a number of proteins110,111,173–175
where, in the absence of large-scale structural changes, allosteric ligand binding modulates
the amplitude of thermal ﬂuctuations by altering the local eﬀective elastic modulus of the
protein86. The conﬁgurational entropy of a macromolecular system can be calculated using a
formalism ﬁrst proposed by Juergen Schlitter (1993)176, using the covariance matrix of atom-
positional ﬂuctuations.
The derivation of the Schlitter entropy for macromolecular systems is based on a quantum-
mechanical treatment of a system with a of a one-dimensional degree of freedom x with states
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A single harmonic oscillator demands that the energy of a state is proportional to its variance
(ǫn ≃ 〈n|x2|n〉), and the complete entropy of a single harmonic oscillator is given by:
S =
kBα
eα − 1 − kB ln [1− e
−α] (5.8)
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where α = h¯ωβ, h¯ = h2π , h is Plank’s constant and ω is the frequency of the oscillator,
which depends on the quantum-mechanically deﬁned variance 〈x2〉. For a classical system the
equipartition function provides the link between the quantum-mechanically deﬁned variance
and that deﬁned in classical mechanics. Therefore, the conﬁgurational entropy of a classical












where σ′ij is the mass-weighted covariance matrix as previously deﬁned in Equ. 5.2.
The approximative conﬁgurational entropy was calculated for all simulations of tetrameric
PKM2 using Equ. 5.9, in order to determine whether allosteric ligands might induce an
entropic change to the PKM2 structure. No signiﬁcant diﬀerences in the converged conﬁgura-
tional entropy calculated from simulated trajectories of tPKM2apo, tPKM2FBP , tPKM2FBP+Ser
and tPKM2FBP+Phe (Fig. 5.7), negating the likelihood of a purely entropy-driven allosteric
mechanism of PKM2 regulation.
Figure 5.7: Allosteric ligands do not change the configurational entropy of PKM2. The
time-dependent configurational entropy was computed for simulated trajectories of tPKM2apo (grey),
tPKM2FBP (green), tPKM2FBP+Ser (blue) and tPKM2FBP+Phe (orange).
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5.3 Identification of PKM2 allosteric hub residues using a novel
software AlloHubMat
Ligand-induced changes to the collision cross section of PKM2 (Section 4.2.5) together with
evidence from MD simulations of B-domain closure upon allosteric activator binding (Section
5.2.5) suggested that backbone motions within tetrameric PKM2 contribute towards the al-
losteric transition of the protein. In the absence of changes to the conﬁgurational entropy of
PKM2 upon ligand binding (Section 5.2.6), we hypothesised that FBP binding elicits a net-
work of correlated motions within the backbone of PKM2, and that these concerted motions
form the basis of a network of residues which connect the FBP binding pocket to the active site.
We set out to quantify the network of correlated motions in MD simulations of PKM2 as
a means for identifying residues involved in the allosteric mechanism. Particularly success-
ful has been the the use of structural fragment analysis methods177, and in particular the
GSAtools developed by Pandini et al. (2013)124, which were applied towards identiﬁng dis-
tally correlated motions in the backbone of proteins in order to elucidate allosteric pathways
driven by local conformational switches123,125,128,130. The GSAtools method uses information
theory to compute the normalised mutual information (nMI) between each fragment-encoded
position in the protein (Section 1.3.3). Given that each element in the nMI matrix has a time
component, the network of correlated motions is likely to change over the simulated time. In
this context, the time-evolution of correlated motions derived from an information theoretical
treatment of the protein structure has never been explored. Moreover, no methods had been
previously developed to allow for the comparison of nMI matrices extracted from multiple
replicate MD trajectories.
We therefore developed a novel computational framework, named AlloHubMat (Allosteric
Hub prediction using Matrices that capture allosteric coupling), to predict allosteric hub
fragments from the network of dynamic correlated motions, based on explicitly identiﬁed con-
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Function Description
read_pdb_ﬁle() Read PDB topology ﬁle.
read_traj_ﬁle() Read DCD MD trajectory ﬁle.
superpose_trj() Remove roto-translational motion from MD trajectory.
encode_dcd_trajectory() Encode trajectory with the M32K25 structural alphabet.
split_sa_align() Split the structural alphabet alignment into regular blocks.
mi_mat() Compute the mutual information matrix.
comp_eigensystem() Compute the eigen system of the mutual information matrix.
block_overlap() Compute the covariance overlap between each mutual
information matrix.
matrix_smooth() Linear smoothing of the covariance overlap blocks.
detect_sectors() Detection of conformational sub-states.
extract_sectors() Extract mutual information for each conformational sub-state.
allosteric_path() Minimal distance pathﬁnder between allosteric and active sites.
identify_hubs() Identify allosteric hub residues.
sectors_2dplot() Plot the covariance overlap of time-contiguous covariance overlap.
sectors_3dplot() Plot the covariance overlap of all combinations of time-blocked
covariance overlap.
Table 5.3: Available functions contained within the R package AlloHubMat1.0
formational sub-states from multiple MD trajectories (Fig. 5.8 A). Extraction of correlated
motions from multiple sub-states within a consistent information theoretical framework al-
lowed us to compare the allosteric networks, both between replicas of the same liganded state
and between diﬀerent liganded states of PKM2. To automate the prediction of allosteric hub
residues from MD trajectories, AlloMatHub was implemented as a stand-alone R package
(Fig. 5.8 B). Here, the core functionalities of AlloHubMat will be described, followed by a
discussion of how the method was used to identify allosteric residues in PKM2.
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Figure 5.8: Schematic of the AlloHubMat and software flowchart. (A) Multiple replicate
molecular dynamics (MD) simulations are calculated using the GROMACS molecular dynamics en-
gine140. All MD simulations are encoded with the M32K25 structural alphabet125, and the strength of
dynamic protein backbone correlations over the MD trajectory is computed using information theory
mutual information statistics. The backbone correlations are explicitly used to identify and extract
configurational sub-states from the MD trajectories. A global allosteric network is then constructed
by integrating over the correlation matrices, and their respective probabilities, from which allosteric
hub (AlloHub) fragments are extracted. AlloHub fragments are overlapping regions of four consecu-
tive amino acid residues. (B) A software flowchart of AlloMatHub showing the functionalities of the
software.
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5.3.1 Explicit identification of sub-states from MD simulations using infor-
mation theory
Correlated motions have demonstrated as important towards protein dynamics and allostery.
To extract correlated motions from MD trajectories, an information theoretical framework was
used based on a coarse-grained representation of the protein backbone conformation with the
M32K25 structural alphabet125, as previously described (Section 1.3.3).
MD trajectories of tPKM2apo, tPKM2FBP , tPKM2FBP+Ser and tPKM2FBP+Phe were sub-
divided into 20 non-overlapping blocks with an equal time length of 20 ns each. For each block,
the normalised mutual information between distal backbone-encoded fragments [In(Ci;Cj)]





where the columns of the structural fragment alignment are given by Ci and Cj , I(Ci;Cj) is
the mutual information, ǫ(Ci;Cj) is the expected ﬁnite size error and H(Ci, Cj) is the joint
entropy (see Section 1.3.3 for a full derivation of the individual terms of the equation). The
normalised mutual information InB(Ci;Cj) has a range between 0 and 1. Two independent,
random distributions would have a normalised mutual information score of 0, whereas two
identical distributions would have a normalised mutual information equal to 1. Therefore,
two fragments with a normalised mutual information approaching 1 indicates that these two
fragments are correlated in their motion throughout the simulation. In contrast, two frag-
ments with a normalised mutual information approaching 0 reveals that these two fragments
are uncorrelated in their motion.
With the goal of identifying conformational sub-states from a time-trajectory of mutual in-
formation matrices, eigenvalue decomposition was used to compute the geometric evolution of
the protein backbone correlations. The elements of the mutual information matrix are pro-
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portional to the square of the displacement, so the square root of the matrix is required to
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ΩA;B = 1− d(A,B)√
trA+ trB
(5.14)
where λA and λB denote the eigenvalues and vA and vB the eigenvectors of mutual informa-
tion matrices A and B, N is the number of fragments used to encode the polypeptide chain.
The covariance matrix overlap (Ω) ranges from 0 when matrices A and B are orthogonal, and
1 when they are identical.
The geometric diﬀerence between any two mutual information matrices, with identical di-
mensions, could be numerically compared by calculating the covariance overlap between the















The covariance matrix overlap between each time-contiguous mutual information matrix (Equ.
5.15) revealed an oscillatory similarity in the nMI over time (Fig. 5.9 A and B). For some
regions of the MD trajectories the nMI matrices were very self-similar, reﬂected by ΩB;B−1 >
0.2, suggesting that the protein was sampling a local sub-state. Conversely, other regions of
the MD trajectories contained nMI matrices which were very diﬀerent from the previous time
block (ΩB;B−1 → 0), implying non-ergodic sampling. Sub-states were heuristically deﬁned
as regions which displayed Ωi values in the top quartile (Fig. 5.9 C and D). The mutual
information was averaged for each unique sub-state identiﬁed from a given trajectory, for
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further analysis.
Figure 5.9: Conformational sub-states are identified from the geometric progression of the
mutual information matrix. The time-dependent matrix covariance overlap between contiguous
mutual information matrices computed from contiguous trajectory blocks is quantified using Equ. 5.15
for an example replica of (A) tPKM2Apo and (B) tPKM2FBP . The matrix covariance overlap was
computed for all combinations of time-resolved nMI blocks. The resulting matrices were smoothed and
are shown for example replicate MD simulations of (C) tPKM2apo and (D) tPKM2FBP . Sub-states
were identified as regions containing a covariance overlap in the top quartile of the trajectory (shown
as dashed boxes).
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5.3.2 PKM2 sub-states cluster according to the liganded state of the MD
simulation
A total of 7 substates were identiﬁed for all MD simulations of tPKM2apo, 6 for tPKM2FBP , 4
for tPKM2FBP+Ser and 3 for tPKM2FBP+Phe. To investigate whether the correlated motions
for each sub-state could be attributed to the liganded state of the MD simulation, the mutual
information matrices extracted from each unique sub-state were compared with a complete-
linkage hierarchical clustering, using the covariance matrix overlap in Equ. 5.14 as a distance
metric (Fig. 5.10). Clustering of the sub-states revealed four predominant clusters (de-
noted as C1 - C4 ). nMI matrices from tPKM2apo were found to predominate in cluster 1,
tPKM2FBP in cluster 2 and tPKM2FBP+Ser in cluster 3. We found cluster 4 to be populated
by both tPKM2apo and tPKM2FBP+Phe, as well as a number of tPKM2FBP replicas.
The commonality between the sub-state mutual information matrices of the same liganded
state suggested that each of the replicate MD simulations converged to a common sub-state,
which was ligand-dependent. Moreover, this suggested that allosteric ligand-dependent corre-
lated motions were captured by the preceding analysis. Therefore, an ensemble-averaged nMI
matrix was computed for PKM2 in each of the four liganded states, as an integral over all
sub-states (Inss) of the protein (r) weighted by the probability of the sub-state (p):
〈Inens〉 =
∫
Inss p(r) dr (5.16)
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Figure 5.10: PKM2 correlated motions cluster according to the liganded state of the
simulation. A complete-linkage hierarchical clustering of mutual information matrices, computed
from simulated trajectories of tPKM2apo (grey), tPKM2FBP (green), tPKM2FBP+Ser (blue) and
tPKM2FBP+Phe (orange). Four clusters are assigned C1 - C4. For every sub-state, the network of
correlations from each of the four protomers is presented individually.
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5.3.3 A disperse network of hub residues are predicted to propagate FBP-
induced activation of PKM2
The ensemble-averaged matrix of correlated motions identiﬁed from the analysis of tPKM2apo
were subtracted from those of tPKM2FBP to isolate the fragment positions predicted to be
involved in the allosteric state transition, which were termed allosteric hub fragments (Allo-
HubFrags). An inspection of the frequency distribution of the mutual information matrices
of tPKM2apo and tPKM2FBP found that the strength of the fragment correlations were log-
normally distributed with a large Gaussian component, and a long tail to the distribution (Fig.
5.11 A and B). Subtracting the mutual information matrices resulted in the z-transformation
of the distribution of correlations, with a mean µIn = 0 and a standard deviation σIn = 0.04
(Fig. 5.11 C).
The variance of each of the 2119740 individual backbone couplings were computed within
the multiple conformational sub-states for tPKM2apo and tPKM2FBP . We found that when
the average diﬀerence in the mutual information between the two liganded states (µ∆FBP )
was inspected against the variance of each of the couplings (σ∆FBP ), the resulting plot formed
a v-shape with highly correlated fragments showing a high degree of variance (Fig. 5.11 D).
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Figure 5.11: The sub-state mutual information matrix is log-normally distributed. The
distribution of mutual information couplings for the ensemble-averaged mutual information matrices
of (A) tPKM2apo, (B) tPKM2FBP , and (C) the subtracted mutual information matrices of the
preceding two liganded states. (D) The variance of each coupling was computed over each of the
multiple conformational sub-states, for each fragment coupling.
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Rather than ranking fragment positions by their nMI score, the signiﬁcance of the change
in nMI was computed for each coupling (Fig. 5.12 A). From a total of 76 fragments identiﬁed
as signiﬁcant, the top AlloHubFrags were selected for further analysis (Hubs1−10). Hub5 and
Hub6 were found to overlap with a two amino acid residue diﬀerence between the two hubs.
The AlloHubFrags were found to be spatially diverse across the PKM2 structure, though not
obviously structurally contiguous (Fig. 5.12 B). Hub5 and Hub6 were proximal to the A-A’
interface, Hub9 was proximal to the FBP binding pocket, Hub10 localised to the C-C’ inter-
faces and Hub1 and Hub2 were in the B-domain (Fig. 5.12 B).
The subtracted mutual information matrix was next distance-weighted using the Cα distance
matrix (M) determined from the PKM2 crystal structure:
In(Ci;Cj)
′ = In(Ci;Cj) · 1
M
(5.17)
Re-weighting the mutual information matrix with the inverse of the distance matrix had the
eﬀect of down-weighting long-distance correlations and up-weighting short-range correlation,
along which non-bonded chemical interactions could occur. From the distance-weight mu-
tual information matrix, minimal distance pathways between FBP binding-pocket fragments
and active-site fragments were computed using the Dijkstra algorithm in order to predict the
allosteric pathways elicited by FBP. This analysis revealed that all AlloHubFrags, with the
exception of Hub5 and Hub6, were connected to the predicted pathways (Fig. 5.12 B), sup-
porting the hypothesis that the AlloHubFrags propagate the allosteric eﬀect of FBP.
Of the 40 residues within the top ten-ranked AlloHubFrags, we sought to rationally guide
the selection of a number of residues for experimental mutagenesis. Each fragment used to
encode the backbone conformation of the MD trajectories of PKM2 is a collection of four
contiguous residues, and as such, the mutual information between two fragments could not be
readily assigned to an individual amino acid residue. Nevertheless, the chain rule for mutual
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information states that the mutual information of a collection of random variables is the sum
of the conditional mutual informations:
I(X1, X2, ..., Xn;Y ) =
n∑
i=1
I(Xi;Y |Xi−1, Xi−2, ..., X1) (5.18)
Assuming that the variables X1, X2, ..., Xn are random, it would be possible to reconstruct
the per-residue mutual information and thus select top-ranked residues with high mutual
information content for mutagenesis. The validity of this assumption was tested by computing
the distribution of mutual information between neighbouring fragments (Fig. 5.12 C). We
observed a distribution of mutual information between neighbouring fragments, which was
skewed towards higher values, when compared to the same log-normal distribution of the
entire mutual information matrix, suggesting that the majority of neighbouring fragments
were correlated and were non-random. This proved that the underlying assumption of Equ.
5.18 did not hold. Thus, it was not possible to numerically assign a per-residue mutual
information score.
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Figure 5.12: Hub residues are predicted to propagate energy transfer along allosteric path-
ways. (A) A volcano plot showing the difference in mutual information couplings between tPKM2apo
and tPKM2FBP . (B) The spatial distribution of the top ten predicted AlloHubFrags projected onto
a cartoon representation of PKM2. Predicted allosteric pathways between the FBP binding pocket and
the active site are shown as black lines. (C) The distribution of normalised mutual information for
all fragment combinations (black) and for neighbouring fragments (red).
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5.3.4 Design of allosteric hub mutants (AlloHubMs)
In lieu of an analytic solution to the per-residue mutual information, allosteric hub mutants
(AlloHubMuts) were generated by substituting AlloHubFrag residues with amino acids that
were predicted to be tolerated at the respective position based on their occurance in a mul-
tiple sequence alignment of 5381 pyruvate kinase homologues. Of the residues within the
top-ten AlloHubFrags, there was variability in the degree of sequence conservation. Hub7 and
Hub8 contained several highly conserved hydrophobic residues on parallel β-sheets within the
A-domain of the protein. Of these V324, I325, A327, G355 and D357 were found to be very
highly conserved within the alignment (Fig. 5.13 A). Conversely, residues R489 - F492 within
Hub10; and residues T121 - I124 within Hub1 and L203 - K206 Hub2 in the B-domain, were
highly sequence variable (Fig. 5.13 A) and are exposed in the crystal structure of human
PKM2 (Fig. 5.13 B).
Amount a total of 32 PKM2 AlloHubMuts generated, we chose to experimentally charac-
terise seven variants [I124G, F244V, K305Q, F307P, A327S, C358A, R489L (Fig. 5.13 B)]
because they expressed as soluble protein and had very similar secondary structure proﬁles to
that of PKM2(WT).
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Figure 5.13: Design of Allosteric Hub Mutants (AlloHubMuts). Allosteric Hub Mutants (Al-
loHubMuts) were designed based on an empirical prediction of which residues would be tolerated at
each AlloHubFrag position. (A) A logo-plot of the AlloHubFrags from a multiple sequence alignment
of 5381 pyruvate kinase homologues. (B) The residue positions of the AlloHubMuts.
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5.4 Conclusion
Ion-mobility coupled to mass spectrometry measurements in Chapter 4 revealed that PKM2
undergoes conformational changes upon FBP binding, though the molecular details of the
conformational changes were elusive. To this end, we performed an extensive characterisation
of the conformational dynamics of PKM2 bound to various allosteric ligands. MD simulations
of monomeric and tetrameric PKM2 found that allosteric activator binding induces the closure
of the B-domain over the catalytic pocket. The ligand-dependent dynamics of the B-domain
is therefore proposed as a determinant of enzyme activation, which traps highly resident water
molecules proximal to the substrate binding pocket.
A computational method AlloHubMat was developed and applied towards identifying allosteric
hub residues, which orchestrate the transmission of allosteric information between ligand bind-
ing pockets and the active site. We found a network of allosteric hub residues, which are
predicted to potentiate the eﬀects of FBP allosteric within PKM2. The AlloHubFrags were
used as a template to design a collection of single-point mutant variants (AlloHubMuts) of




Allosteric mutants reveal distinct
ligand pathways that combinatorially
regulate PKM2.
6.1 Introduction
Chapter 5 described a novel computational method AlloHubMat to predict allosteric hub
residues from an ensemble of conformational sub-states obtained from multiple replicate molec-
ular dynamics (MD) simulations. The method was applied towards analysing MD trajectories
of tPKM2apo and tPKM2FBP , revealing a network of residues that are predicted to propagate
FBP allostery. We hypothesised that changing the side-chain chemistry of a selection of these
AlloHub residues would perturb allosteric coupling between the FBP pocket and the active
site, thus validating the involvement of these residues in the allosteric mechanism of PKM2.
To this end we designed a selection of AlloHub mutants (AlloHubMuts; I124G, F244V, K305Q,
F307P, A327S, C358A, R489L) and sought to comprehensively characterise their biophysical
and enzymatic behaviour using an integrative experimental strategy detailed herein (Fig.
6.1).
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Figure 6.1: An integrated computational and experimental strategy for identifying residues
which transmit allosteric information between a binding pocket and the active site of
a protein. AlloHubMat is used to identify candidate allosteric residues, which guide the rational
design of allosteric hub mutants (AlloHubMuts). The AlloHubMuts are characterised with a series of
experimental methods, in order to interrogate their biophysical and enzymatic response to FBP, Phe
and Ser.
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6.2 Biophysical characterisation of the AlloHubMuts
6.2.1 AlloHubMuts have the same secondary structure content as PKM2(WT)
Small changes to the local chemical composition of proteins can result in signiﬁcant confor-
mational changes. Even single-point mutants can aﬀect the stability of proteins, resulting in
changes to secondary structural content178. In order to investigate the secondary structure
content of the AlloHubMuts and to determine whether the inserted amino acid changes sig-
niﬁcantly aﬀected the protein fold, far-UV circular dichroism (CD) spectra were acquired for
PKM2(WT) and for each of the AlloHubMuts. A superimposition of the AlloHubMut far-UV
CD spectra with that of PKM2(WT) revealed very little detectable diﬀerence in the shape and
intensities of the spectra (Fig. 6.2), suggesting that none of the AlloHubMuts appreciably
changed the secondary structure content of PKM2.
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Figure 6.2: Far-UV circular dichroism spectra of AlloHubMuts suggest no change in sec-
ondary structure content. Far-UV CD spectra of PKM2(WT) and of the seven AlloHubMuts were
acquired between 200 nm and 260 nm. Spectra of the AlloHubMuts (red) are superimposed with that
of PKM2(WT) (blue); (A) I124G, (B) F244V, (C) K305Q, (D) F307P, (E) A327S, (F) C358A,
(G) R489L. A protein concentration of 0.15 mg · mL−1 was used in the acquisition of all spectra.
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6.2.2 AlloHubMuts at either the A-A’ or C-C’ interfaces show distinct
thermodynamics properties
The far-UV CD spectra of the AlloHubMuts were similar to that of PKM2(WT), suggesting
that the mutants did not signiﬁcantly alter the secondary structure of the protein. Never-
theless, a substantial alteration in secondary structure content would likely be required for
changes to become apparent in the far-UV CD spectrum, given the large size of the PKM2
tetramer (234 kDa). Moreover, local conformational changes could conceivably perturb pro-
tein stability without enacting changes to the secondary structure content.
To this end, thermal unfolding experiments were performed to determine the melting tem-
perature (Tm) of each AlloHubMut. PKM2(K305Q) and PKM2(R489L) were found to be
thermally destabilising, reﬂected by a signiﬁcant decrease in the Tm relative to PKM2(WT)
(Fig. 6.3 and Table 6.1). None of the other AlloHubMuts were found to have a signiﬁ-
cant eﬀect on the melting temperature, compared to PKM2(WT) (Fig. 6.3 A-G). The two
destabilising mutants K305Q and R489L are located at subunit interfaces within the PKM2
structure. K305 forms a charged interaction with E384 on the protomer on the opposite
side of the A-A’ interface (Fig. 6.3 H). Replacing the ǫ-ammonium group of lysine with an
amide group of glutamine caps the side-chain charge and likely prevented the formation of
inter-protomeric charged interactions at position 305, possibly reducing oligomer formation
and stability of the protein. R489 is positioned proximal to the C-C’ interface, though does
not form inter-protomeric interactions in the crystal structure of PKM2. Rather, its guani-
dino group forms charged interactions with the 1’-phosphate group of FBP (Fig. 6.3 I), and
therefore contributes to the binding of FBP. Replacing the guanidino group with an isobutyl
group at position 489 likely reducing the binding aﬃnity of FBP.
Ligand binding can increase a protein’s thermal stability because the ligand favours the folded
state in the folded-to-unfolded equilibrium. Nevertheless, we consistently found that the addi-
tion of saturating concentrations of FBP to PKM2(WT) did not change the melting temper-
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ature of the protein (Fig. 6.4 A). The lack of FBP-induced thermal stabilisation was likely
due to co-puriﬁcation of PKM2(WT) with endogenous FBP (Section 3.2.1). Similarly, I124G,
F244V, F307P, A327S and C358A showed no signiﬁcant changes in their thermal stabilities
upon FBP addition (Fig. 6.4 and Table 6.1), suggesting that these variants also retain sub-
stoichiometric amounts of endogenous FBP during protein puriﬁcation.
The mutation with the largest destabilising eﬀect was PKM2(K305Q), which produced a
19.1 ◦C decrease in the apparent melting temperature and a 174.9 (kJ/mol) decrease in the
change in enthalpy at Tm, compared to the wild-type. In contrast, the PKM2(R489L) at the
C-C’ interface produced a comparatively small decrease in the melting temperature (5.6 ◦C).
Intriguingly, the thermal stability of the R489L mutant was rescued the ∆TWT→R489Lm from
5.6 to 2.4 ◦C - equivalent to wild-type levels (Fig. 6.4 and Table 6.1). In contrast, even when
in the presence of 1 mM FBP, PKM2(K305Q) was markedly less stable than the wild-type
protein (Fig. 6.4 and Table 6.1).
Taken together, experimental analyses of the thermal stability of the AlloHubMuts revealed
that all AlloHubMuts, with the exception of K305Q and R489L, had similar equilibrium un-
folding kinetics as PKM2(WT). Given that the position of R489 is proximal to the FBP
binding pocket and the ﬁnding that FBP addition rescued the thermal stability of the mutant
variant, it is likely that PKM2(R489L) reﬂects the thermal stability of PKM2 devoid of FBP.
Conversely, PKM2(K305Q) is hypothesised to introduce changes to the A-A’ interface charged
interactions, resulting in protein destabilisation, which is not rescued by FBP addition.
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PKM2 variant ∆H (kJ/mol) ∆S (kJ/K · mol) Tm (◦C)
WT 525.8 ± 44.8 8.2 ± 0.7 63.9 ± 0.1
WT + 1 mM FBP 492.4 ± 23.6 7.8 ± 0.4 63.1 ± 0.1
I124G 336.5 ± 23. 1 5.4 ± 0.4 61.3 ± 0.1
I124G + 1 mM FBP 600.0 ± 22.6 9.8 ± 0.4 61.3 ± 0.4
F244V 477.2 ± 16.9 7.6 ± 0.3 62.5 ± 0.1
F244V + 1 mM FBP 525.0 ± 34.5 8.6 ± 0.6 61.3 ± 0.1
K305Q 350.9 ± 13.5 7.8 ± 0.3 44.8 ± 0.1
K305Q + 1 mM FBP 479.5 ± 20.9 8.7 ± 0.4 54.8 ± 0.1
F307P 477.8 ± 18.2 7.7 ± 0.3 62.3 ± 0.1
F307P + 1 mM FBP 695.2 ± 36.2 11.3 ± 0.6 61.7 ± 0.1
A327S 558.2 ± 14.8 9.2 ± 0.2 60.8 ± 0.4
A327S + 1 mM FBP 653.4 ± 40.8 10.9 ± 0.7 59.9 ± 0.1
C358A 493.9 ± 20.1 7.9 ± 0.3 62.7 ± 0.1
C358A + 1 mM FBP 660.4 ± 22.2 11.0 ± 0.4 60.3 ± 0.1
K433E 488.4 ± 9.6 5.1 ± 0.2 56.8 ± 0.1
K433E + 1 mM FBP 678.0 ± 27.6 11.6 ± 0.5 58.1 ± 0.1
R489L 232.9 ± 21.4 4.0 ± 0.4 58.2 ± 0.3
R489L + 1 mM FBP 643.3 ± 45.6 10.5 ± 0.7 61.5 ± 0.1
Table 6.1: Equilibrium thermal unfolding kinetic parameters of the AlloHubMuts. A two-
phase unfolding model (Methods Section 2.3.6) was fit to each of the unfolding curves shown in Fig.
6.3. The change in enthalpy (∆H ) and entropy (∆S) between the folded and semi-unfolded states, as
well as the melting temperature (Tm) is reported.
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Figure 6.3: Thermal unfolding spectra of the AlloHubMuts fitted to a two-phase unfolding
model. (A-G) Far-UV CD intensity at 222 nm of PKM2(WT) (blue) and the AlloHubMuts (red)
were monitored over a range of temperatures between 30 °C and 80 °C, in the absence of any added
ligands. Data points were fitted to a two-phase unfolding curve. (H) A schematic of the local structure
of K305 at the A-A’ interface and (I) R489 at the FBP binding pocket.
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Figure 6.4: The thermal stability of PKM2(K305Q) and PKM2(R489L) is increased upon
FBP addition. Far-UV CD intensity at 222 nm was monitored for (A) PKM2(WT) and (B-H) the
AlloHubMuts in the absence (blue) and in the presence (green) of 1 mM FBP.
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6.2.3 R489L reduces the binding affinity to FBP
The reduced thermal stability of PKM2(R489L) and the fact that R489 forms a charge-charge
interaction with the 1’-phosphate group of FBP, suggested that this mutant may have a reduced
FBP binding aﬃnity. Binding aﬃnities of the AlloHubMuts to FBP (Table 6.2) were calculated
from ﬂuorescence titration measurements (Fig. 6.5 A-G), as previously described (Section
3.2.1). All of the AlloHubMuts bound to FBP with nano molar aﬃnity, with the exception
of PKM2(R489L), which was estimated to bind to FBP with an apparent aﬃnity of (14.0
± 2.7) mM. Despite the two-order of magnitude decrease in the apparent binding aﬃnity
of PKM2(R489L) for FBP, ligand binding saturated the measured tryptophan ﬂuorescence
changes at mM concentrations (Fig. 6.5 G).
PKM2 KFBPD
WT (21.4 ± 9.0) nM
I124G (39.5 ± 33.5) nM
F244V (30.7 ± 33.1) nM
K305Q (39.4 ± 34.1) nM
F307P (4.0 ± 12.8) nM
A327S (43.2 ± 48.7) nM
C358A (35.3 ± 23.6) nM
R489L (14.0 ± 2.7) mM
Table 6.2: Steady-state dissociation constants of the AlloHubMuts for FBP. A 1:1 stoi-
chiometry binding curve (3.2.1) was fit to the binding curves in Fig. 6.5. The KFBPD is reported in
variable units.
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Figure 6.5: The AlloHubMuts have a nano molar affinity for FBP with the exception of
PKM2(R489L). The ratio of the fluorescence emission intensity at 325 nm and 350 nm were recorded
over a range of FBP concentrations. Apparent binding curves were fit assuming a 1:1 stoichiometry
(red).
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6.3 Characterisation of the functional response of AlloHubMuts
to allosteric ligands
The AlloHubMuts were identiﬁed by the software AlloHubMat as candidate residues, which
coordinated the allosteric eﬀect of FBP. It was postulated that changing the chemical compo-
sition of these residues would perturb the allosteric coupling between the FBP binding pocket
and the active site. To test this hypothesis we sought to characterise the steady-state enzyme
kinetics of each AlloHubMut and the activity response of each mutant to the addition of FBP.
6.3.1 Several AlloHubMuts attenuate the allosteric coupling between the
FBP pocket and the active site
To assess the functional eﬀect of perturbing the in silico-determined allosteric pathways, we
measured the steady-state kinetics of the AlloHubMuts in the absence and in the presence
of saturating concentrations of FBP. Initial velocity curves were determined over a range
of concentrations of phosphoenolpyruvate and revealed that all of the AlloHubMuts had a
lower apparent maximal velocity, compared to PKM2(WT), in the absence of FBP (Table
6.3). The addition of FBP resulted in a marked increase in the apparent maximal velocity
of PKM2(I124G) and PKM2(R489L) (Table 6.3). PKM2(K305Q) was inactive, both in the
absence and in the presence of FBP, suggesting that this AlloHubMut was catalytically dead
(Table 6.3). In contrast, PKM2(F307P) appeared to be constitutively active, with a low ap-
parent KPEPM , which was unchanged upon FBP addition (Table 6.3).
As described previously in Chapter 3, FBP was found to exert its functional allosteric eﬀect
on PKM2(WT) by increasing the enzyme-substrate aﬃnity, without changing the maximal
velocity. It was therefore postulated that allosteric activation results from a coupling between
FBP and PEP binding, mediated by the AlloHub residues (Fig. 6.6 A). Consequently, we
sought to quantitatively determine the coupling between the FBP pocket and the active site
for PKM2(WT) and each of the AlloHubMuts, to discern whether, and to which extent, mu-
tations along the predicted FBP pathway perturbed the allosteric coupling.
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Assuming a single-substrate-single-modiﬁer mechanism of PKM2 catalysis (Fig. 6.6 B),
the coupling between the allosteric pocket and the substrate binding site was determined by
calculating the log-fold ratio of the Michaelis-Menten constant of the protein saturated with










A logQ > 0 indicates a positive coupling (activation) and logQ < 0 negative coupling (inhibi-
tion). AlloHubMuts I124G, F244V, K305Q, F307P and R489L were all found to show attenu-
ated allosteric coupling between the active site and the FBP pocket compared to PKM2(WT)
(Fig. 6.6 C), indicating that AlloHubMat identiﬁed residues that mediate the allosteric eﬀect
of FBP. In contrast, AlloHubMuts A327S and C358A both had a coupling co-eﬃcient (Q),
which was unchanged from that of WT, suggesting either that the amino acid substitutions
were functionally neutral, or that these residues are not required for FBP-induced activation.
6.3.2 AlloHub residues A327 and C358 mediate multi-ligand allosteric cou-
pling
Previous work presented in Chapters 3 and 4, found that the allosteric inhibitor phenylalanine
(Phe) acts to reduce the activating eﬀect of FBP through a functional cross-talk. We sought
to investigate whether AlloHubMuts, which abrogated FBP-induced allostery, also perturbed
the cross-talk between FBP and Phe.
To this end, the coupling co-eﬃcient was measured for the doubly liganded PKM2FBP+Phe
state (QFBP+Phe). AlloHubMuts I124G, F244V and R489L revealed the same QFBP+Phe as
the wild-type variant (Fig. 6.6 D), suggesting either that the allosteric coupling between
FBP, Phe and the active site was unchanged for these mutant substitutions, or that residues
I124, F244 and R489 do not contribute to the FBP-Phe cross-talk.
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In contrast, the simultaneous addition of FBP and Phe failed to produce an allosteric re-
sponse for AlloHubMuts K305Q and F307P (Fig. 6.6 D), further suggesting that these
variants are allosterically inert. Moreover, the addition of Phe to A327S and C358, failed to
attenuate FBP-induced activation of these AlloHubMuts, indicating that residues A327 and
C358 have a role in coupling the allosteric eﬀect of Phe with that of FBP.
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Figure 6.6: The AlloHubMuts perturb either FBP-active site coupling or FBP-Phe cou-
pling. (A) A structural schematic showing the locations of the AlloHubMuts on PKM2 protomer.
(B) A single-substrate-single-modifier scheme was used to quantify the coupling co-efficient (Q) be-
tween FBP and substrate binding and between FBP and Phe and substrate binding. (C) The allosteric
response of PKM2(WT) and AlloHubMuts to FBP, quantified by the allosteric coefficient, which de-
notes the change of the KPEPM upon addition of saturating concentrations of FBP (see Methods Section
2.3.5). The Q-coefficient for wild type PKM2 (WT) is shown as a dotted line for comparison. Each
of the Q-coefficients of the AlloHubMuts were statistically compared to PKM2(WT) using a Wilcoxon
ranked-sum test (n = 4); a p-value < 0.05 was deemed significant (denoted by an asterisk); n.s.: not
significant. (D) The magnitude of allosteric inhibition by Phe, in the presence of FBP, determined
for PKM2(WT) and AlloHubMuts, quantified by the allosteric co-efficient Q as in (B). Raw initial
velocity rate curves are shown in the absence of added ligands in (E), in the presence of saturating
FBP (F) and in the presence of saturating FBP and 400 µM Phe (G).
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AlloHubM Ligand KPEPM (mM) kcat (s
−1) kcat/KPEPM (s
−1· mM−1)
I124G Apo 1.07 ± 0.13 190.27 ± 7.31 177.82 ± 56.23
FBP 0.29 ± 0.04 307.10 ± 6.11 1058.97 ± 152.75
FBP+Phe 1.44 ± 0.34 221.92 ± 17.26 153.98 ± 37.88
F244V Apo 1.14 ± 0.11 237.44 ± 7.36 210.44 ± 27.15
FBP 0.55 ± 0.07 279.62 ± 9.93 522.42 ± 87.51
FBP+Phe 1.15 ± 0.30 222.51 ± 18.29 195.87 ± 55.46
K305Q Apo 0.01 ± 0.01 8.06 ± 0.57 790.01 ± 605.56
FBP 0.01 ± 0.04 8.40 ± 0.43 1038.01 ± 535.50
FBP+Phe 0.04 ± 0.01 12.21 ± 1.40 408.37 ± 136.10
F307P Apo 0.13 ± 0.01 180.47 ± 3.05 1413.87 ± 133.12
FBP 0.15 ± 0.02 227.20 ± 5.02 1508.53 ± 190.71
FBP+Phe 0.21 ± 0.03 328.71 ± 12.37 1568.32 ± 268.58
A327S Apo 1.37 ± 0.42 31.8 ± 2.43 23.21 ± 5.79
FBP 0.17 ± 0.02 119.01 ± 6.86 700.06 ± 343.00
FBP+Phe 0.15 ± 0.02 100.19 ± 5.32 667.93 ± 266.00
C358A Apo 4.71 ± 0.99 214.73 ± 21.40 45.59 ± 21.62
FBP 0.58 ± 0.18 191.13 ± 16.22 329.53 ± 90.11
FBP+Phe 1.25 ± 0.07 199.01 ± 21.87 159.20 ± 31.24
R489L Apo 0.69 ± 0.19 60.05 ± 4.91 89.38 ± 36.93
FBP 0.36 ± 0.10 112.25 ± 7.60 317.20 ± 125.71
FBP+Phe 1.44 ± 0.40 132.99 ± 15.74 158.19 ± 122.56
Table 6.3: Steady-state enzyme kinetic parameters of the AlloHubMuts. The enzyme activity
of the AlloHubMuts were measured over a range of phosphoenolpyruvate concentrations between 0 mM
and 10 mM in the absence of added ligands, in the presence of saturating concentrations of FBP and
in the presence of FBP and 400 µM (physiological concentrations) Phe. A protein concentration of 5
nM was used for all measurements. Activity measurements were repeated four times; the mean and
standard deviations are shown.
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6.3.3 Native spectra of AlloHubMut uncouples oligomerisation from al-
losteric activation
Native spectra of PKM2(WT), in Chapter 4, showed that FBP-induced allosteric activation is
accompanied by stabilisation of the high-substrate aﬃnity tetrameric state. This observation
led to the hypothesis that tetramerisation and enzyme activation are coupled. It would be
expected, therefore, that a mutant which prevents tetramer formation would reveal a reduced
(or no) allosteric response to FBP, prompting the lack of oligomerisation as a possible expla-
nation as to why some of the AlloHubMuts had a reduced coupling between the FBP pocket
and the active site (Sections 6.3.1 and 6.3.2).
To this end, native spectra of the AlloHubMuts were acquired in the absence of any added lig-
ands (Fig. 6.7 A), and following pre-incubation with FBP at a ratio of 2:1 (ligand-to-protein)
(Fig. 6.7 B). A327S and C358A both formed of monomers, dimers and tetramers, at an ap-
proximate ratio of 1:3:6 (Fig. 6.7 C). The addition of FBP to A327S and C358A resulted in
a complete conversion of lower-order oligomers into tetramers, similar to PKM2(WT) (Fig.
6.7 C). In contrast, F244V and R489L formed monomer-dimer-tetramer equilibria, both at
approximate ratios of 1:3:6, which was unperturbed following the addition of FBP (Fig. 6.7
C). The oligomeric response of A327S and C358A and the lack of response of F244V and
R489L ﬁt with the previous observation that A327S and C358A maintain an intact allosteric
coupling between the FBP pocket and the active site, and that F244V and R489L have a
signiﬁcantly reduced enzymatic response to FBP (Section 6.3.1).
PKM2(I124G) formed a monomer-dimer-tetramer mixture, in the absence of added ligands,
at an ratio equivalent to that of the wild-type (Fig. 6.7 C). The addition of FBP to I124G
resulted in an apparent tetramerisation, despite the observation that this mutant has a signif-
icantly reduced enzymatic response to FBP binding. Conversely, K305Q exclusively formed
monomers in the absence of FBP, likely due to the removal of a charged interaction between
K305 and E384 at the A-A’ interface (Fig. 6.3 H). Nevertheless, the addition of FBP
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to K305Q resulted in the formation of a signiﬁcant fraction of tetramers, with a monomer-
dimer-tetramer distribution of approximately 4:1:5 (Fig. 6.7). Taken together, the ﬁnding
that I124G and K305Q undergo an apparent tetramerisation upon FBP addition, despite the
negated coupling between the FBP pocket and the active site, provided evidence to suggest
that PKM2 allosteric activation is uncoupled from oligomerisation.
210
J.A.S MACPHERSON CHAPTER 6
Figure 6.7: Native spectra of the AlloHubMuts reveal a complex relationship between al-
losteric activation and oligomerisation. Nano-electrospray ionisation mass spectrometry was
used to acquire native spectra of (A) PKM2(WT) and the AlloHubMuts, individually in the absence
of added ligands and (B) in the presence of FBP. PKM2 variants were pre-incubated with FBP at
a ratio of (2:1; protein-to-ligand). (C) The oligomeric state distribution was quantified for each of
the AlloHubMuts and presented as stacked bars showing the relative intensities of monomers (orange),
dimers (white) and tetramers (blue).
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6.4 Conclusion
In summary, evaluation of the allosteric properties of AlloHubMuts demonstrated that a novel
computational method AlloHubMat identiﬁed residues involved in FBP-induced allostery. Two
of the AlloHubMuts were found not to response to FBP per se, but rather to attenuate Phe-
induced disruption of allosteric activation by FBP, revealing two residues (A327 and C358)
that mediate a functional cross-talk between allosteric networks elicited from distinct ligand




Cellular life exists under conditions where the concentrations of nutrients, growth factors and
oxygen are in constant ﬂux. The dynamic instability of extracellular conditions requires that
biological catalysts are highly eﬃcient so that essential chemical compounds are generated at
suﬃcient concentrations from the available extracellular nutrient pool. Moreover, the rate of
chemical synthesis must be tightly controlled to maintain cellular homeostasis in response to
signalling cues. Allostery is an important feature of enzyme regulation, which is potent and
highly speciﬁc, and contributes towards maintaining organised ﬂux through cellular pathways.
Despite the ubiquity and demonstrated importance of allosteric regulation, an understanding
of its mechanisms at the molecular level is limited, as is the curration of proteome-wide data
on allosteric proteins.
A detailed description of the regulatory mechanisms of PKM2 is relevant for understand-
ing metabolic reprogramming in disease settings such as cancer, where it has been shown
that inhibition of PKM2 activity can promote cancer cell growth by facilitating the provi-
sion of glucose-derived carbons for anabolic processes such as de novo lipogenesis17, serine
biosynthesis19, nucleotide synthesis17,44, and the production of reducing equivalents such as
glutathione40. The discovery of a class of small molecules that activate PKM2 catalysis47–49,
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and the ﬁnding that these small molecule activators alleviate the progression of xenograft
breast tumours17, support the hypothesis that exogenous regulation of PKM2 activity acts on
a metabolic vulnerability of cancer cells25,31,32,34. Given the cancer-associated role of PKM2
regulation, knowledge of the molecular processes by which ligand binding incites changes to
enzyme activity are of therapeutic interest.
In addition to feed-forward activation by fructose 1,6-bisphosphate (FBP), PKM2 is regu-
lated by a number of other endogenous ligands, including the amino acids L-serine (Ser; an
allosteric activator)64 and L-phenylalanine (Phe; an allosteric inhibitor)168. Investigations
into PKM2 regulation, thus far, have focused on the eﬀects of individual ligands per se on
the structure17,20,55,63, function17,19,23 and dynamics62,66,74 of PKM2. It is unclear whether
ligands that concurrently bind to distinct allosteric pockets elicit in functionally independent
eﬀects, or whether the binding of multiple allosteric ligands with opposing functional signals
produces a synergistic response.
Here I oﬀer evidence that PKM2 regulation constitutes a functional cross-talk between the ef-
fects of FBP and amino acids, which act in a combinatorial manner to modulate the allosteric
transition of the tetrameric form of the protein between the inactive and active states. Using a
novel method for predicting allosteric hub residues, AlloHubMat, a network of protein residues
is identiﬁed that couple FBP binding with enhanced substrate aﬃnity. Moreover, two residues
(A327 and C358) are identiﬁed that facilitate the cross-talk between FBP and Phe.
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7.1 PKM2 is concurrently regulated by multiple allosteric lig-
ands in a range of cellular conditions
An investigation into PKM2 regulation was initiated by determining the binding aﬃnity of
PKM2 to its endogenous regulators. An apparent dissociation constant in the nano-molar
range [KFBPD = (21.4 ± 9.0) nM] was estimated from measurements of FBP binding to PKM2
(Section 3.2.1). Tight binding between FBP and PKM2 resulted in puriﬁed recombinant
PKM2 retaining substoichiometric amounts of E. coli -derived FBP throughout the puriﬁca-
tion, despite extensive dialysis (Section 3.2.1). Amounts of co-puriﬁed FBP were quantiﬁed
in all puriﬁcations of PKM2 and found that as much as 75 % of the protein was pre-bound to
the ligand (Section 3.2.1). Previous studies have reported co-puriﬁcation of FBP with PKM2,
suggesting a similarly high binding aﬃnity as that reported here22,23,63. Our estimate of the
binding aﬃnity is in approximate agreement with that of Yan et al. (2016)62: KFBPD = 210
nM; and Gavriilidou et al. (2018)63: KFBPD = 910 nM. Neither publication, however, provide
estimates of the amounts of FBP in the starting material of puriﬁed PKM2 and it is therefore
unlikely that these studies account for the eﬀect of ligand co-puriﬁcation on the starting free
protein concentration.
The consequence of tight binding between FBP and PKM2 has been overlooked, thus far,
as it raises questions regarding the biological role of FBP as an allosteric regulator of PKM2.
To this end, intracellular concentrations of FBP were measured under fully-fed and glucose-
deprived culture conditions in three human cancer cell lines (Section 3.5.1). Our ﬁndings re-
vealed that intracellular FBP concentrations far exceeded the concentration of ligand required
to achieve full saturation of PKM2. Consequently, under steady-state growth conditions, a
signiﬁcant fraction of PKM2 is predicted to be bound to FBP, even in the background of other
regulatory stimuli such as post-translational-modiﬁcations, that inﬂuence FBP binding23,82
(Section 3.5.3).
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A protein concentration of 5 µM was used to measure the ﬂuorescence spectrum of PKM2
and thereby monitor FBP binding (Section 3.2.1), which was approximately 240-fold greater
than the calculated FBP binding aﬃnity. Ideally, the concentrations of protein and ligand
used for binding experiments should be in the same range as the measured KD. Owing to the
low quantum yield of tryptophan in intrinsic PKM2 ﬂuorescence measurements, it was neces-
sary to use PKM2 concentrations in the low µM range in order to obtain measurements with
acceptable signal-to-noise ratios. Furthermore, PKM2 is a notoriously ’sticky’ protein with a
tendency to bind to the walls of the tube. While for many of the assays it was possible to
avoid this (use of coated tubes, minimal sample mixing) diluting PKM2 to low concentrations
for ﬂuorescence measurements leads to signiﬁcant loss of protein that makes such conditions
unsuitable.
With these considerations in mind, the question is: can we derive meaningful KD values
from our binding data? Simulations of ligand-receptor binding, and ﬁtting of these data with
the quadratic expression in Equ. 3.4, found that as the free protein concentration increases, the
% error in calculating the KD also increases and reaches 130 - 175 % at protein concentrations
240-fold in excess of the binding aﬃnity (similar to our experimental conditions in measuring
FBP-PKM2 binding). This observation also reﬂects the large experiemental error reported
for the KD of FBP for PKM2 (48 %). Nevertheless, in spite of the large error associated
with this measurement, due to the experimental limitations detailed above, we are still able to
determine a range and an upper limit for the KD values we measure. The upper-limit of the
FBP-PKM2 binding aﬃnity, taking into account the theoretical percentage error, corresponds
to 58 nM. Importantly, this upper limit is between 500- and 4000-fold lower that the measured
intracellular concentration of FBP and therefore our assertion that PKM2 is saturated remains
valid. This assertion is further supported by the persistence of FBP binding to puriﬁed PKM2
despite extensive dialysis during the process of puriﬁcation. Furthermore, in addition to FBP
binding to PKM2, we also determined the AC95, which indicates the concentration of FBP
that results in 95 % PKM2 activation, which we show is 529 nM i.e. 610-fold lower than the
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measured intracellular concentration (Section 3.2.3).
The notion that FBP is constitutively bound to PKM2 under a range of extracellular glu-
cose conditions (0 mM - 11 mM) is supported by the ﬁnding that addition of exogenous
FBP had little eﬀect on PKM2 activity assayed in cell lysates, cultured both in fully-fed and
glucose-starved conditions (Section 3.5.2). Moreover, exogenous addition of phenylalanine to
HCT116 cell lysates resulted in a dose-dependent decrease in the kcat (Section 3.5.2), rather
than an increase in the KPEPM observed when puriﬁed recombinant PKM2 activity was assay
upon addition of phenylalanine (Section 3.4.1). While seemly contradictory, Phe inhibition of
recombinant puriﬁed PKM2 in the presence of saturating concentrations of FBP was found
also to reduce the kcat, revealing an alternate mechanism of inhibition by Phe, and possibly
other inhibitory amino acids, in the presence of constitutively bound FBP (Section 3.4.1), fur-
ther supporting the hypothesis that, under the presently tested cell culture conditions, PKM2
is constitutively bound to FBP. Additionally, our results show that competition between ac-
tivating (Ser) and inhibiting (Phe) amino acids determines the rate of product turnover of
PKM2, while constitutive FBP binding maintains the protein in a high-substrate aﬃnity state
(Section 3.4.1).
Other amino acids L-alanine (Ala), L-tryptophan (Trp) and L-cysteine (Cys) have previous
been shown to inhibit PKM2 activity per se in the same way as Phe20. Therefore, com-
petition between activating and inhibitory amino acids may provide a potent mechanism of
feed-forward activation and feed-back inhibition of FBP-bound PKM2 activity (Fig. 7.1).
Under conditions of high PKM2 activity, glucose-derived phosphoenolpyruvate is rapidly con-
verted to pyruvate, expanding the intracellular pool size of pyruvate. Excess pyruvate can
then be consumed by a number of reactions including reduction by lactate dehydrogenase
to form lactate, or oxidation by pyruvate dehydrogenase to form acetyl-CoA. Alternatively
pyruvate can be used as a substrate by one of the alanine aminotransferase enzymes. Alanine
aminotransferase 1 (GPT)-catalysed transamination between pyruvate and glutamate forms
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α-ketoglutarate and alanine (Fig. 7.1). Accumulation of the alanine pool would feed-back
inhibit FBP-bound PKM2 (PKM2FBP ), likely by the same hyperbolic-mixed mechanism ob-
served for phenylalanine. Sustained allosteric inhibition of PKM2FBP would result in the accu-
mulation of glycolytic intermediates, leading to utilisation of 3-phosphoglycerate for de novo
serine biosynthesis. Subsequent accumulation of serine would feed-forward activate PKM2
(Fig. 7.1), as shown by Chaneton et al. (2012)19. The ﬁndings presented herein, which
support the idea that PKM2 is constitutively saturated with the activator FBP, suggest that
serine-induced activation does not act to increase the substrate aﬃnity of PKM2. Rather, high
concentrations of serine, relative to the concentrations of alanine and other inhibitory amino
acids, would act to out-compete the inhibitory amino acids from the amino acid binding pocket
on PKM2, thereby alleviating the negative eﬀect on the kcat. Given that Phe, Ser, Ala, His and
Trp bind to a common allosteric pocket20, it is likely that their relative, rather than absolute,
concentrations determine the activity of FBP-bound PKM2 (Fig. 7.1). Whether intracellular
ﬂux through lower glycolysis is determined by the ratio between activating-to-inhibiting amino
acid ligands is beyond the scope of this thesis, and warrants further investigation.
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Figure 7.1: Proposed model of PKM2 regulation by amino acids. Work presented herein
suggests that FBP is constitutively bound to PKM2, thereby locking the enzyme in a high-substrate
affinity state. PKM2 enzyme activity can subsequently be regulated by activating and inhibitory amino
acids which collectively compete for a single binding site. Therefore, high concentrations of inhibitory
amino acids relative to activating amino acids, would act to reduce the rate of product turnover through
a hyperbolic-mixed allosteric mechanism. Conversely, high concentrations of activating amino acids,
relative to the pool size of inhibitory amino acids, would result in a high kcat by alleviating the effect
of inhibitory amino acids.
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7.2 FBP and Phe regulate PKM2 through a functional cross-
talk
The proposed model of PKM2 regulation outlined in Section 7.1 is supported by the ﬁnding
that, while FBP and Phe bind to spatially distinct pockets on PKM2, both ligands inﬂuence
the mode of action of the other without reciprocal eﬀects on their binding aﬃnities. The
ability of Phe to perturb FBP-induced activation, suggests a functional cross-talk between
the allosteric mechanisms of FBP and Phe. Previous studies have suggested that PKM2 en-
zyme activity is correlated with oligomerisation17,20,22,59,63,64,70,168. Therefore, to explore
whether the combined eﬀects of concurrent FBP and Phe regulation could be explained by
changes to the oligomeric state of the protein, native mass spectrometry (MS) was used as
a means to study the oligomeric structure and dynamics of PKM2 in the gas phase (Chapter 4).
Native spectra of PKM2 revealed that the protein adopts a mixed population of monomers,
dimers and tetramers (Section 4.2.1). FBP addition was found to promote tetramerisation
(Section 4.2.3), in agreement with a recent native MS study63. An integrative approach using
ion-mobility MS and in vacuo MD simulations found that the dimers in the native spectra
were formed stably about the A-A’ interface (Section 4.2.2), which implies that FBP binding
induces dimer-dimer association about the C-C’ interface. This is supported by a previous
study showing that a G415R mutation prevents tetramerisation about the C-C’ interface and
is thereby insensitive to FBP-induced activation62. In contrast, Phe addition had the eﬀect of
preferentially stabilising the dimeric species of PKM2 (Section 4.3.1). Our results thus support
the concept that FBP-induced activation stabilises the tetrameric species, while Phe-induced
inhibition promotes dimeric PKM2.
The ﬁnding herein that Phe binding per se destabilises tetramers is in agreement with previous
studies70,168, and contests the ﬁndings of two recent reports suggesting that Phe, and several
other amino acids, promote the formation of an inactive tense T-state tetramer20,22. Critically,
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our observation that concurrent addition of Phe and FBP synergistically promotes the for-
mation of tetramers (Section 4.3.2) raises the possibility that Phe-induced stabilisation of the
inactive tetramer reported by Morgan et al. (2013)22 and Yuan et al. (2018)20 is confounded
by the presence of residually co-puriﬁed FBP. Indeed Morgan et al. (2013)22 generated a mu-
tant variant R489A in order to "[abolish] FBP binding and [prevent] contamination by FBP,
which is commonly bound during puriﬁcation of the protein from Escherichia coli culture."
Nevertheless, it is unclear whether partial FBP occupancy is accounted for in these studies,
as the amounts of co-puriﬁed FBP in preparations of recombinant puriﬁed PKM2 are not
reported. It is notable, therefore, that Morgan et al. (2013)22 chose to test oligomerisation
upon Phe addition with PKM2(WT) (partially FBP-bound) rather than with PKM2(R489A)
(fully apo). Based on the ﬁndings presented herein, one might speculate that the stabilisation
of PKM2 tetramers by Phe observed by Morgan et al. (2013)22 and Yuan et al. (2018)20
could be attributed to signiﬁcant amounts of residually co-puriﬁed FBP from E. coli, which
we found to be as high as 78 % of the concentration of puriﬁed PKM2 (Section 3.2.1).
In addition to allosteric eﬀects on PKM2 oligomerisation, several studies have invoked inter-
domain structural changes consequent to ligand binding20,22,55,62,77. To this end, ion mobil-
ity coupled to native mass spectrometry (IM-MS) measurements were used to compute the
rotationally-averaged collision cross section (DTCCSHe) of PKM2 as a measure of the confor-
mational heterogeneity of the protein. FBP binding resulted in a subtle shift in the DTCCSHe
distribution, favouring a more extended form of the protein (Section 4.2.5). This was par-
tially reversed by the simultaneous addition of both FBP and Phe, favouring a more apo-like
DTCCSHe distribution (Section 4.3.4). The apparent ligand-induced changes in PKM2 ion
mobility may indicate a conformational shift between the T-state (tense) and the R-state (re-
laxed) tetramer, as described previously by Morgan et al. (2013)22 and Yuan et al. (2018)20.
Although informative, it is diﬃcult to relate changes in ion mobility with speciﬁc structural
events. Therefore, to study the process of ligand-induced structural rearrangement, we turned
to an in silico thermodynamic model of PKM2 (Chapter 5).
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MD simulations of tetrameric PKM2 found that allosteric activators FBP and Ser induced a
closure of the B-domain cap over the active site pocket, whereas simulations of PKM2FBP+Phe
and PKM2Apo tetramers revealed an opening of the B-domain cap (Section 5.2.5). The concept
of PKM2 ligand-dependent B-domain cap dynamics is supported by high B-factors calculated
fro atoms in the B-domain of a crystal structure previously published by Dombrauckas et
al. (2005)55. This hypothesis is supported by molecular dynamics simulations published by
Gehrig et al. (2017)77 and by Naithani et al. (2015)74, both describing an FBP-induced
closure of the B-domain. Nevertheless, high-resolution evidence of the simulated phenomena
remains elusive. Small-angle X-ray scattering measurements of PKM2 tetramers by Yan et al.
(2016)62 observed a small decrease in the radius of gyration upon addition of FBP from 43 Åto
41 Å. The authors attributed no signiﬁcance to the observed FBP-induced change, stating that
"binding of FBP did not signiﬁcantly alter the Rg of PKM2(WT)"62. In retrospect, however,
it is tempting to speculate that this small change in the Rg may reﬂect the B-domain cap
closure in the T- to R-state tetramer transition. This could be addressed experimentally us-
ing methyl-TROSY (transverse relaxation optimised spectroscopy) NMR spectroscopy, which
enables the study of the conformational dynamics of large biomolecular systems179.
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7.3 AlloHubMat reveals residues that mediate the cross-talk
between FBP- and Phe-induced allosteric regulation
To identify residues that mediate allosteric regulation of PKM2, the conformational dynam-
ics of PKM2 tetramers upon FBP addition were analysed using molecular dynamics simu-
lations of PKM2apo and PKM2FBP tetramers. Building on a previous approach by Pandini
et al. (2012)123, the mutual information between sampled conformational states from MD
trajectories encoded in a coarse-grained representation within the framework of the M32K25
structural alphabet125. Proteins have been shown both experimentally117,180,181 and compu-
tationally147,182 to sample distinct conformational sub-states. This sampling of phase space
is relevant for allosteric regulation of enzyme activity87,183–185, leading to the prevailing view
that protein dynamics and allosteric regulation are ensemble phenomena86. Therefore, explic-
itly identifying allosteric signals that are representative of the ensemble of protein sub-states is
critical. To this end, a novel computational framework, named AlloHubMat (Allosteric Hub
prediction using Matrices that capture allosteric coupling) was developed to predict allosteric
hub fragments from the network of dynamic correlated motions, based on explicitly identiﬁed
conformational sub-states from multiple MD trajectories and obtain an ensemble-averaged
mutual information network (Section 5.3).
At its core, AlloHubMat uses the M32K25 structural alphabet (SA) as a low-dimensional
representation of the torsional space accessible to proteins125. Each fragment in the alphabet
contains two angles and a torsion angle, and is partitioned into 25 states forming a discrete-
state model of protein structure. Previous SAs have used a similar fragment-based representa-
tion in the form of a set of Cartesian coordinates (MSM2000)186, or a vectorial description of
consecutive Cα atoms (CGT2004)187. The M32K25 SA has the advantage, compared to other
SAs, of being derived from a density-based approach188, so that the most dominant conforma-
tions are highly populated with multiple states125. Therefore, even relatively subtle changes in
the protein backbone are captured by changes between states within the M32K25 model. Allo-
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HubMat overcomes limitations of previous approaches120,123 that do not account for how distal
correlated motions may change in direction and magnitude as the protein samples distinct sub-
states over the course of an MD simulation, and predicts networks of allosteric residues from
MD simulations using a consistent numerical framework to measure time-dependent correlated
motions. The approach used by AlloHubMat facilitates the extraction of consensus allosteric
networks from replicate MD simulations of a protein in a given liganded state, and the com-
parison of the consensus networks between simulations of diﬀerent liganded states.
Analysis of MD simulations of tetrameric PKM2 with AlloMatHub identiﬁed a number of
candidate fragments as allosteric hub fragments (AlloHubFrags; Section 5.3.3). Starting from
a selection of allosteric hub fragments (AlloHubFrags), single-point mutant variants (Fig. 7.2
A) were designed and tested for their enzymatic response to FBP binding. Mutagenesis of
several of the hubs (I124G, F244V, K305Q, F307P and R489L) disrupted FBP-induced ac-
tivation (Section 6.3.1), demonstrating the utility of AlloHubMat for identifying bona fide
mediators of allostery. Of the ﬁve mutants that abrogated allosteric activation of PKM2,
three mutants (F244V, F307P and R489L) disrupted the process of oligomerisation (Section
6.3.3), suggesting that these AlloHubs mediate the FBP-induced monomer/dimer to tetramer
transition (Fig. 7.2 B). Conversely, AlloHubMuts I124G and K305Q maintained the ability
to tetramerise upon FBP addition (Section 6.3.3), though their allosteric activation was per-
turbed (Section 6.3.1). Additional mutants of residues A327 and C358 preserved the allosteric
coupling between FBP binding and enzyme activation, though prevented the inhibitory eﬀect
of Phe on PKM2FBP activity (Fig. 7.2 B; Section 6.3.1). The ﬁnding that A327S and C358A
maintained wild type-like FBP activation but perturbed Phe inhibition indicated a role for
these two residues in mediating a cross-talk between the allosteric mechanisms of Phe and
FBP, which enables the inhibitory amino acid to inhibit the eﬀect of FBP. C358 has been
previously identiﬁed as an oxidation substrate of reactive oxygen species, whereby PKM2 can
be post-translationally modiﬁed resulting in enzyme inhibition40. None of the AlloHubMuts
fell within residues 389-429 that diﬀer between PKM2 (allosterically regulated) and the consti-
224
J.A.S MACPHERSON CHAPTER 7
tutively active splice-isoform (PKM1), suggesting that residues that confer diﬀerences in the
allosteric properties of the two isoforms are dispersed throughout the protein structure. Zhong
et al. (2017)66 recently reported a synergistic mechanism whereby adenosine monophosphate
(AMP) and glucose-6-phosphate (G6P) activate M. tuberculosis pyruvate kinase. AMP binds
to the equivalent of the FBP binding pocket, whereas G6P binds to a diﬀerent pocket that
is also distinct from the equivalent of the amino acid binding pocket on human PKM2. The
synergistic mechanism between G6P and AMP is somewhat similar to the one described be-
tween FBP and Phe, here. Therefore, it is tempting to speculate that allosteric synergism
upon concurrent binding of diﬀerent ligands is a common mechanism of enzyme regulation.
Evidence presented in Chaters 5 and 6 suggests that AlloHubMat is able to identify residues
involved in the allosteric mechanism of an enzyme. Nevertheless, a recent large-scale alanine
scanning mutagenesis study of liver pyruvate kinase (PKL) approximated that more than 30
% of the protein residues are involved in its allosteric regulation76. Consequently, it can be
argued that a statistical validation of AlloHubMat should focus on measuring the eﬀect of
mutating non-hub residues as negative controls for assessing the precision of the method. A
comprehensive validation of the method was beyond the scope of this Thesis. Moreover, the
mechanism enzyme regulation is likely case-dependent; for some proteins conﬁgurational en-
tropy is the main driver of allostery110,111,173–175, and for others enthapic motions dominate
the allosteric transition113,167,179,189–191. This reasoning would conclude that a case-by-case
validation of methods to predict allosteric regulation is required, which largely defeats the pur-
pose of a predictive computational method. Moreover, high-throughput analyses of protein
allostery using site-directed mutagenesis is compounded by the challenging task of purifying
a very large number of mutant variants and investigating whether the introduced chemical
perturbations abrogate coupling between distal sites, oligomerisation, or both. To this end,
proteome-wide curation of data resulting from the experimental characterisation of enzyme
mutants would address the outstanding challenge of benchmarking AlloHubMut and other
computational methods for predicting allosteric hubs.
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The spatial resolution of AlloHubMat is currently limited to fragments of four successive Cα
atoms. In Chapter 5, single-point mutants were designed from four-residue candidate hubs,
based on an empirical analysis of the per-residue conservation within the identiﬁed hubs. In
addition to identifying hub fragments, it would be desirable to explicitly identify the residue(s)
within a hub fragment that contribute most to ochestrating the allosteric mechanism. Given
that neighbouring fragments were found to be correlated, it was not possible to derive the per-
residue mutual information using the chain rule for mutual information (Section 5.3.3). Future
developments could improve the resolution of AlloHubMat by incorporating other sequence-
based192,193 and statistical mechanical194–196 methods, to build a combined predictive score.
Sequence-based methods to measure residue co-evolution of distal residues197 have been highly
successful in predicting allosteric pathways in a number of cases198,199, and would add chem-
ical and evolutionary information that is lost in our coarse-grained approximation of protein
dynamics.
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Figure 7.2: The location and function of the AlloHubMuts. (A) A structural schematic of
PKM2 showing the location the seven AlloHub mutations (AlloHubMuts) on the protomer. The FBP
molecule is shown in green and the locations of the amino acid binding pocket and the active site are
annotated. (B) FBP-induced tetramerisation is propagated by a network of residues involving F244,
F307 and R489. An apo T-state tetramer is populated in the ensemble of available states, to which
FBP can bind, inducing a transition to the R-state tetramer. This T-state to R-state transition is
accompanied by subtle conformational changes, likely involving the closure of the B-domain cap over
the active-site pocket, which is correlated with an increased substrate binding affinity. The R- to T-state
transition is mediated by I124 and K305, and mutations at these positions perturb the formation of a
high substrate-affinity R-state tetramer.
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7.4 Conclusion
Allosteric regulation of PKM2 by FBP has long been viewed as a prototypical example of feed-
forward regulation in biology, though the molecular mechanism of FBP activation remained
largely elusive. PKM2 is additionally regulated by a plethora of endogenous ligands including
several amino acids. It has been unclear, thus far, how PKM2 integrates the signals elicited by
concurrently bound ligands, and the functional consequences of multi-ligand binding. To this
end, the allosteric mechanism of PKM2 was investigated using an integrative computational
and experimental approach.
Estimations of the fraction of intracellular PKM2 bound to its ligands found that that FBP
concentrations far exceed that, which is required for full saturation of PKM2. Under steady-
state growth conditions, a signiﬁcant fraction of PKM2 is already bound to the activator FBP,
even in the context of other regulatory cues, such as PTMs, that may inﬂuence ligand bind-
ing. Constitutive PKM2-FBP binding implicated FBP as an ’allosteric co-factor’, rather than
a reversible activator of PKM2 catalysis, raising questions regarding how PKM2 activity is
regulated in the context of saturating FBP. Subsequent to FBP binding, amino acids Phe and
Ser were found to reversibly modulate the maximal velocity of FBP-bound PKM2, suggesting
an important role of amino acid regulation in lower glycolysis.
Simultaneous Phe and FBP binding was found to synergistically promote PKM2 tetrameri-
sation, despite the two ligands revealing opposing eﬀects on oligomerisation per se, revealing
a functional cross-talk. To unravel the atomic basis by which allosteric coupling between
distal sites is propagated within a protein, a novel computational method AlloHubMat was
developed. Analysis of molecular dynamics simulations using AlloHubMat, and extensive
experimental characterisation of candidate mutant variants, found that the process of FBP-
induced activation is propagated by a network of residues involving I124, F244, K305, F307
and R489. Moreover, mutations of A327 and C358 were found to perturb the eﬀect of Phe on
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FBP-induced activation, thus revealing molecular details of the FBP-Phe cross-talk.
In summary, results herein reveal that PKM2 integrates multiple allosteric inputs to regu-
late enzyme activity. This phenomenon is analogous to multiple-input-single-output (MISO)
controllers in control system engineering, which integrate multiple transmission signals (al-
losteric ligands) and relay a single signal to a receiver (enzyme activity). Beyond PKM2, it is
likely that many more proteins in the cell possess the ability to bind to multiple regulatory
ligands. Though whether a systems-control mechanism of integrating the inputs from multiple
ligands is a general property of such proteins is unknown. Identifying allosteric hubs using
AlloHubMat to design mutants that perturb the allosteric response of proteins to individual,
or multiple, ligands presents a powerful toolbox for the study of both the mechanistic basis of
allosteric signal integration as well as the functional consequences of combinatorial allosteric
inputs on enzyme regulation.
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